{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.14.10-dev",
    "document_metadata": {
      "name": "Angiogenesis-2.0-Hs",
      "authors": "Causal Biological Networks Database",
      "licenses": "\t        Please cite:\t\t        - www.causalbionet.com\t        - https://bionet.sbvimprover.com\t\t        as well as any relevant publications.\t\t        The sbv IMPROVER project, the website and the Symposia are part of a collaborative project\t        designed to enable scientists to learn about and contribute to the development of a new crowd\t        sourcing method for verification of scientific data and results. The current challenges, website\t        and biological network models were developed and are maintained as part of a collaboration among\t        Selventa, OrangeBus and ADS. The project is led and funded by Philip Morris International. For more\t        information on the focus of Philip Morris Internationalâ€™s research, please visit www.pmi.com.\t        ",
      "version": "2.0",
      "contact": "CausalBiologicalNetworks.RD@pmi.com",
      "description": "The Angiogenesis network depicts the causal mechanisms that lead to the angiogenic processes of migration, proliferation and vascular permeability downstream of growth factor signaling (PDGF, TGF, IGF, FGF, VEGF, and angiopoietin), as well as key angiogenic processes of sprouting and tubulogenesis including the DLL4-NOTCH pathway. The model also contains causal mechanisms involved in the regulation of HIF1A transcriptional activity leading to angiogenesis."
    },
    "namespace_url": {},
    "namespace_pattern": {
      "chebi": ".*",
      "mesh": ".*",
      "mgi": ".*",
      "fplx": ".*",
      "go": ".*",
      "hgnc": ".*"
    },
    "annotation_url": {},
    "annotation_pattern": {
      "cl": ".*"
    },
    "annotation_list": {}
  },
  "nodes": [
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "sphingosine 1-phosphate",
        "identifier": "37550"
      },
      "id": "135c81ea84a5448b96ccc52371d2c009",
      "bel": "a(chebi:37550 ! \"sphingosine 1-phosphate\")"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "angiotensin II",
        "identifier": "48432"
      },
      "id": "e2510a6a6ea7cb236f1522e9e2fd0db6",
      "bel": "a(chebi:48432 ! \"angiotensin II\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "angiogenesis",
        "identifier": "0001525"
      },
      "id": "8c58085552d8caa54eb5a69d941b1e24",
      "bel": "bp(go:0001525 ! angiogenesis)"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "blood vessel development",
        "identifier": "0001568"
      },
      "id": "b022e0ead4b9801c606e3e0dc4054156",
      "bel": "bp(go:0001568 ! \"blood vessel development\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "cell migration",
        "identifier": "0016477"
      },
      "id": "6128f883ff0ce964740dcfac3415e7a2",
      "bel": "bp(go:0016477 ! \"cell migration\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "regulation of vascular permeability",
        "identifier": "0043114"
      },
      "id": "eeaf72dacdd459db452e2e6700d8ee86",
      "bel": "bp(go:0043114 ! \"regulation of vascular permeability\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "mesh",
        "name": "Apoptosis",
        "identifier": "D017209"
      },
      "id": "a92f13ced8b2e7f516c1e9e475e8a14e",
      "bel": "bp(mesh:D017209 ! Apoptosis)"
    },
    {
      "function": "Complex",
      "concept": {
        "namespace": "fplx",
        "name": "PI3K",
        "identifier": "PI3K"
      },
      "id": "2de818cb7bd5f3eacdbb22c78861bdd8",
      "bel": "complex(fplx:PI3K ! PI3K)"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "CTBP1",
            "identifier": "2494"
          },
          "id": "695225ce96e56c0498e14d27ed96e18d",
          "bel": "p(hgnc:2494 ! CTBP1)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "ETV6",
            "identifier": "3495"
          },
          "id": "68882ea2e02430926f939dbef0e1cc01",
          "bel": "p(hgnc:3495 ! ETV6)"
        }
      ],
      "id": "b3a38a8c2ee75ed0cb9dfb6cc8f6107f",
      "bel": "complex(p(hgnc:2494 ! CTBP1), p(hgnc:3495 ! ETV6))"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "KLHL20",
            "identifier": "25056"
          },
          "id": "8c4bfe36363b0d5e2b9a4bb8010716a5",
          "bel": "p(hgnc:25056 ! KLHL20)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "ECT2",
            "identifier": "3155"
          },
          "id": "d282d0d4530344158b14b29ed6486918",
          "bel": "p(hgnc:3155 ! ECT2)"
        }
      ],
      "id": "c7e80a42a6172e61717222afb2edf087",
      "bel": "complex(p(hgnc:25056 ! KLHL20), p(hgnc:3155 ! ECT2))"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "ITGA2",
            "identifier": "6137"
          },
          "id": "03d0e09962d31864d291d6f37fc9469e",
          "bel": "p(hgnc:6137 ! ITGA2)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "ITGB1",
            "identifier": "6153"
          },
          "id": "205f17e81451031805037b86f4295763",
          "bel": "p(hgnc:6153 ! ITGB1)"
        }
      ],
      "id": "4e448cee60f9fd1adebb7152419f5501",
      "bel": "complex(p(hgnc:6137 ! ITGA2), p(hgnc:6153 ! ITGB1))"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "ITGA6",
            "identifier": "6142"
          },
          "id": "d104c287efc93d973e34a8bdbdd305f0",
          "bel": "p(hgnc:6142 ! ITGA6)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "ITGB1",
            "identifier": "6153"
          },
          "id": "205f17e81451031805037b86f4295763",
          "bel": "p(hgnc:6153 ! ITGB1)"
        }
      ],
      "id": "5697fa262e3e30b221212f061bf3177e",
      "bel": "complex(p(hgnc:6142 ! ITGA6), p(hgnc:6153 ! ITGB1))"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "ITGAV",
            "identifier": "6150"
          },
          "id": "6990c458423689ae3596979592bf444d",
          "bel": "p(hgnc:6150 ! ITGAV)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "ITGB3",
            "identifier": "6156"
          },
          "id": "625abead240b698a82ddd715b0bede45",
          "bel": "p(hgnc:6156 ! ITGB3)"
        }
      ],
      "id": "4b20a36ac9514114fc3c0a6d1309ebe9",
      "bel": "complex(p(hgnc:6150 ! ITGAV), p(hgnc:6156 ! ITGB3))"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "PDGFA",
            "identifier": "8799"
          },
          "id": "aa494a1240c61645cad1581cbc7788b2",
          "bel": "p(hgnc:8799 ! PDGFA)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "PDGFA",
            "identifier": "8799"
          },
          "id": "aa494a1240c61645cad1581cbc7788b2",
          "bel": "p(hgnc:8799 ! PDGFA)"
        }
      ],
      "id": "895a74a78ee41a24c42234d81b2709bd",
      "bel": "complex(p(hgnc:8799 ! PDGFA), p(hgnc:8799 ! PDGFA))"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "PDGFA",
            "identifier": "8799"
          },
          "id": "aa494a1240c61645cad1581cbc7788b2",
          "bel": "p(hgnc:8799 ! PDGFA)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "PDGFB",
            "identifier": "8800"
          },
          "id": "4b690f3e9133cbd49f517d04eccfac50",
          "bel": "p(hgnc:8800 ! PDGFB)"
        }
      ],
      "id": "f17d069b68808945659d012bab03ba89",
      "bel": "complex(p(hgnc:8799 ! PDGFA), p(hgnc:8800 ! PDGFB))"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "PDGFB",
            "identifier": "8800"
          },
          "id": "4b690f3e9133cbd49f517d04eccfac50",
          "bel": "p(hgnc:8800 ! PDGFB)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "PDGFB",
            "identifier": "8800"
          },
          "id": "4b690f3e9133cbd49f517d04eccfac50",
          "bel": "p(hgnc:8800 ! PDGFB)"
        }
      ],
      "id": "e481cdb33879675a6f2ae7f020257f67",
      "bel": "complex(p(hgnc:8800 ! PDGFB), p(hgnc:8800 ! PDGFB))"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "PDGFC",
            "identifier": "8801"
          },
          "id": "4ad3f83b08a9afba8fe4357adbb93610",
          "bel": "p(hgnc:8801 ! PDGFC)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "PDGFC",
            "identifier": "8801"
          },
          "id": "4ad3f83b08a9afba8fe4357adbb93610",
          "bel": "p(hgnc:8801 ! PDGFC)"
        }
      ],
      "id": "ebf505c19d72bbc55948bb798edf4de6",
      "bel": "complex(p(hgnc:8801 ! PDGFC), p(hgnc:8801 ! PDGFC))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "PI3K_p110",
        "identifier": "PI3K_p110"
      },
      "id": "8b79e969188c2874eba3fa100a633e65",
      "bel": "p(fplx:\"PI3K_p110\" ! \"PI3K_p110\")"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "AKT",
        "identifier": "AKT"
      },
      "id": "c89a87549439c8dc34a13d9082b33a57",
      "bel": "p(fplx:AKT ! AKT)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "FGF",
        "identifier": "FGF"
      },
      "id": "8eaf133300c0f42f2978043ee767a136",
      "bel": "p(fplx:FGF ! FGF)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "FGFR",
        "identifier": "FGFR"
      },
      "id": "a0618a8f570a2bb3ef7b9b6ecba33cb9",
      "bel": "p(fplx:FGFR ! FGFR)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "Notch",
        "identifier": "Notch"
      },
      "id": "0aa81e1dd978c7ab474caab6d8455241",
      "bel": "p(fplx:Notch ! Notch)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "PDGF",
        "identifier": "PDGF"
      },
      "id": "1332d29585c4e74986d1f8a79c992f6f",
      "bel": "p(fplx:PDGF ! PDGF)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "PDGFR",
        "identifier": "PDGFR"
      },
      "id": "ceabc5eb3548a94aa4fb0deec30e440b",
      "bel": "p(fplx:PDGFR ! PDGFR)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "PKC",
        "identifier": "PKC"
      },
      "id": "5bd82f8dca4f5ec860178491eafd427c",
      "bel": "p(fplx:PKC ! PKC)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "TGFB",
        "identifier": "TGFB"
      },
      "id": "2ea3a352aefaf597fbda8a8606b415ff",
      "bel": "p(fplx:TGFB ! TGFB)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "p38",
        "identifier": "p38"
      },
      "id": "16819634e2bac5ec6d922818bf87ef22",
      "bel": "p(fplx:p38 ! p38)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BCL6B",
        "identifier": "1002"
      },
      "id": "78b03d12bc41e4ecff069b7d03ff395f",
      "bel": "p(hgnc:1002 ! BCL6B)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ROCK1",
        "identifier": "10251"
      },
      "id": "964fb60c30fded2508c5e200af812c7d",
      "bel": "p(hgnc:10251 ! ROCK1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ROCK2",
        "identifier": "10252"
      },
      "id": "28e581cc4cf2f839ffa03b0135ec72d1",
      "bel": "p(hgnc:10252 ! ROCK2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BDKRB1",
        "identifier": "1029"
      },
      "id": "857f9993bd20203c2ad5d4755de5c153",
      "bel": "p(hgnc:1029 ! BDKRB1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BDKRB2",
        "identifier": "1030"
      },
      "id": "fee2e8df2656e49cd7460bbcbc0ff00a",
      "bel": "p(hgnc:1030 ! BDKRB2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "S100A11",
        "identifier": "10488"
      },
      "id": "a56cde67e4509382bfe4cad920125f56",
      "bel": "p(hgnc:10488 ! S100A11)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CXCL12",
        "identifier": "10672"
      },
      "id": "d10a14f6842cb2804b69e74540bd8c94",
      "bel": "p(hgnc:10672 ! CXCL12)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SEMA3E",
        "identifier": "10727"
      },
      "id": "d787f20c69ae830466237a39f645f259",
      "bel": "p(hgnc:10727 ! SEMA3E)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SHC1",
        "identifier": "10840"
      },
      "id": "f7cc889a0c9912b775b1dfc04366054a",
      "bel": "p(hgnc:10840 ! SHC1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SHH",
        "identifier": "10848"
      },
      "id": "96482b11bb4f6df08aecc52dd6b4b43a",
      "bel": "p(hgnc:10848 ! SHH)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SLIT2",
        "identifier": "11086"
      },
      "id": "3a4825ebf0ab54186c1e050e93ba302d",
      "bel": "p(hgnc:11086 ! SLIT2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SRC",
        "identifier": "11283"
      },
      "id": "bfb8457bb7e17304088e9a033df759aa",
      "bel": "p(hgnc:11283 ! SRC)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TEK",
        "identifier": "11724"
      },
      "id": "03a7bc08153e704693a118617b8e5a51",
      "bel": "p(hgnc:11724 ! TEK)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TGFA",
        "identifier": "11765"
      },
      "id": "3acfa96015dcb23855abac455f0a6355",
      "bel": "p(hgnc:11765 ! TGFA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TGFB1",
        "identifier": "11766"
      },
      "id": "576a88bfbb29664cc1307c6239712c90",
      "bel": "p(hgnc:11766 ! TGFB1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TGFB2",
        "identifier": "11768"
      },
      "id": "3f3b74f13f88d5a10bb394c1c82c3bb8",
      "bel": "p(hgnc:11768 ! TGFB2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TGFBR1",
        "identifier": "11772"
      },
      "id": "6cbcf911f2657f94fd0d724a01f99d50",
      "bel": "p(hgnc:11772 ! TGFBR1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TGFBR2",
        "identifier": "11773"
      },
      "id": "8b36b060e7a955c3b509c18bee64a5e6",
      "bel": "p(hgnc:11773 ! TGFBR2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TIE1",
        "identifier": "11809"
      },
      "id": "affe8d1e50f1c64f7d183b6bf3bff435",
      "bel": "p(hgnc:11809 ! TIE1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TIMP2",
        "identifier": "11821"
      },
      "id": "fe087bed95da6428bdff0ba723c4d4c4",
      "bel": "p(hgnc:11821 ! TIMP2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TNXB",
        "identifier": "11976"
      },
      "id": "269910520f701e3d9059f6ac694f7547",
      "bel": "p(hgnc:11976 ! TNXB)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "EGLN1",
        "identifier": "1232"
      },
      "id": "5c4ecac813f746436cc7d068287eb710",
      "bel": "p(hgnc:1232 ! EGLN1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "UNC5B",
        "identifier": "12568"
      },
      "id": "b9b7e40ea7eb6b88f293ce2d13abba7c",
      "bel": "p(hgnc:12568 ! UNC5B)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "VEGFA",
        "identifier": "12680"
      },
      "id": "710d068636280068962cf864d9ed7526",
      "bel": "p(hgnc:12680 ! VEGFA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "VEGFB",
        "identifier": "12681"
      },
      "id": "db796c7e0df5ecf83a6d14d69517d594",
      "bel": "p(hgnc:12681 ! VEGFB)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "VEGFC",
        "identifier": "12682"
      },
      "id": "36961465a71a542c11e2c07289d99dc8",
      "bel": "p(hgnc:12682 ! VEGFC)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "VHL",
        "identifier": "12687"
      },
      "id": "f570e94d2633821333904f4882e0390c",
      "bel": "p(hgnc:12687 ! VHL)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "VTN",
        "identifier": "12724"
      },
      "id": "93f1aaa242ffb009d8917bfce74e6302",
      "bel": "p(hgnc:12724 ! VTN)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "EGLN2",
        "identifier": "14660"
      },
      "id": "81d5a3d02140b48b974ab19a20f2ee33",
      "bel": "p(hgnc:14660 ! EGLN2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "EGLN3",
        "identifier": "14661"
      },
      "id": "fcc1ccc6c337f312df9cf04ed1e76343",
      "bel": "p(hgnc:14661 ! EGLN3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NIN",
        "identifier": "14906"
      },
      "id": "c0454cc41c8059bc7db087c705ed4529",
      "bel": "p(hgnc:14906 ! NIN)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SIRT1",
        "identifier": "14929"
      },
      "id": "ee235c4b7fcc97b9f15cd3eb36039f18",
      "bel": "p(hgnc:14929 ! SIRT1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "KRIT1",
        "identifier": "1573"
      },
      "id": "f3d33e05f3c7528cc5a03c06ca9dc788",
      "bel": "p(hgnc:1573 ! KRIT1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "HIF1AN",
        "identifier": "17113"
      },
      "id": "ab801b5e62e5942d1d77d9157c0fe687",
      "bel": "p(hgnc:17113 ! HIF1AN)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ACVRL1",
        "identifier": "175"
      },
      "id": "cd7fe2caadabbd326655cf92e5c4a287",
      "bel": "p(hgnc:175 ! ACVRL1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CDH5",
        "identifier": "1764"
      },
      "id": "a9dad911f4cf9270b9769e379b2fa6e8",
      "bel": "p(hgnc:1764 ! CDH5)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ROBO4",
        "identifier": "17985"
      },
      "id": "9786872285b6a7047730ebc329425998",
      "bel": "p(hgnc:17985 ! ROBO4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "EGFL7",
        "identifier": "20594"
      },
      "id": "6d091569bc11f295d2da2152d74608e6",
      "bel": "p(hgnc:20594 ! EGFL7)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SESN2",
        "identifier": "20746"
      },
      "id": "c44106b9611ecfd89c16eb9582022b66",
      "bel": "p(hgnc:20746 ! SESN2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "COL18A1",
        "identifier": "2195"
      },
      "id": "fc173b0ddd18862f6f8d827eacf99655",
      "bel": "p(hgnc:2195 ! COL18A1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CREBBP",
        "identifier": "2348"
      },
      "id": "01de036498e9d2398ec4408f35b2c460",
      "bel": "p(hgnc:2348 ! CREBBP)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ITGB1BP1",
        "identifier": "23927"
      },
      "id": "461c8596f792e613db86eb2ae797493c",
      "bel": "p(hgnc:23927 ! ITGB1BP1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CTBP1",
        "identifier": "2494"
      },
      "id": "695225ce96e56c0498e14d27ed96e18d",
      "bel": "p(hgnc:2494 ! CTBP1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "KLHL20",
        "identifier": "25056"
      },
      "id": "8c4bfe36363b0d5e2b9a4bb8010716a5",
      "bel": "p(hgnc:25056 ! KLHL20)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CUL2",
        "identifier": "2552"
      },
      "id": "05d896b72a49ba7d801b1673d96a7b7a",
      "bel": "p(hgnc:2552 ! CUL2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CXCR4",
        "identifier": "2561"
      },
      "id": "10238c9a86c1e317588bbc279fca4314",
      "bel": "p(hgnc:2561 ! CXCR4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "DLL4",
        "identifier": "2910"
      },
      "id": "24d3afc74dc59d210e302926bf38f0dc",
      "bel": "p(hgnc:2910 ! DLL4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ECT2",
        "identifier": "3155"
      },
      "id": "d282d0d4530344158b14b29ed6486918",
      "bel": "p(hgnc:3155 ! ECT2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "EDN1",
        "identifier": "3176"
      },
      "id": "c1190ee45b1a868b8f931688a6d39ee8",
      "bel": "p(hgnc:3176 ! EDN1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "EFNB2",
        "identifier": "3227"
      },
      "id": "2d7f16b92e7e97a4381b0b57f7aad19e",
      "bel": "p(hgnc:3227 ! EFNB2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "EGFR",
        "identifier": "3236"
      },
      "id": "492cb9f801f6a3e2281a782c674cec7e",
      "bel": "p(hgnc:3236 ! EGFR)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "EIF4E",
        "identifier": "3287"
      },
      "id": "5fcab178119a08da9738e0807423268f",
      "bel": "p(hgnc:3287 ! EIF4E)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ENG",
        "identifier": "3349"
      },
      "id": "948200f36a07b32e5a329b41090df3bc",
      "bel": "p(hgnc:3349 ! ENG)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "AGTR1",
        "identifier": "336"
      },
      "id": "1ce0646ca7c8b1eef0ab59c82b77ce71",
      "bel": "p(hgnc:336 ! AGTR1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "EP300",
        "identifier": "3373"
      },
      "id": "46e575893877dfd1675f60f34eb83ef2",
      "bel": "p(hgnc:3373 ! EP300)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "EPAS1",
        "identifier": "3374"
      },
      "id": "1e724bd8af074b6e905d8cdb850d2afe",
      "bel": "p(hgnc:3374 ! EPAS1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "EPHB4",
        "identifier": "3395"
      },
      "id": "31412f8b4868867efdfc67c259764cc5",
      "bel": "p(hgnc:3395 ! EPHB4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ETV6",
        "identifier": "3495"
      },
      "id": "68882ea2e02430926f939dbef0e1cc01",
      "bel": "p(hgnc:3495 ! ETV6)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "F2",
        "identifier": "3535"
      },
      "id": "0ebac429d2bf305e643f427fe2c1e70d",
      "bel": "p(hgnc:3535 ! F2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FGF1",
        "identifier": "3665"
      },
      "id": "7c4f6209d0bad67bc2fbe8c00ea0afaf",
      "bel": "p(hgnc:3665 ! FGF1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FGF10",
        "identifier": "3666"
      },
      "id": "bb4e82c036b5b14e7b38a8184f97cae8",
      "bel": "p(hgnc:3666 ! FGF10)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FGF16",
        "identifier": "3672"
      },
      "id": "aa89d12311d78592bbc852922687d32b",
      "bel": "p(hgnc:3672 ! FGF16)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FGF18",
        "identifier": "3674"
      },
      "id": "7d98421e5ba5fd19d69e962c3f66397b",
      "bel": "p(hgnc:3674 ! FGF18)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FGF2",
        "identifier": "3676"
      },
      "id": "15956b3e3182f3f4e8bc88068182b9c7",
      "bel": "p(hgnc:3676 ! FGF2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FGF5",
        "identifier": "3683"
      },
      "id": "1666bca3e0eb49ae44d65fdd7bb1f40d",
      "bel": "p(hgnc:3683 ! FGF5)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FGF7",
        "identifier": "3685"
      },
      "id": "787666f9d48ca373485bc75b3336900e",
      "bel": "p(hgnc:3685 ! FGF7)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FGF8",
        "identifier": "3686"
      },
      "id": "38c8e20f7b18c8b204d696d9183603e8",
      "bel": "p(hgnc:3686 ! FGF8)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FGF9",
        "identifier": "3687"
      },
      "id": "09ba0ed6b427c52ac0fc9a4212f29913",
      "bel": "p(hgnc:3687 ! FGF9)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FGFR1",
        "identifier": "3688"
      },
      "id": "473b5d31306a390fe0360a2d152df990",
      "bel": "p(hgnc:3688 ! FGFR1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FGFR2",
        "identifier": "3689"
      },
      "id": "4133652a3a5bc0c2010108467c7c8e38",
      "bel": "p(hgnc:3689 ! FGFR2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FGFR3",
        "identifier": "3690"
      },
      "id": "508e71924a47593badd0a04dfbde0ef0",
      "bel": "p(hgnc:3690 ! FGFR3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FGFR4",
        "identifier": "3691"
      },
      "id": "770a4cde1919d1d4358044c80583772b",
      "bel": "p(hgnc:3691 ! FGFR4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FLT1",
        "identifier": "3763"
      },
      "id": "a1f0743492fac9a2945db486ad9ab7a4",
      "bel": "p(hgnc:3763 ! FLT1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FOXC2",
        "identifier": "3801"
      },
      "id": "31a499e8cedfc15ec2ffcbb8c7965136",
      "bel": "p(hgnc:3801 ! FOXC2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FOXO1",
        "identifier": "3819"
      },
      "id": "1992e5ece9571674b23761d92a8ea7fb",
      "bel": "p(hgnc:3819 ! FOXO1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FOXO3",
        "identifier": "3821"
      },
      "id": "6b1d99779dedc2bbf2d22f64555d0526",
      "bel": "p(hgnc:3821 ! FOXO3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FZD4",
        "identifier": "4042"
      },
      "id": "b0cad9b6290fda7e07c4a4407725b05b",
      "bel": "p(hgnc:4042 ! FZD4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "GDF2",
        "identifier": "4217"
      },
      "id": "17c79c4df8466865b90409a1e93f2a71",
      "bel": "p(hgnc:4217 ! GDF2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ANGPT1",
        "identifier": "484"
      },
      "id": "24932809ba2b7b1c97271d435842d7e6",
      "bel": "p(hgnc:484 ! ANGPT1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ANGPT2",
        "identifier": "485"
      },
      "id": "1e46a1e1b8f63a5b63624892e34c3a26",
      "bel": "p(hgnc:485 ! ANGPT2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "HEY1",
        "identifier": "4880"
      },
      "id": "0a865ad4f1dad7a087c5b58d9fee199f",
      "bel": "p(hgnc:4880 ! HEY1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "HEY2",
        "identifier": "4881"
      },
      "id": "5ed95712a5a0d86f4321c80f9d648091",
      "bel": "p(hgnc:4881 ! HEY2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "HGF",
        "identifier": "4893"
      },
      "id": "6aa4db01d5a5dfad58da465db6af3572",
      "bel": "p(hgnc:4893 ! HGF)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "HIF1A",
        "identifier": "4910"
      },
      "id": "2562b840e72dd3d56dace7723920dd1d",
      "bel": "p(hgnc:4910 ! HIF1A)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TNC",
        "identifier": "5318"
      },
      "id": "99cc958b75cc64a596efb23a6794766d",
      "bel": "p(hgnc:5318 ! TNC)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ANXA2",
        "identifier": "537"
      },
      "id": "6539a74cb82e035261717e4d93917cfe",
      "bel": "p(hgnc:537 ! ANXA2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IGF1",
        "identifier": "5464"
      },
      "id": "4d7442aeba6e8dd1fe329e9d1e57eea0",
      "bel": "p(hgnc:5464 ! IGF1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IGF1R",
        "identifier": "5465"
      },
      "id": "b55ce217b1b1d243cfef99a3306fbc45",
      "bel": "p(hgnc:5465 ! IGF1R)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RBPJ",
        "identifier": "5724"
      },
      "id": "2490c3b495662441b4180cb317a51c6b",
      "bel": "p(hgnc:5724 ! RBPJ)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ITGA2",
        "identifier": "6137"
      },
      "id": "03d0e09962d31864d291d6f37fc9469e",
      "bel": "p(hgnc:6137 ! ITGA2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ITGA6",
        "identifier": "6142"
      },
      "id": "d104c287efc93d973e34a8bdbdd305f0",
      "bel": "p(hgnc:6142 ! ITGA6)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ITGAV",
        "identifier": "6150"
      },
      "id": "6990c458423689ae3596979592bf444d",
      "bel": "p(hgnc:6150 ! ITGAV)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ITGB1",
        "identifier": "6153"
      },
      "id": "205f17e81451031805037b86f4295763",
      "bel": "p(hgnc:6153 ! ITGB1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ITGB3",
        "identifier": "6156"
      },
      "id": "625abead240b698a82ddd715b0bede45",
      "bel": "p(hgnc:6156 ! ITGB3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "JAG1",
        "identifier": "6188"
      },
      "id": "befe0f08829bf42a246eab89db8e0fc8",
      "bel": "p(hgnc:6188 ! JAG1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "KDR",
        "identifier": "6307"
      },
      "id": "04acdd6fe94a9adc2b80c0d3a611cc56",
      "bel": "p(hgnc:6307 ! KDR)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "KLF2",
        "identifier": "6347"
      },
      "id": "1f2d85203f593b41c5bfbc9e73f48cbd",
      "bel": "p(hgnc:6347 ! KLF2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "KNG1",
        "identifier": "6383"
      },
      "id": "ad9ddd57e0b1bc2d9d0101153461f581",
      "bel": "p(hgnc:6383 ! KNG1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "LGALS3",
        "identifier": "6563"
      },
      "id": "fec1ae9dcda07fae900d09f145ddb81a",
      "bel": "p(hgnc:6563 ! LGALS3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RHOA",
        "identifier": "667"
      },
      "id": "7d595d03c52521703630f503febe384c",
      "bel": "p(hgnc:667 ! RHOA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SMAD1",
        "identifier": "6767"
      },
      "id": "258001b6bf53486d2258b94f671f87e0",
      "bel": "p(hgnc:6767 ! SMAD1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SMAD2",
        "identifier": "6768"
      },
      "id": "7377ea2f4514b6fba895dac30dd1b44b",
      "bel": "p(hgnc:6768 ! SMAD2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SMAD3",
        "identifier": "6769"
      },
      "id": "c9faa3eecd12e0a390fd43f2ddfeb5bb",
      "bel": "p(hgnc:6769 ! SMAD3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SMAD4",
        "identifier": "6770"
      },
      "id": "1cce812745466e6df1789e98dbaa9e13",
      "bel": "p(hgnc:6770 ! SMAD4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SMAD5",
        "identifier": "6771"
      },
      "id": "d88a2fbf8dc0828ba30658c6f5815e0d",
      "bel": "p(hgnc:6771 ! SMAD5)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAP2K1",
        "identifier": "6840"
      },
      "id": "1887028bf690a022109acb77071c0cf8",
      "bel": "p(hgnc:6840 ! MAP2K1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAPK1",
        "identifier": "6871"
      },
      "id": "e0c0225b558aed46aa00177aa93224b5",
      "bel": "p(hgnc:6871 ! MAPK1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAPK3",
        "identifier": "6877"
      },
      "id": "6dd741794d73ab1e916725d3d79849b7",
      "bel": "p(hgnc:6877 ! MAPK3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ARNT",
        "identifier": "700"
      },
      "id": "757e0d74101657021ef91e552c5d4ec7",
      "bel": "p(hgnc:700 ! ARNT)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MET",
        "identifier": "7029"
      },
      "id": "ce462c19d4c168710c91918863582c1f",
      "bel": "p(hgnc:7029 ! MET)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MMP14",
        "identifier": "7160"
      },
      "id": "a24b746452133b5505a3fb1556dd1479",
      "bel": "p(hgnc:7160 ! MMP14)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MMP2",
        "identifier": "7166"
      },
      "id": "1c85abe98843efda56d81a58c088ebd5",
      "bel": "p(hgnc:7166 ! MMP2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MMP9",
        "identifier": "7176"
      },
      "id": "f6fc79beb30e63df945575f6f15f77e3",
      "bel": "p(hgnc:7176 ! MMP9)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NCF1",
        "identifier": "7660"
      },
      "id": "867823442c5116039d8b2d5d78b50eef",
      "bel": "p(hgnc:7660 ! NCF1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NOS3",
        "identifier": "7876"
      },
      "id": "f52ea9d9f5f7e8ab99497517eb817168",
      "bel": "p(hgnc:7876 ! NOS3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NOTCH4",
        "identifier": "7884"
      },
      "id": "d7937a2edfd9f2cdc4fd84a5a80448dc",
      "bel": "p(hgnc:7884 ! NOTCH4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NR2F2",
        "identifier": "7976"
      },
      "id": "ebac8245e24f5effd2bdbdb01430257d",
      "bel": "p(hgnc:7976 ! NR2F2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NRP1",
        "identifier": "8004"
      },
      "id": "21b46bda9183328b99dbcdf2c46d738b",
      "bel": "p(hgnc:8004 ! NRP1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "OLR1",
        "identifier": "8133"
      },
      "id": "95da70f31ef4b38cf95891a0da037355",
      "bel": "p(hgnc:8133 ! OLR1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SERPINE1",
        "identifier": "8583"
      },
      "id": "8cfda9a9ba6a4ba16abe74bd3c2c92ce",
      "bel": "p(hgnc:8583 ! SERPINE1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PDGFA",
        "identifier": "8799"
      },
      "id": "aa494a1240c61645cad1581cbc7788b2",
      "bel": "p(hgnc:8799 ! PDGFA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PDGFB",
        "identifier": "8800"
      },
      "id": "4b690f3e9133cbd49f517d04eccfac50",
      "bel": "p(hgnc:8800 ! PDGFB)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PDGFC",
        "identifier": "8801"
      },
      "id": "4ad3f83b08a9afba8fe4357adbb93610",
      "bel": "p(hgnc:8801 ! PDGFC)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PDGFRA",
        "identifier": "8803"
      },
      "id": "8d9db70f1f3a53dda834dd7d21b2b883",
      "bel": "p(hgnc:8803 ! PDGFRA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PDGFRB",
        "identifier": "8804"
      },
      "id": "bea0ff73ec82d823c8e4d313776e69c7",
      "bel": "p(hgnc:8804 ! PDGFRB)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PLCG1",
        "identifier": "9065"
      },
      "id": "3298beb16b7138b5ecf07eff669c9c27",
      "bel": "p(hgnc:9065 ! PLCG1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PLXND1",
        "identifier": "9107"
      },
      "id": "281ce83796cccd01600e5c408b2be411",
      "bel": "p(hgnc:9107 ! PLXND1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PPARA",
        "identifier": "9232"
      },
      "id": "6ec335b16b97c1cffba83bb911ab1da9",
      "bel": "p(hgnc:9232 ! PPARA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PRKAA1",
        "identifier": "9376"
      },
      "id": "7b521443e73daf51cd8cc1f1a558e24f",
      "bel": "p(hgnc:9376 ! PRKAA1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PTGS2",
        "identifier": "9605"
      },
      "id": "a599840205cea50660db6b94062760db",
      "bel": "p(hgnc:9605 ! PTGS2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PTK2",
        "identifier": "9611"
      },
      "id": "1045d07f02ab51325b28218a8804e558",
      "bel": "p(hgnc:9611 ! PTK2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PTN",
        "identifier": "9630"
      },
      "id": "d1f672cc7bfd4bb01c5ca3c955fe3392",
      "bel": "p(hgnc:9630 ! PTN)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PXN",
        "identifier": "9718"
      },
      "id": "0c81072c13c84ac11a44252d85d2dfc5",
      "bel": "p(hgnc:9718 ! PXN)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RAF1",
        "identifier": "9829"
      },
      "id": "faf889e46379ebf3f5cb34b8ad27eb64",
      "bel": "p(hgnc:9829 ! RAF1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RAP1B",
        "identifier": "9857"
      },
      "id": "59e293fcc7f9a5fdd23afccc8fd4e98f",
      "bel": "p(hgnc:9857 ! RAP1B)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RBX1",
        "identifier": "9928"
      },
      "id": "74b9b173fea98ef4a587eec7ae31d443",
      "bel": "p(hgnc:9928 ! RBX1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "mgi",
        "name": "Bcl6b",
        "identifier": "1278332"
      },
      "id": "3be78a93c75b8440b873ba0fe3617294",
      "bel": "p(mgi:1278332 ! Bcl6b)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "mgi",
        "name": "Robo4",
        "identifier": "1921394"
      },
      "id": "b0b9c51cfb5ec41942a9ff1475cd86de",
      "bel": "p(mgi:1921394 ! Robo4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "mgi",
        "name": "Plxnd1",
        "identifier": "2154244"
      },
      "id": "f21de8b1e6897d956d3d1e59e33701b4",
      "bel": "p(mgi:2154244 ! Plxnd1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "mgi",
        "name": "Rbpj",
        "identifier": "96522"
      },
      "id": "6c09e121f8ed353fa50f2e8c334b128d",
      "bel": "p(mgi:96522 ! Rbpj)"
    },
    {
      "function": "Pathology",
      "concept": {
        "namespace": "mesh",
        "name": "Pulmonary Disease, Chronic Obstructive",
        "identifier": "D029424"
      },
      "id": "98cb883d84a9775f973f1e99c68ba3a2",
      "bel": "path(mesh:D029424 ! \"Pulmonary Disease, Chronic Obstructive\")"
    },
    {
      "function": "RNA",
      "concept": {
        "namespace": "hgnc",
        "name": "MIR34A",
        "identifier": "31635"
      },
      "id": "5698beb967f33af81a61f7d7a4d38913",
      "bel": "r(hgnc:31635 ! MIR34A)"
    },
    {
      "function": "RNA",
      "concept": {
        "namespace": "hgnc",
        "name": "PDGFB",
        "identifier": "8800"
      },
      "id": "847307e43c78ccf952931595b76527f9",
      "bel": "r(hgnc:8800 ! PDGFB)"
    }
  ],
  "links": [
    {
      "line": 333,
      "relation": "increases",
      "evidence": "Ang II potently induced a concentration-dependent (maximal, 10(-7) mol/L) and time-dependent increase in vascular permeability factor mRNA expression by human vascular smooth muscle cells that was maximal after 3 hours and diminished by 24 hours. Ang II-induced vascular permeability factor mRNA expression by human vascular smooth muscle cells was inhibited by the specific Ang II receptor antagonist losartan (DuP 753), confirming that this is an Ang II receptor subtype 1-mediated event.",
      "citation": {
        "db": "Other",
        "db_id": "7737726"
      },
      "annotations": {},
      "source": 1,
      "target": 50,
      "key": "d8da2291c6a637ec0eed8648e7ea9aab"
    },
    {
      "line": 333,
      "relation": "increases",
      "evidence": "When different concentrations of AngII were tested in 3-h stimulation periods, the percentage of increase in the levels of released VPF/VEGF was significantly higher than control cells for AngII concentrations of 100 nM (62 +/- 11% mean +/- SD, P < 0.0001) and 1 microM (17.3 +/- 10.9%, P < 0.01).",
      "citation": {
        "db": "Other",
        "db_id": "10215323"
      },
      "annotations": {},
      "source": 1,
      "target": 50,
      "key": "33ebe568491022bf98a326dbfb558f0b"
    },
    {
      "line": 136,
      "relation": "subProcessOf",
      "evidence": "Effects of hypoxia on molecular determinants of angiogenesis Angiogenesis is a complex process, involving multiple gene products expressed by different cell types, all contributing to an integrated sequence of events44. Consistent with a major role for hypoxia in the overall process, a large number of genes involved in different steps of angiogenesis are independently responsive to hypoxia in tissue culture. Examples include nitric oxide synthases involved in governing vascular tone, growth factors such as VEGF, angiopoietins, fibroblast growth factors and their various receptors, and genes involved in matrix metabolism, including matrix metalloproteinases, plasminogen activator receptors and inhibitors, and collagen prolyl hydroxylase16, 17, 18, 19, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61 (Table 1). Similarly, many of the individual phenotypic processes in angiogenesis such as cell migration or endothelial tube formation can be induced by hypoxic tissue culture62, 63, 64. These analyses in isolated systems have sometimes apparently shown both positive and negative effects of hypoxia, for instance on endothelial proliferation65, 66, 67. It is not yet clear whether such phenomena reflect fundamentally different responses based on severity of hypoxia, or counter-regulatory controls that are normally integrated in a productive way.",
      "citation": {
        "db": "PubMed",
        "db_id": "12778166"
      },
      "annotations": {},
      "source": 4,
      "target": 2,
      "key": "a2237f7d85bfe78fbbd328c8555af295"
    },
    {
      "line": 102,
      "relation": "subProcessOf",
      "evidence": "Effects of hypoxia on molecular determinants of angiogenesis Angiogenesis is a complex process, involving multiple gene products expressed by different cell types, all contributing to an integrated sequence of events44. Consistent with a major role for hypoxia in the overall process, a large number of genes involved in different steps of angiogenesis are independently responsive to hypoxia in tissue culture. Examples include nitric oxide synthases involved in governing vascular tone, growth factors such as VEGF, angiopoietins, fibroblast growth factors and their various receptors, and genes involved in matrix metabolism, including matrix metalloproteinases, plasminogen activator receptors and inhibitors, and collagen prolyl hydroxylase16, 17, 18, 19, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61 (Table 1). Similarly, many of the individual phenotypic processes in angiogenesis such as cell migration or endothelial tube formation can be induced by hypoxic tissue culture62, 63, 64. These analyses in isolated systems have sometimes apparently shown both positive and negative effects of hypoxia, for instance on endothelial proliferation65, 66, 67. It is not yet clear whether such phenomena reflect fundamentally different responses based on severity of hypoxia, or counter-regulatory controls that are normally integrated in a productive way.",
      "citation": {
        "db": "PubMed",
        "db_id": "12778166"
      },
      "annotations": {},
      "source": 5,
      "target": 2,
      "key": "b9c83c946d01617a7a37b9a9af50e809"
    },
    {
      "line": 42,
      "relation": "subProcessOf",
      "evidence": "angioblasts and stem cells into endothelial cells, angiogenesis, i.e., the sprouting of new capillaries from the preexisting vasculature, and",
      "citation": {
        "db": "PubMed",
        "db_id": "11841347"
      },
      "annotations": {},
      "source": 2,
      "target": 3,
      "key": "bd326f0c066d7db107207fe31df7ae85"
    },
    {
      "relation": "partOf",
      "source": 69,
      "target": 8,
      "key": "2368d0011b9bf1ffa137611d6b72582c"
    },
    {
      "relation": "hasComponent",
      "source": 69,
      "target": 8,
      "key": "7f7f8a1c1f4e7eac5c931640a55027ca"
    },
    {
      "relation": "partOf",
      "source": 84,
      "target": 8,
      "key": "724263a267e999bb4573b18cc2d341c8"
    },
    {
      "relation": "hasComponent",
      "source": 84,
      "target": 8,
      "key": "df7b4ec61afdc740da8846ba322773a0"
    },
    {
      "line": 122,
      "relation": "increases",
      "evidence": "KLEIP directly binds to the RhoGEF ECT2, which promotes the exchange from GDP with GTP on RhoA",
      "citation": {
        "db": "PubMed",
        "db_id": "17395875"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 9,
      "target": 126,
      "key": "fd0ed27c51de4213022b9e29e6e5439b"
    },
    {
      "relation": "partOf",
      "source": 70,
      "target": 9,
      "key": "88c51307a1b510bfac4119f5a1148089"
    },
    {
      "relation": "hasComponent",
      "source": 70,
      "target": 9,
      "key": "c2a5b7f93d856487515a07d03a9dbcd6"
    },
    {
      "relation": "partOf",
      "source": 74,
      "target": 9,
      "key": "06ae37253ec9f4cd74a278a1a1fa4526"
    },
    {
      "relation": "hasComponent",
      "source": 74,
      "target": 9,
      "key": "1dd082652f760f66ef3ffd176e170b5c"
    },
    {
      "relation": "partOf",
      "source": 116,
      "target": 10,
      "key": "c33483f84fa1b25de521ed5fbe912a0d"
    },
    {
      "relation": "hasComponent",
      "source": 116,
      "target": 10,
      "key": "ddfb0c543920358dd583c1cf8237f13b"
    },
    {
      "relation": "partOf",
      "source": 119,
      "target": 10,
      "key": "e784ea26eecfc7f0caea278a8f2b4c5d"
    },
    {
      "relation": "hasComponent",
      "source": 119,
      "target": 10,
      "key": "1cb0a9a2a529ee05c386c37e13a53c50"
    },
    {
      "relation": "partOf",
      "source": 119,
      "target": 11,
      "key": "f2c5e0550d23c438e96305460065ceb2"
    },
    {
      "relation": "hasComponent",
      "source": 119,
      "target": 11,
      "key": "92a7833972fafb04010d325d7b84b8f0"
    },
    {
      "relation": "partOf",
      "source": 117,
      "target": 11,
      "key": "4f93ed5e8d160b849d188d107fdad5e2"
    },
    {
      "relation": "hasComponent",
      "source": 117,
      "target": 11,
      "key": "f31ce50bbec15a7fc931a94cbdfad586"
    },
    {
      "line": 153,
      "relation": "increases",
      "evidence": "The receptors for insulin, plateletderived growth factor (PDGF), epidermal growth factor (EGF), and vascular endothelial growth factor (VEGF) are optimally activated by their ligands only under appropriate cell attachment conditions (24-28). Although a systematic analysis has not been conducted, certain integrins appear to be preferentially associated with specific growth factor receptors. Thus, the avb3 integrin can be immunoprecipitated in complexes with the insulin, PDGF, and VEGF receptors (26, 28), whereas a5b1 and perhaps other b1 integrins associate with the EGF receptor (25, 27).",
      "citation": {
        "db": "PubMed",
        "db_id": "10446041"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 12,
      "target": 122,
      "key": "8902dc47609016d0d51735d33666c5f7"
    },
    {
      "line": 153,
      "relation": "increases",
      "evidence": "Finally, the ?v?3 integrin physically associates with VEGFR2, and the binding of ?v?3 to its ECM ligands increases VEGF signalling in cell cultures38,39.",
      "citation": {
        "db": "PubMed",
        "db_id": "12635171"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 12,
      "target": 122,
      "key": "4ae4a5bbca2b4ceefd712301585a3866"
    },
    {
      "line": 153,
      "relation": "increases",
      "evidence": "VEGFR-2 phosphorylation and mitogenicity induced by VEGF-A165 were enhanced in cells plated on the alphavbeta3 ligand, vitronectin",
      "citation": {
        "db": "PubMed",
        "db_id": "10022831"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 12,
      "target": 122,
      "key": "a72e52633ef5f780ca0a6788d3c45d70"
    },
    {
      "relation": "partOf",
      "source": 118,
      "target": 12,
      "key": "d5e51ab3144e417e92532ca82c6bf76c"
    },
    {
      "relation": "partOf",
      "source": 120,
      "target": 12,
      "key": "4ba84950dc39f9dd50c6f1d0b06f1727"
    },
    {
      "relation": "partOf",
      "source": 147,
      "target": 13,
      "key": "0179cf54b34bd093cc27ba24eaa46782"
    },
    {
      "relation": "hasComponent",
      "source": 147,
      "target": 13,
      "key": "2b9c677ebd887469298ce7d99aa81d13"
    },
    {
      "relation": "partOf",
      "source": 147,
      "target": 14,
      "key": "24250d7da16ed48e41feae2bc153f898"
    },
    {
      "relation": "hasComponent",
      "source": 147,
      "target": 14,
      "key": "02fd5e5dd69c8d8f60f5277aa28b6a27"
    },
    {
      "relation": "partOf",
      "source": 148,
      "target": 14,
      "key": "1ca21cbc0940fb0f3836182c30f9e687"
    },
    {
      "relation": "hasComponent",
      "source": 148,
      "target": 14,
      "key": "f12bf15b2d586e455de415fb31e01b50"
    },
    {
      "relation": "partOf",
      "source": 148,
      "target": 15,
      "key": "9c869ea13d608908724383dfe545dc7c"
    },
    {
      "relation": "hasComponent",
      "source": 148,
      "target": 15,
      "key": "5beea18afdf40111204884ae69b55c34"
    },
    {
      "relation": "partOf",
      "source": 149,
      "target": 16,
      "key": "478561828ceac460aacd2e0418e56f5c"
    },
    {
      "relation": "hasComponent",
      "source": 149,
      "target": 16,
      "key": "1dd1a590b98bf6ea85dcc8229b15d5ce"
    },
    {
      "line": 106,
      "relation": "directlyIncreases",
      "evidence": "VEGFa binds both VEGFR1 and VEGFR2 receptors, PlGF and VEGFb bind VEGFR1 and VEGFe binds VEGFR2. VEGFR3 is a receptor for VEGFs c and d (Veikkola and Alitalo, 1999).",
      "citation": {
        "db": "PubMed",
        "db_id": "10728593"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 149,
      "target": 122,
      "key": "343cc04281cbf12e9de38503f96c3f64"
    },
    {
      "line": 106,
      "relation": "directlyIncreases",
      "evidence": "VEGF-E bound KDR/Flk-1 (VEGFR-2) and induced its autophosphorylation to almost the same extent as VEGF165, but did not bind Flt-1 (VEGFR-1) nor induce autophosphorylation of Flt-1 (from full text, Fig 6, NIH3T3 cells)",
      "citation": {
        "db": "PubMed",
        "db_id": "9813035"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 149,
      "target": 122,
      "key": "408698e653bb0a9b5344c434c46adf13"
    },
    {
      "line": 155,
      "relation": "increases",
      "evidence": "Recent studies in endothelial cells have shown that TGF-? signals through ALK1, activating the Smad1/5 pathway, and through ALK5, activating the Smad2/3 pathway [6]. These two pathways have in a dose-dependent manner opposing effects on endothelial cell behaviour: ALK1 promotes cell proliferation and migration, whereas ALK5 inhibits both processes.",
      "citation": {
        "db": "PubMed",
        "db_id": "16594992"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 61,
      "target": 131,
      "key": "d70e8c110d6bd1049668f50ee868c26a"
    },
    {
      "line": 155,
      "relation": "increases",
      "evidence": "TGF-? activated ALK1 can phosphorylate Smad1 and Smad5, and consequently, promote endothelial migration, an effect mediated through induction of the dominant-negative helixloop- helix transcription factor Id1 which can promote cell proliferation.151, 154",
      "citation": {
        "db": "PubMed",
        "db_id": "16462725"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 61,
      "target": 131,
      "key": "0a4c5e8652ddbdb167f19d755d5a442a"
    },
    {
      "line": 155,
      "relation": "increases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "10564272"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 61,
      "target": 131,
      "key": "9559abcb87aec17b323a554ef9c2d393"
    },
    {
      "line": 155,
      "relation": "increases",
      "evidence": "ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration",
      "citation": {
        "db": "PubMed",
        "db_id": "15664386"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 61,
      "target": 131,
      "key": "bfaedab8690bf15e6692bdc3f4e6cb8f"
    },
    {
      "line": 240,
      "relation": "increases",
      "evidence": "TGF-? activated ALK1 can phosphorylate Smad1 and Smad5, and consequently, promote endothelial migration, an effect mediated through induction of the dominant-negative helixloop- helix transcription factor Id1 which can promote cell proliferation.151, 154",
      "citation": {
        "db": "PubMed",
        "db_id": "16462725"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 61,
      "target": 127,
      "key": "a16e17ce41be6f5f306163afd9d01ea8"
    },
    {
      "line": 240,
      "relation": "increases",
      "evidence": "ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration",
      "citation": {
        "db": "PubMed",
        "db_id": "15664386"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 61,
      "target": 127,
      "key": "637100e0c77c436a8591ab121670a859"
    },
    {
      "line": 240,
      "relation": "increases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "10564272"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 61,
      "target": 127,
      "key": "249c377966b7b58a1a02b609ef96c698"
    },
    {
      "line": 240,
      "relation": "increases",
      "evidence": "Recent studies in endothelial cells have shown that TGF-? signals through ALK1, activating the Smad1/5 pathway, and through ALK5, activating the Smad2/3 pathway [6]. These two pathways have in a dose-dependent manner opposing effects on endothelial cell behaviour: ALK1 promotes cell proliferation and migration, whereas ALK5 inhibits both processes.",
      "citation": {
        "db": "PubMed",
        "db_id": "16594992"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 61,
      "target": 127,
      "key": "6118e1d96c12adfad1ba7909406b434a"
    },
    {
      "line": 240,
      "relation": "increases",
      "evidence": "activation of the ALK1/Smad1 pathway was recently demonstrated in liver and kidney fibrosis [19â€“21].",
      "citation": {
        "db": "PubMed",
        "db_id": "17917537"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 61,
      "target": 127,
      "key": "fce963f2669341b24e83db157dc1e80b"
    },
    {
      "line": 92,
      "relation": "increases",
      "evidence": "Ang II via type 1 receptor upregulates the expression of LOX-1, a lectin-like receptor for oxidized low-density lipoprotein.",
      "citation": {
        "db": "PubMed",
        "db_id": "17893372"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 80,
      "target": 145,
      "key": "101cca64fb87672c17646644f688e0c6"
    },
    {
      "line": 92,
      "relation": "increases",
      "evidence": "Another example is the oxidized LDL-induced NF-kB-mediated overexpression of Angiotensin Receptor-1 (AT1) which may up-regulate LOX-1 expression and enhances the toxicity of oxidized LDLs[93] and alter the balance between cell survival/apoptosis.[94,95]",
      "citation": {
        "db": "PubMed",
        "db_id": "15346645"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 80,
      "target": 145,
      "key": "ad689bf70de66b858160b76c4b163deb"
    },
    {
      "line": 92,
      "relation": "increases",
      "evidence": "Importantly, the increase in LOX-1 mRNA expression in response to Ang II was completely blocked by losartan, a specific AT1 blocker, but not by PD123319, a specific AT2 blocker (n56, Figure 5). The increased LOX-1 protein expression in response to Ang II was also blocked by pretreatment of HCAECs with losartan, but not with PD123319 (n56, Figure 6).",
      "citation": {
        "db": "PubMed",
        "db_id": "10325241"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 80,
      "target": 145,
      "key": "f6f3e9dc9365a2dacee5b5ae65999810"
    },
    {
      "line": 60,
      "relation": "directlyIncreases",
      "evidence": "Two other endothelial cell-specific receptors, called Tie-1 and Tie-2 (for \\\"tyrosine kinase with immunoglobulin- and EGF-like domains\\\") have been identified several years ago. Knock-out experiments in mice have suggested a role for these receptors in blood vessel maturation. The ligands for Tie-2 have only recently been discovered: angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) both bind Tie-2, but only the binding of Ang-1 results in signal transduction and regulation of blood vessel maturation (227). Therefore, Ang-2 is a natural antagonist of Ang-1 (146).",
      "citation": {
        "db": "PubMed",
        "db_id": "11172729"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 105,
      "target": 45,
      "key": "54d67e5d03d5c4cc0312fcc8f4fcdef7"
    },
    {
      "line": 169,
      "relation": "directlyIncreases",
      "evidence": "During postnatal angiogenesis, quiescent vascular endothelial cells are induced to proliferate through the combined action of different factors: the de novo expression of angiopoietin-2, an endogenous antagonist of angiopoietin-1, which releases the endothelial cells from the stabilizing effects of the vessel wall, the local secretion or activation of vascular growth factors (e.g. VEGF), and the inactivation or suppression of endogenous anti-angiogenic molecules (e.g. thrombospondins)",
      "citation": {
        "db": "PubMed",
        "db_id": "14984767"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 105,
      "target": 39,
      "key": "74c744bcb8b228f9ea454c75d2c4c77c"
    },
    {
      "line": 169,
      "relation": "directlyIncreases",
      "evidence": "Two other endothelial cell-specific receptors, called Tie-1 and Tie-2 (for \\\"tyrosine kinase with immunoglobulin- and EGF-like domains\\\") have been identified several years ago. Knock-out experiments in mice have suggested a role for these receptors in blood vessel maturation. The ligands for Tie-2 have only recently been discovered: angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) both bind Tie-2, but only the binding of Ang-1 results in signal transduction and regulation of blood vessel maturation (227). Therefore, Ang-2 is a natural antagonist of Ang-1 (146).",
      "citation": {
        "db": "PubMed",
        "db_id": "11172729"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 105,
      "target": 39,
      "key": "ed995e816cdf56d3be19e2bcc7d8ca84"
    },
    {
      "line": 169,
      "relation": "directlyIncreases",
      "evidence": "Our results suggest that although both Ang1 and Ang2 can activate the Tie-2 receptor in bmLECs, Ang1 and Ang2 may have distinct roles in mesenteric lymphatic endothelial cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "17341311"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 105,
      "target": 39,
      "key": "b395a1a34e5a1c84c926c509ef24cb08"
    },
    {
      "line": 169,
      "relation": "directlyIncreases",
      "evidence": "Remarkably, although Ang2 bound to the same Tie2 receptor as did Ang1, it could not activate it. Instead, Ang2 provided the first example of a naturally occurring antagonist for a tyrosine receptor.",
      "citation": {
        "db": "PubMed",
        "db_id": "12891700"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 105,
      "target": 39,
      "key": "08761027abeced5b3fc49e3b9663f4f8"
    },
    {
      "line": 169,
      "relation": "directlyIncreases",
      "evidence": "Tie2 is an endothelial tyrosine kinase receptor for Ang1; both are essential for blood vessel remodelling during embryonic angiogenesis1, 2, 3, 4, 5, 6, 7, 8",
      "citation": {
        "db": "PubMed",
        "db_id": "18425119"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 105,
      "target": 39,
      "key": "91ab6a62872f15cf614d2ae056deffca"
    },
    {
      "line": 95,
      "relation": "directlyDecreases",
      "evidence": "Two other endothelial cell-specific receptors, called Tie-1 and Tie-2 (for \\\"tyrosine kinase with immunoglobulin- and EGF-like domains\\\") have been identified several years ago. Knock-out experiments in mice have suggested a role for these receptors in blood vessel maturation. The ligands for Tie-2 have only recently been discovered: angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) both bind Tie-2, but only the binding of Ang-1 results in signal transduction and regulation of blood vessel maturation (227). Therefore, Ang-2 is a natural antagonist of Ang-1 (146).",
      "citation": {
        "db": "PubMed",
        "db_id": "11172729"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 106,
      "target": 39,
      "key": "dadd7938f0bbf001a7304540ca956b98"
    },
    {
      "line": 95,
      "relation": "directlyDecreases",
      "evidence": "During postnatal angiogenesis, quiescent vascular endothelial cells are induced to proliferate through the combined action of different factors: the de novo expression of angiopoietin-2, an endogenous antagonist of angiopoietin-1, which releases the endothelial cells from the stabilizing effects of the vessel wall, the local secretion or activation of vascular growth factors (e.g. VEGF), and the inactivation or suppression of endogenous anti-angiogenic molecules (e.g. thrombospondins)",
      "citation": {
        "db": "PubMed",
        "db_id": "14984767"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 106,
      "target": 39,
      "key": "0b64224b9633b0094da6fd5989361b4c"
    },
    {
      "line": 95,
      "relation": "directlyDecreases",
      "evidence": "this is accompanied by the loosening of pericyte covering (basement membrane degradation), which is thought to be a function of ANG2, a ligand of TIE2 TIE2 is a tyrosine kinase receptor that is selectively expressed in endothelial cells",
      "citation": {
        "db": "PubMed",
        "db_id": "12778130"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 106,
      "target": 39,
      "key": "f00765ddf6d742c56a98e13806e0832e"
    },
    {
      "line": 95,
      "relation": "directlyDecreases",
      "evidence": "Remarkably, although Ang2 bound to the same Tie2 receptor as did Ang1, it could not activate it. Instead, Ang2 provided the first example of a naturally occurring antagonist for a tyrosine receptor.",
      "citation": {
        "db": "PubMed",
        "db_id": "12891700"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 106,
      "target": 39,
      "key": "00dfb6102db479e5270ba1e250d044d5"
    },
    {
      "line": 142,
      "relation": "decreases",
      "evidence": "In this study we demonstrate that angiopoietin-1, but not angiopoietin-2, is chemotactic for endothelial cells. In contrast, angiopoietin-1 as well as angiopoietin-2 exhibit no proliferative effect on endothelial cells. Excess soluble Tie2, but not Tie1 receptor, abolish the chemotactic response of endothelial cells toward angiopoietin-1. Angiopoietin-2 dose-dependently blocks directed migration toward angiopoietin-1, consistent with the role of angiopoietin-2 as a naturally occurring inhibitor of angiopoietin-1",
      "citation": {
        "db": "PubMed",
        "db_id": "9660821"
      },
      "annotations": {},
      "source": 106,
      "target": 105,
      "key": "d684086bd7bb74d33b536fcaaf17cdfe"
    },
    {
      "line": 142,
      "relation": "decreases",
      "evidence": "Also members of the selectin family, in particular P-selectin and E-selectin, which promotes adhesion of leukocytes to cytokine-activated vascular endothelium, have been shown to play a role in angiogenesis (134). E-selectin was found to induce endothelial migration and tube formation in vitro and angiogenesis in vivo (167). However, little is known about the mechanism of action of these molecules and mice deficient in both E-selectin and P-selectin are viable and fertile (139).",
      "citation": {
        "db": "PubMed",
        "db_id": "11172729"
      },
      "annotations": {},
      "source": 106,
      "target": 105,
      "key": "b4a64a85311ab33a9c5ba0b59b4e692b"
    },
    {
      "line": 173,
      "relation": "directlyDecreases",
      "evidence": "Two other endothelial cell-specific receptors, called Tie-1 and Tie-2 (for \\\"tyrosine kinase with immunoglobulin- and EGF-like domains\\\") have been identified several years ago. Knock-out experiments in mice have suggested a role for these receptors in blood vessel maturation. The ligands for Tie-2 have only recently been discovered: angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) both bind Tie-2, but only the binding of Ang-1 results in signal transduction and regulation of blood vessel maturation (227). Therefore, Ang-2 is a natural antagonist of Ang-1 (146).",
      "citation": {
        "db": "PubMed",
        "db_id": "11172729"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 106,
      "target": 45,
      "key": "3b864f205008df40081ec10110bc7a8b"
    },
    {
      "line": 216,
      "relation": "increases",
      "evidence": "annexin 2 depletion attenuated Akt activation, which was associated with increased phosphorylation of VE-cadherin and endothelial barrier leakage. Disrupting homotypic VE-cadherin interactions with EGTA, antibodies to the extracellular domain of VE-cadherin, or gene silencing all resulted in decreased Akt (but not Erk1/2) activation. Furthermore, expression of constitutively active Akt restored reduced endothelial sprouting responses observed with annexin 2 and VE-cadherin knockdown",
      "citation": {
        "db": "PubMed",
        "db_id": "20947498"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 112,
      "target": 18,
      "key": "258e28e66e794d27f6774d98e397b4ec"
    },
    {
      "line": 207,
      "relation": "directlyIncreases",
      "evidence": "EPAS1 forms a heterodimeric complex with the aryl hydrocarbon nuclear transporter prior to transcriptional activation of target genes. EPAS1 expression is limited to the endothelium of mouse embryos and, in agreement with its cell type-specific expression pattern, is capable of specifically activating the transcription of the endothelial tyrosine kinase gene Tie-2.",
      "citation": {
        "db": "PubMed",
        "db_id": "9000051"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 135,
      "target": 82,
      "key": "d778e7ec88565338804420233a215756"
    },
    {
      "line": 207,
      "relation": "directlyIncreases",
      "evidence": "Like HIF-1{alpha}, the EPAS1 protein is stabilized during hypoxia and forms a heterodimer with aryl hydrocarbon receptor nuclear translocator (ARNT) and transactivates the vascular endothelial growth factor (VEGF) promoter.",
      "citation": {
        "db": "PubMed",
        "db_id": "15192019"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 135,
      "target": 82,
      "key": "147666b0a27e800e04578e7a9f5e0477"
    },
    {
      "line": 310,
      "relation": "directlyIncreases",
      "evidence": "HIF-1 alpha can then translocate to the nucleus and facilitate transcription of numerous target genes, the majority of which are involved in glycolysis and angiogenesis via heterodimerisation with the beta subunit (HIF-1 beta/ARNT).",
      "citation": {
        "db": "PubMed",
        "db_id": "12054621"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 135,
      "target": 110,
      "key": "283d6dfff567c0ef6a1515e2080385db"
    },
    {
      "line": 310,
      "relation": "directlyIncreases",
      "evidence": "Here we demonstrate that HIF-1 alpha required Arnt for DNA binding in vitro and functional activity in vivo.",
      "citation": {
        "db": "PubMed",
        "db_id": "8816435"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 135,
      "target": 110,
      "key": "3ec18b5acfef0ec1db7f225cd540c153"
    },
    {
      "line": 310,
      "relation": "directlyIncreases",
      "evidence": "in the absence of oxygen, HIF1 binds to hypoxia-response elements, thereby activating the expression of numerous hypoxia-response genes, such as VEGF",
      "citation": {
        "db": "PubMed",
        "db_id": "11902584"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 135,
      "target": 110,
      "key": "44ebe7e8e731caf3e34eee8bd9af8d8c"
    },
    {
      "line": 63,
      "relation": "increases",
      "evidence": "annexin 2 depletion attenuated Akt activation, which was associated with increased phosphorylation of VE-cadherin and endothelial barrier leakage. Disrupting homotypic VE-cadherin interactions with EGTA, antibodies to the extracellular domain of VE-cadherin, or gene silencing all resulted in decreased Akt (but not Erk1/2) activation. Furthermore, expression of constitutively active Akt restored reduced endothelial sprouting responses observed with annexin 2 and VE-cadherin knockdown",
      "citation": {
        "db": "PubMed",
        "db_id": "20947498"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 62,
      "target": 18,
      "key": "0c573eee6212f0c632dd11130c2a7643"
    },
    {
      "line": 65,
      "relation": "decreases",
      "evidence": "Endostatin blocked VEGF-induced tyrosine phosphorylation of KDR/Flk-1 and activation of ERK, p38 MAPK, and p125(FAK) in human umbilical vein endothelial cells",
      "citation": {
        "db": "PubMed",
        "db_id": "12029087"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 66,
      "target": 26,
      "key": "b4b1d0367712a3f6126289c822257f31"
    },
    {
      "line": 128,
      "relation": "decreases",
      "evidence": "Endostatin blocked VEGF-induced tyrosine phosphorylation of KDR/Flk-1 and activation of ERK, p38 MAPK, and p125(FAK) in human umbilical vein endothelial cells",
      "citation": {
        "db": "PubMed",
        "db_id": "12029087"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 66,
      "target": 122,
      "key": "7a88262a11e9733d9e06e038b27d5d96"
    },
    {
      "line": 298,
      "relation": "decreases",
      "evidence": "We demonstrated that endostatin treatment ...reducing VEGFR-2 (Flk-1) expression;",
      "citation": {
        "db": "Other",
        "db_id": "23688086"
      },
      "annotations": {},
      "source": 66,
      "target": 122,
      "key": "876e90e80c91706c647bf8ad461354a2"
    },
    {
      "line": 154,
      "relation": "decreases",
      "evidence": "Additionally, although human tumstatin binding to alpha v beta 3 integrin leads to the inhibition of Cap-dependent translation (protein synthesis) mediated by focal adhesion kinase/phosphatidylinositol 3-kinase/Akt/mTOR/4E-BP1 pathway, human endostatin binding to alpha 5 beta 1 integrin leads to the inhibition of focal adhesion kinase/c-Raf/MEK1/2/p38/ERK1 mitogen-activated protein kinase pathway, with no effect on phosphatidylinositol 3-kinase/Akt/mTOR/4E-BP1 and Cap-dependent translation.",
      "citation": {
        "db": "PubMed",
        "db_id": "12682293"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 66,
      "target": 157,
      "key": "e950a51c0dffb0901a0018ea6c68886e"
    },
    {
      "line": 154,
      "relation": "decreases",
      "evidence": "Endostatin blocked VEGF-induced tyrosine phosphorylation of KDR/Flk-1 and activation of ERK, p38 MAPK, and p125(FAK) in human umbilical vein endothelial cells",
      "citation": {
        "db": "PubMed",
        "db_id": "12029087"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 66,
      "target": 157,
      "key": "195f8ef2e1bc925fb8d2fa1f7561775d"
    },
    {
      "line": 306,
      "relation": "decreases",
      "evidence": "We demonstrated that endostatin treatment ... reducing VEGF expression;",
      "citation": {
        "db": "Other",
        "db_id": "23688086"
      },
      "annotations": {},
      "source": 66,
      "target": 50,
      "key": "58e068be12a1cf510e00a289177f7324"
    },
    {
      "line": 307,
      "relation": "decreases",
      "evidence": "We demonstrated that endostatin treatment ...inhibiting ERK1/2 activation;",
      "citation": {
        "db": "Other",
        "db_id": "23688086"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 66,
      "target": 133,
      "key": "70f66dc178953b9e5c2b3b0967b8c68a"
    },
    {
      "line": 307,
      "relation": "decreases",
      "evidence": "Endostatin blocked VEGF-induced tyrosine phosphorylation of KDR/Flk-1 and activation of ERK, p38 MAPK, and p125(FAK) in human umbilical vein endothelial cells",
      "citation": {
        "db": "PubMed",
        "db_id": "12029087"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 66,
      "target": 133,
      "key": "cce37471c64abb746d328f19badcd2d0"
    },
    {
      "line": 308,
      "relation": "decreases",
      "evidence": "We demonstrated that endostatin treatment ...inhibiting ERK1/2 activation",
      "citation": {
        "db": "Other",
        "db_id": "23688086"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 66,
      "target": 134,
      "key": "781137b93f0ae1dfb440dcbca7c65f49"
    },
    {
      "line": 308,
      "relation": "decreases",
      "evidence": "Endostatin blocked VEGF-induced tyrosine phosphorylation of KDR/Flk-1 and activation of ERK, p38 MAPK, and p125(FAK) in human umbilical vein endothelial cells",
      "citation": {
        "db": "PubMed",
        "db_id": "12029087"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 66,
      "target": 134,
      "key": "d9c33e583e3c9c38232eb13c16a2e1e9"
    },
    {
      "line": 62,
      "relation": "directlyIncreases",
      "evidence": "The transactivation activity of HIF complexes requires the recruitment of p300/CREB-binding protein (CBP) by HIF-1 alpha and HIF-2 alpha that undergo oxygen-dependent degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "12588875"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 67,
      "target": 82,
      "key": "946b45f281778b04726c2be19424628c"
    },
    {
      "line": 110,
      "relation": "increases",
      "evidence": "from full ext - Figure 2 (Dâ€“F) Transient transfection assays showing that Gal-HIF-1a function is reduced in MEFs with multiple DCH1 alleles (mean7s.e.m., NÂ¼3) (D), and can be rescued by WT CBP (E, F) or p300 (F), but not by CBPDCH1 (E) (mean7s.e.m., NÂ¼2â€“4). (G, H) Transactivation by factors utilizing other domains of p300 and CBP or other coactivators is unimpaired (mean7s.d., NÂ¼4).",
      "citation": {
        "db": "PubMed",
        "db_id": "16237459"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 67,
      "target": 110,
      "key": "2fbfea7dee1923af6d11b5ebc3e81bc3"
    },
    {
      "line": 110,
      "relation": "increases",
      "evidence": "HIF-1a N-TAD partially overlaps with the oxygenregulated degradation box and consequently, when transiently expressed in cells, the minimal N-TAD fragment is completely degraded under normoxic conditions (under which no N-TAD-mediated transactivation activity is observed [16,17]). Functional data indicate that the activity of this domain can be enhanced by the transcriptional coactivator CBP/p300 [16].",
      "citation": {
        "db": "PubMed",
        "db_id": "17885420"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 67,
      "target": 110,
      "key": "d9ac870f6c4b40270f4de6790af5a255"
    },
    {
      "line": 126,
      "relation": "directlyIncreases",
      "evidence": "Although both the glutathione S-transferase-CXCR4 N- and C-terminal fusion proteins were associated with the purified CyPA, truncation of the C-terminal domain of CXCR4 robustly inhibited the receptor co-immunoprecipitation with CyPA in intact cells, thereby suggesting a critical role of the receptor C terminus in this interaction. Ligand stimulation of CXCR4 by CXCL12 induced CyPA phosphorylation and nuclear translocation, both of which were inhibited by truncation of the C-terminal domain of CXCR4.",
      "citation": {
        "db": "PubMed",
        "db_id": "17991743"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 33,
      "target": 72,
      "key": "40e5a39c78976cfac9c2d14fcb01dc3e"
    },
    {
      "line": 126,
      "relation": "directlyIncreases",
      "evidence": "Here we show that CD24 affects the function of the chemokine receptor CXCR4. Using isolated CD19-positive bone marrow B cells from CD24-knockout mice and CD24-/- pre-B lymphocytic cell lines, we demonstrate that CD24 expression reduces SDF-1-mediated cell migration and signalling via CXCR4.",
      "citation": {
        "db": "PubMed",
        "db_id": "16390867"
      },
      "annotations": {
        "cl": {
          "0000542": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 33,
      "target": 72,
      "key": "2b66dc54cd7981ef7fccd753d2420646"
    },
    {
      "line": 126,
      "relation": "directlyIncreases",
      "evidence": "The chemokine stromal-derived factor-1alpha (SDF-1alpha) and its receptor, CXCR4, play a crucial role in adhesion and migration of human cancer cells",
      "citation": {
        "db": "PubMed",
        "db_id": "17904532"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 33,
      "target": 72,
      "key": "6b84040dadd1e5abc9dd551801c231e6"
    },
    {
      "line": 109,
      "relation": "increases",
      "evidence": "In the present study, we show that VEGF-induced DLL4 expression depends on NOTCH activation. VEGF-induced DLL4 expression was prevented by the blockage of NOTCH signaling with ??-secretase or ADAM inhibitors in human cardiac microvascular ECs. Similar to VEGF-A, recombinant DLL4 itself stimulated NOTCH signaling and resulted in up-regulation of DLL4, suggesting a positive feed-forward mechanism.",
      "citation": {
        "db": "PubMed",
        "db_id": "20959466"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 73,
      "target": 21,
      "key": "3b92b50cd4e29992f3fc9ceb0abd5d04"
    },
    {
      "line": 109,
      "relation": "increases",
      "evidence": "Regulation of T cell activation by Notch ligand, DLL4",
      "citation": {
        "db": "PubMed",
        "db_id": "19494260"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 73,
      "target": 21,
      "key": "29b16fcb1dcfa64a0ca36a9243993b2e"
    },
    {
      "line": 189,
      "relation": "increases",
      "evidence": "ET-1 also increases hypoxia-inducible factor-1alpha (HIF-1alpha) accumulation and activates the HIF-1 transcription complex",
      "citation": {
        "db": "PubMed",
        "db_id": "12023962"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 75,
      "target": 110,
      "key": "14a1473e490b24401e0d8f0d90ae8636"
    },
    {
      "line": 168,
      "relation": "directlyIncreases",
      "evidence": "HUVECs expressed three kinds of EphB kinases known to bind to ephrinB2: EphB2, EphB3, and EphB4",
      "citation": {
        "db": "PubMed",
        "db_id": "12039842"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 76,
      "target": 83,
      "key": "d1bc720e9f4056d9e129daacdad3dfb6"
    },
    {
      "line": 168,
      "relation": "directlyIncreases",
      "evidence": "Although initially characterized in the nervous system, ephrin A, ephrin B2, and EphB4 are expressed by endothelial cells and recent knockout studies have suggested key role for ephrin B2 and it EphB4 receptor during vascular development mainly in early angiogenic remodeling (Gerety et al., 1999).",
      "citation": {
        "db": "PubMed",
        "db_id": "12891700"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 76,
      "target": 83,
      "key": "a133db9fda431f70e261edc81c058365"
    },
    {
      "line": 132,
      "relation": "directlyDecreases",
      "evidence": "our results show that EGFL7 and endothelial-specific NOTCH physically interact in vivo and strongly suggest that Egfl7 antagonizes Notch in both the postnatal retina and in primary endothelial cells. Specifically, Egfl7 inhibits Notch reporter activity and down-regulates the level of Notch target genes when overexpressed",
      "citation": {
        "db": "PubMed",
        "db_id": "20947685"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 64,
      "target": 21,
      "key": "8497a552afa5839af103daa6f285b500"
    },
    {
      "line": 190,
      "relation": "increases",
      "evidence": "Studies to date suggest that, in these cancers, several (if not all) of the critical downstream signaling pathways, including the phosphoinositide 3-kinase (PI3K)/Akt, signal transducers and activators of transcription, and extracellular signal-regulated kinase 1 and 2 pathways, are solely controlled by EGFR. Thus, when the tumors are exposed to EGFR inhibitors, these intracellular pathways are turned off and the cancer cells undergo apoptosis (21, 22, 24, 25).",
      "citation": {
        "db": "PubMed",
        "db_id": "18483355"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 134,
      "key": "af10cae018be311c99fe7f8f9c592740"
    },
    {
      "line": 190,
      "relation": "increases",
      "evidence": "\\\"Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation.\\\" In the current study, we demonstrate that various PPARalpha (nafenopin) and gamma (ciglitazone and troglitazone) agonists rapidly induced extracellular signal-regulated kinase (Erk) and/or p38 phosphorylation in rat liver epithelial cells (GN4). The selective epidermal growth factor receptor (EGFR) kinase inhibitors, PD153035 and ZD1839 (Iressa), abolished PPARalpha and gamma agonist-dependent Erk activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "12966092"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 134,
      "key": "6dd4c7904b333039d387ed46663086d5"
    },
    {
      "line": 190,
      "relation": "increases",
      "evidence": "activation of ERK depended on EGFR, Src tyrosine kinase and calcium calmodulin in PC12 cells (31), while requiring ras/Raf-1/MEK activation in human neutrophils (58).",
      "citation": {
        "db": "PubMed",
        "db_id": "19273391"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 134,
      "key": "a2942517a669fd9f97779b392ef96698"
    },
    {
      "line": 190,
      "relation": "increases",
      "evidence": "addition of AG1478 also suppressed ATP-mediated phosphorylation of ERK1/2 and I-?B? (Fig. 4A), indicating the involvement of EGFR activation in these signaling events.",
      "citation": {
        "db": "PubMed",
        "db_id": "19386603"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 134,
      "key": "d6883b74d798663f9f6223e52d8e2329"
    },
    {
      "line": 190,
      "relation": "increases",
      "evidence": "Expression of wild-type (wt) Cbp remarkably suppressed EGF-induced activation of Src, ERK1/2, and Akt-1 enzymes, and NIH3T3 cell transformation, as well as colony formation of a breast cancer cell line (MDA-MB-468) in soft agar.",
      "citation": {
        "db": "PubMed",
        "db_id": "16636672"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 134,
      "key": "dda57431c1e7a8a08a0a52cdd3929f53"
    },
    {
      "line": 190,
      "relation": "increases",
      "evidence": "The treatment of NCI-N87 cells with EGF resulted in increases in phosphorylation of Erk1/2, Akt, and P38. Blockade of the Erk, phosphatidylinositol-3 kinase/Akt, or P38 pathways in this cell line",
      "citation": {
        "db": "PubMed",
        "db_id": "12618892"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 134,
      "key": "01e5db8e93d1af0fb3d09c78858deec4"
    },
    {
      "line": 190,
      "relation": "increases",
      "evidence": "GRP induced rapid activation of p44/42 MAPK in lung cancer cells through EGFR.",
      "citation": {
        "db": "PubMed",
        "db_id": "15967120"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 134,
      "key": "221d24f3a9b11a2f7e260033f6fd29f0"
    },
    {
      "line": 190,
      "relation": "increases",
      "evidence": "PK1 induced a time-dependent increase in expression of IL-8 and COX-2, which was significantly reduced by inhibitors of Gq, cSrc, epidermal growth factor receptor (EGFR), and MAPK kinase. Treatment of third-trimester placenta with 40 nm PK1 induced a rapid phosphorylation of cSrc, EGFR, and ERK1/2. Phosphorylation of ERK1/2 in response to PK1 was dependent on sequential phosphorylation of cSrc and EGFR.",
      "citation": {
        "db": "PubMed",
        "db_id": "18372330"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 134,
      "key": "963fff35c0bce205db7489a17b9ac6a8"
    },
    {
      "line": 261,
      "relation": "increases",
      "evidence": "PK1 induced a time-dependent increase in expression of IL-8 and COX-2, which was significantly reduced by inhibitors of Gq, cSrc, epidermal growth factor receptor (EGFR), and MAPK kinase. Treatment of third-trimester placenta with 40 nm PK1 induced a rapid phosphorylation of cSrc, EGFR, and ERK1/2. Phosphorylation of ERK1/2 in response to PK1 was dependent on sequential phosphorylation of cSrc and EGFR.",
      "citation": {
        "db": "PubMed",
        "db_id": "18372330"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 133,
      "key": "c3723dc41b36ba291d522861ec5e4d9c"
    },
    {
      "line": 261,
      "relation": "increases",
      "evidence": "Studies to date suggest that, in these cancers, several (if not all) of the critical downstream signaling pathways, including the phosphoinositide 3-kinase (PI3K)/Akt, signal transducers and activators of transcription, and extracellular signal-regulated kinase 1 and 2 pathways, are solely controlled by EGFR. Thus, when the tumors are exposed to EGFR inhibitors, these intracellular pathways are turned off and the cancer cells undergo apoptosis (21, 22, 24, 25).",
      "citation": {
        "db": "PubMed",
        "db_id": "18483355"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 133,
      "key": "562a32069959b38dbc40bb1c734ca51c"
    },
    {
      "line": 261,
      "relation": "increases",
      "evidence": "\\\"Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation.\\\" In the current study, we demonstrate that various PPARalpha (nafenopin) and gamma (ciglitazone and troglitazone) agonists rapidly induced extracellular signal-regulated kinase (Erk) and/or p38 phosphorylation in rat liver epithelial cells (GN4). The selective epidermal growth factor receptor (EGFR) kinase inhibitors, PD153035 and ZD1839 (Iressa), abolished PPARalpha and gamma agonist-dependent Erk activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "12966092"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 133,
      "key": "e83278277832bb7625351a3cd382569e"
    },
    {
      "line": 261,
      "relation": "increases",
      "evidence": "As previously reported, expression of Dok-R in EGF-stimulated cells resulted in a dramatic decrease in the induction of Erk-2 activation as well as a delay in the activation kinetics (Fig. 1), while Dok-R {Delta}PRR completely lost this Erk-2 attenuating capacity, which demonstrates that the key residues for mediating this attenuation are found within the PRR.",
      "citation": {
        "db": "PubMed",
        "db_id": "15831486"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 133,
      "key": "f3fcf6f668b8e731304062c9d5df7cc2"
    },
    {
      "line": 261,
      "relation": "increases",
      "evidence": "activation of ERK depended on EGFR, Src tyrosine kinase and calcium calmodulin in PC12 cells (31), while requiring ras/Raf-1/MEK activation in human neutrophils (58).",
      "citation": {
        "db": "PubMed",
        "db_id": "19273391"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 133,
      "key": "83fc80f91eb32fca56ebc246172c0fb4"
    },
    {
      "line": 261,
      "relation": "increases",
      "evidence": "Expression of wild-type (wt) Cbp remarkably suppressed EGF-induced activation of Src, ERK1/2, and Akt-1 enzymes, and NIH3T3 cell transformation, as well as colony formation of a breast cancer cell line (MDA-MB-468) in soft agar.",
      "citation": {
        "db": "PubMed",
        "db_id": "16636672"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 133,
      "key": "4842b34d27119545873d6c2113d4069e"
    },
    {
      "line": 261,
      "relation": "increases",
      "evidence": "The treatment of NCI-N87 cells with EGF resulted in increases in phosphorylation of Erk1/2, Akt, and P38. Blockade of the Erk, phosphatidylinositol-3 kinase/Akt, or P38 pathways in this cell line",
      "citation": {
        "db": "PubMed",
        "db_id": "12618892"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 133,
      "key": "881bbb54a591ae213aa5c461d13c8ee4"
    },
    {
      "line": 261,
      "relation": "increases",
      "evidence": "addition of AG1478 also suppressed ATP-mediated phosphorylation of ERK1/2 and I-?B? (Fig. 4A), indicating the involvement of EGFR activation in these signaling events.",
      "citation": {
        "db": "PubMed",
        "db_id": "19386603"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 133,
      "key": "e61f993a6ac4ec8d0294ac60fce26ae9"
    },
    {
      "line": 261,
      "relation": "increases",
      "evidence": "GRP induced rapid activation of p44/42 MAPK in lung cancer cells through EGFR.",
      "citation": {
        "db": "PubMed",
        "db_id": "15967120"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 133,
      "key": "d82ff08896438e6fa73e274e20ff5e6b"
    },
    {
      "line": 261,
      "relation": "increases",
      "evidence": "Mig-6 overexpression results in reduced activation of the mitogenactivated protein kinase ERK2 in response to EGF,",
      "citation": {
        "db": "PubMed",
        "db_id": "11843178"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 133,
      "key": "bfbf67ab1bd9d455f95098f3a438fe85"
    },
    {
      "line": 261,
      "relation": "increases",
      "evidence": "An important finding is that intact BRCA1 also prevents EGF and IGF-I signaling through ERK to cell proliferation. EGF and IGF-1 are strongly implicated in the biology of human breast cancer, where they signal through this member of the MAP kinase family to cell growth (27, 52).",
      "citation": {
        "db": "PubMed",
        "db_id": "15199145"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 133,
      "key": "ebedcfdaa8ff499c624902e893650a4c"
    },
    {
      "line": 139,
      "relation": "increases",
      "evidence": "Cellular oxygen partial pressure is sensed by a family of prolyl-4-hydroxylase domain (PHD) enzymes that modify hypoxia-inducible factor (HIF) alpha subunits. Upon hydroxylation under normoxic conditions, HIFalpha is bound by the von Hippel-Lindau tumor suppressor protein and targeted for proteasomal destruction.",
      "citation": {
        "db": "PubMed",
        "db_id": "15741220"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 48,
      "target": 110,
      "key": "dc8fb65dab90f5045383423a11539830"
    },
    {
      "line": 139,
      "relation": "increases",
      "evidence": "Here we show using suppression by small interference RNA that each of the three PHD isoforms contributes in a non-redundant manner to the regulation of both HIF-1alpha and HIF-2alpha subunits and that the contribution of each PHD under particular culture conditions is strongly dependent on the abundance of the enzyme. From Gene summary: At normal oxygen levels, the alpha subunit of HIF is targeted for degration by prolyl hydroxylation.",
      "citation": {
        "db": "PubMed",
        "db_id": "15247232"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 48,
      "target": 110,
      "key": "a373b827623c836b5e3994a0628dbabc"
    },
    {
      "line": 139,
      "relation": "increases",
      "evidence": "Hypoxia-inducible factor (HIF) is a master transcriptional regulator of hypoxia-inducible genes and consists of a labile alpha subunit (such as HIF1alpha) and a stable beta subunit (such as HIF1beta or ARNT). In the presence of oxygen, HIFalpha family members are hydroxylated on one of two conserved prolyl residues by members of the egg-laying-defective nine (EGLN) family. Prolyl hydroxylation generates a binding site for a ubiquitin ligase complex containing the von Hippel-Lindau (VHL) tumor suppressor protein, which results in HIFalpha destruction. In addition, the HIFalpha transcriptional activation function is modulated further by asparagine hydroxylation by FIH (factor-inhibiting HIF), which affects recruitment of the coactivators p300 and CBP. These findings provide new mechanistic insights into oxygen sensing by metazoans and are the first examples of protein hydroxylation being used in intracellular signaling. The existence of three human EGLN family members, as well as other putative hydroxylases, raises the possibility that this signal is used in other contexts by other proteins. In the presence of oxygen, HIFalpha family members are hydroxylated on one of two conserved prolyl residues by members of the egg-laying-defective nine (EGLN) family. Prolyl hydroxylation generates a binding site for a ubiquitin ligase complex containing the von Hippel-Lindau (VHL) tumor suppressor protein, which results in HIFalpha destruction.",
      "citation": {
        "db": "PubMed",
        "db_id": "15952883"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 48,
      "target": 110,
      "key": "1b5c32ee8dba741076f2978aacf905ec"
    },
    {
      "line": 139,
      "relation": "increases",
      "evidence": "Furthermore, siRNA silencing of PHD-2, which stabilizes HIF-1a protein under normoxic conditions, increased MIP-1b mRNA expression by ?14-fold in the absence of ET-1 (Fig. 3B, lane 4) compared with that of nontransfected THP-1 cells (Fig. 3B, lane 1).",
      "citation": {
        "db": "PubMed",
        "db_id": "20952681"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 48,
      "target": 110,
      "key": "0102b47542581fe55f844811d7b41b68"
    },
    {
      "line": 139,
      "relation": "increases",
      "evidence": "Cellular iron is needed for cell survival and hydroxylation of hypoxia-inducible factor-1alpha (HIF-alpha) by prolyl hydroxylases (PHD). One mechanism of iron uptake is mediated by the cell surface transferrin receptor (TfR). Because iron is required for cell growth and suppression of HIF-alpha levels",
      "citation": {
        "db": "PubMed",
        "db_id": "16510596"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 48,
      "target": 110,
      "key": "49cb2453228c7ad29ce537278143c47c"
    },
    {
      "line": 213,
      "relation": "increases",
      "evidence": "Cellular oxygen partial pressure is sensed by a family of prolyl-4-hydroxylase domain (PHD) enzymes that modify hypoxia-inducible factor (HIF) alpha subunits. Upon hydroxylation under normoxic conditions, HIFalpha is bound by the von Hippel-Lindau tumor suppressor protein and targeted for proteasomal destruction.",
      "citation": {
        "db": "PubMed",
        "db_id": "15741220"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 55,
      "target": 110,
      "key": "c9100cdadc7e16f2c4e0c3ad3f270f98"
    },
    {
      "line": 213,
      "relation": "increases",
      "evidence": "Hypoxia-inducible factor (HIF) is a master transcriptional regulator of hypoxia-inducible genes and consists of a labile alpha subunit (such as HIF1alpha) and a stable beta subunit (such as HIF1beta or ARNT). In the presence of oxygen, HIFalpha family members are hydroxylated on one of two conserved prolyl residues by members of the egg-laying-defective nine (EGLN) family. Prolyl hydroxylation generates a binding site for a ubiquitin ligase complex containing the von Hippel-Lindau (VHL) tumor suppressor protein, which results in HIFalpha destruction. In addition, the HIFalpha transcriptional activation function is modulated further by asparagine hydroxylation by FIH (factor-inhibiting HIF), which affects recruitment of the coactivators p300 and CBP. These findings provide new mechanistic insights into oxygen sensing by metazoans and are the first examples of protein hydroxylation being used in intracellular signaling. The existence of three human EGLN family members, as well as other putative hydroxylases, raises the possibility that this signal is used in other contexts by other proteins. In the presence of oxygen, HIFalpha family members are hydroxylated on one of two conserved prolyl residues by members of the egg-laying-defective nine (EGLN) family. Prolyl hydroxylation generates a binding site for a ubiquitin ligase complex containing the von Hippel-Lindau (VHL) tumor suppressor protein, which results in HIFalpha destruction.",
      "citation": {
        "db": "PubMed",
        "db_id": "15952883"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 55,
      "target": 110,
      "key": "22de5b081e9d0a01e10eb36208a81806"
    },
    {
      "line": 213,
      "relation": "increases",
      "evidence": "Hydroxylation of Pro-402 and Pro-564 is required for interaction of HIF-1a with the VHL tumour-suppressor protein2.VHL is the recognition component of an E3 ubiquitin-protein ligase that targets HIF-1a for proteasomal degradation. Acetylation of HIF-1aat lysine-532 by the ARD1 acetyltransferase enhances the interaction of VHL with HIF-1a, promoting its ubiquitylation and degradation30. Figure 2 | O2-dependent regulation of HIF-1 activity. O2 regulates the rate at which HIF-1a protein is degraded. In normoxic conditions, O2-dependent hydroxylation of proline (P) residues 402 and 564 in HIF-1a by the enzymes PHD (prolyl hydroxylase-domain protein) is required for the binding of the von (VHL) tumour-suppressor protein, which is the recognition component of an E3 ubiquitin-protein ligase. VHL binding is also promoted by acetylation of lysine (K) residue 532 by the ARD1 acetyltransferase. Ubiquitylation of HIF-1a targets the protein for degradation by the 26S proteasome. O2 also regulates the interaction of HIF-1a with transcriptional co-activators.",
      "citation": {
        "db": "PubMed",
        "db_id": "13130303"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 55,
      "target": 110,
      "key": "a26e8ff2d2bc7562de755fc8345c780b"
    },
    {
      "line": 213,
      "relation": "increases",
      "evidence": "Cellular iron is needed for cell survival and hydroxylation of hypoxia-inducible factor-1alpha (HIF-alpha) by prolyl hydroxylases (PHD). One mechanism of iron uptake is mediated by the cell surface transferrin receptor (TfR). Because iron is required for cell growth and suppression of HIF-alpha levels",
      "citation": {
        "db": "PubMed",
        "db_id": "16510596"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 55,
      "target": 110,
      "key": "4293801bedc1f86930d936c7ae0480ff"
    },
    {
      "line": 213,
      "relation": "increases",
      "evidence": "Here we show using suppression by small interference RNA that each of the three PHD isoforms contributes in a non-redundant manner to the regulation of both HIF-1alpha and HIF-2alpha subunits and that the contribution of each PHD under particular culture conditions is strongly dependent on the abundance of the enzyme. From Gene summary: At normal oxygen levels, the alpha subunit of HIF is targeted for degration by prolyl hydroxylation.",
      "citation": {
        "db": "PubMed",
        "db_id": "15247232"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 55,
      "target": 110,
      "key": "4a1dd3ffdc2d3abc146ea2c08639c709"
    },
    {
      "line": 262,
      "relation": "increases",
      "evidence": "Hypoxia-inducible factor (HIF) is a master transcriptional regulator of hypoxia-inducible genes and consists of a labile alpha subunit (such as HIF1alpha) and a stable beta subunit (such as HIF1beta or ARNT). In the presence of oxygen, HIFalpha family members are hydroxylated on one of two conserved prolyl residues by members of the egg-laying-defective nine (EGLN) family. Prolyl hydroxylation generates a binding site for a ubiquitin ligase complex containing the von Hippel-Lindau (VHL) tumor suppressor protein, which results in HIFalpha destruction. In addition, the HIFalpha transcriptional activation function is modulated further by asparagine hydroxylation by FIH (factor-inhibiting HIF), which affects recruitment of the coactivators p300 and CBP. These findings provide new mechanistic insights into oxygen sensing by metazoans and are the first examples of protein hydroxylation being used in intracellular signaling. The existence of three human EGLN family members, as well as other putative hydroxylases, raises the possibility that this signal is used in other contexts by other proteins. In the presence of oxygen, HIFalpha family members are hydroxylated on one of two conserved prolyl residues by members of the egg-laying-defective nine (EGLN) family. Prolyl hydroxylation generates a binding site for a ubiquitin ligase complex containing the von Hippel-Lindau (VHL) tumor suppressor protein, which results in HIFalpha destruction.",
      "citation": {
        "db": "PubMed",
        "db_id": "15952883"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 56,
      "target": 110,
      "key": "8f0ec60f85b7ca17022907ea7fd1b859"
    },
    {
      "line": 262,
      "relation": "increases",
      "evidence": "Cellular oxygen partial pressure is sensed by a family of prolyl-4-hydroxylase domain (PHD) enzymes that modify hypoxia-inducible factor (HIF) alpha subunits. Upon hydroxylation under normoxic conditions, HIFalpha is bound by the von Hippel-Lindau tumor suppressor protein and targeted for proteasomal destruction.",
      "citation": {
        "db": "PubMed",
        "db_id": "15741220"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 56,
      "target": 110,
      "key": "662f1b2c94e64174b7bcec298343b9e6"
    },
    {
      "line": 262,
      "relation": "increases",
      "evidence": "Here we show using suppression by small interference RNA that each of the three PHD isoforms contributes in a non-redundant manner to the regulation of both HIF-1alpha and HIF-2alpha subunits and that the contribution of each PHD under particular culture conditions is strongly dependent on the abundance of the enzyme. From Gene summary: At normal oxygen levels, the alpha subunit of HIF is targeted for degration by prolyl hydroxylation.",
      "citation": {
        "db": "PubMed",
        "db_id": "15247232"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 56,
      "target": 110,
      "key": "840eccf1b33c1b27f4060a2fdcb7f4e0"
    },
    {
      "line": 262,
      "relation": "increases",
      "evidence": "In cells with stable gain and loss of MUC1 function, we have shown that MUC1 up-regulates prolyl hydroxylase 3 (PHD3) expression and promotes HIF-1alpha degradation.  PHD3 = EGLN3",
      "citation": {
        "db": "PubMed",
        "db_id": "17102128"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 56,
      "target": 110,
      "key": "abe018d9a63bc32ee4ae2bf2a69f19d0"
    },
    {
      "line": 96,
      "relation": "increases",
      "evidence": "from full text - To verify that the sustained mRNA translation in serum-deprived Tsc2?/? MEFs contributes to elevated HIF1? protein levels, we exposed the cells to eIF4E ASO, which was shown to effectively reduce the expression of eIF4E (6). Exposure to eIF4E ASO diminished the induction of HIF1? protein in serum-deprived Tsc2?/? MEFs (see Fig. ?Fig.8A8A).",
      "citation": {
        "db": "PubMed",
        "db_id": "19620286"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 78,
      "target": 110,
      "key": "94217aa0c318a29b78bb38b15658b7e5"
    },
    {
      "line": 96,
      "relation": "increases",
      "evidence": "growth factors, cytokines and other signalling molecules stimulate HIF-1a synthesis via activation of the phosphatidylinositol 3-kinase (PI3K) or mitogen- activated protein kinase (MAPK) pathways (FIG. 1).",
      "citation": {
        "db": "PubMed",
        "db_id": "13130303"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 78,
      "target": 110,
      "key": "b6f5efb6f881b769863552c593f73058"
    },
    {
      "line": 176,
      "relation": "decreases",
      "evidence": "Endothelial cells lacking endoglin do not grow because TGF-beta/ALK1 signalling is reduced and TGF-beta/ALK5 signalling is increased",
      "citation": {
        "db": "PubMed",
        "db_id": "15385967"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 79,
      "target": 43,
      "key": "79ea1fcf068f0f315efee40bf56acff0"
    },
    {
      "line": 300,
      "relation": "increases",
      "evidence": "Endothelial cells lacking endoglin do not grow because TGF-beta/ALK1 signalling is reduced and TGF-beta/ALK5 signalling is increased",
      "citation": {
        "db": "PubMed",
        "db_id": "15385967"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 79,
      "target": 61,
      "key": "4f1599d6fc1d8f11f22a870ca4f3d82b"
    },
    {
      "line": 300,
      "relation": "increases",
      "evidence": "Endoglin (ENG) promotes angiogenesis by enhancing activation of TGF-beta type I receptors ALK-1 and ALK-5.",
      "citation": {
        "db": "Other",
        "db_id": "20060813"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 79,
      "target": 61,
      "key": "361abeec0e63cda91f8f460d9ff8dcf4"
    },
    {
      "line": 87,
      "relation": "directlyIncreases",
      "evidence": "To identify the modified residue, the relevant tryptic peptides from each sample were further analyzed by tandem mass spectrometry. Comparison of the fragment patterns revealed that Asn 851 contained the additional oxygen atom (Fig. 4B). Together these data show that FIH-1 is an asparaginyl hydroxylase that inhibits HIF transcriptional activity by preventing CAD association with the coactivator p300.",
      "citation": {
        "db": "PubMed",
        "db_id": "12080085"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 81,
      "target": 82,
      "key": "a0decb8a71fa23a5b7144966cf80831d"
    },
    {
      "line": 87,
      "relation": "directlyIncreases",
      "evidence": "The transactivation activity of HIF complexes requires the recruitment of p300/CREB-binding protein (CBP) by HIF-1 alpha and HIF-2 alpha that undergo oxygen-dependent degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "12588875"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 81,
      "target": 82,
      "key": "9b6de8dbd325e43d4cb80b1c78ff36db"
    },
    {
      "line": 97,
      "relation": "directlyIncreases",
      "evidence": "(from text) Furthermore, decreasing endogenous levels of FOXO3a protein by siRNA increases HIF-1 transcriptional activity in PTEN-positive HEK-293 cells (Fig. 6Fig. 6. D and E). Collectively, our findings support the argument that FOXO3a is a negative regulator of HIF-1 transcriptional activity by interfering with the ability of p300 to serve a transcriptional coactivator.",
      "citation": {
        "db": "PubMed",
        "db_id": "18268343"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 81,
      "target": 110,
      "key": "fc23dae8e13eca074bd97690b129485d"
    },
    {
      "line": 97,
      "relation": "directlyIncreases",
      "evidence": "CITED4 blocks the binding of hypoxia-inducible factor 1alpha to p300 in vitro and inhibits hypoxia-inducible factor-1alpha transactivation",
      "citation": {
        "db": "PubMed",
        "db_id": "15342390"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 81,
      "target": 110,
      "key": "4db6dd11724822c0c1ab45cef3b8a483"
    },
    {
      "line": 108,
      "relation": "increases",
      "evidence": "Administration of thrombin significantly promoted EPCs proliferation and adhesion. Thrombin also increased the tube formation in Matrigel assay.",
      "citation": {
        "db": "PubMed",
        "db_id": "21670961"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 85,
      "target": 3,
      "key": "1b6cc62aab326d277bf9aeb98e592b8e"
    },
    {
      "line": 279,
      "relation": "increases",
      "evidence": "However, the selective dependence of angiogenic vessels on the activation of these receptors by VEGF might be more important than the quantity of VEGFRs expressed, as angiogenic vessels are highly vulnerable to inhibition of VEGF activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "12635171"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 99,
      "target": 2,
      "key": "d5397ab574010ddecf714e42b10241e1"
    },
    {
      "line": 279,
      "relation": "increases",
      "evidence": "Recent studies of the VEGFR1 ligand PlGF have proposed that VEGFR1 mediates tumor growth and angiogenesis by recruiting tumor-promoting inflammatory cells .",
      "citation": {
        "db": "PubMed",
        "db_id": "19763275"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 99,
      "target": 2,
      "key": "7f1cfeba3a55e48edc6a095585661794"
    },
    {
      "line": 143,
      "relation": "decreases",
      "evidence": "Here, we show that Foxo1 and Foxo3a are the most abundant Foxo isoforms in mature endothelial cells and that overexpression of constitutively active Foxo1 or Foxo3a, but not Foxo4, significantly inhibits endothelial cell migration and tube formation in vitro.",
      "citation": {
        "db": "PubMed",
        "db_id": "16100571"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 101,
      "target": 4,
      "key": "74bd5dc0e8fe5850ccb91d06a600c940"
    },
    {
      "line": 145,
      "relation": "decreases",
      "evidence": "Gene expression profiling showed that Foxo1 and Foxo3a specifically regulate a nonredundant but overlapping set of angiogenesis- and vascular remodeling-related genes.",
      "citation": {
        "db": "PubMed",
        "db_id": "16100571"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 101,
      "target": 2,
      "key": "586937dca0c59a477561ca0f93683b16"
    },
    {
      "line": 144,
      "relation": "decreases",
      "evidence": "Here, we show that Foxo1 and Foxo3a are the most abundant Foxo isoforms in mature endothelial cells and that overexpression of constitutively active Foxo1 or Foxo3a, but not Foxo4, significantly inhibits endothelial cell migration and tube formation in vitro.",
      "citation": {
        "db": "PubMed",
        "db_id": "16100571"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 102,
      "target": 4,
      "key": "74b0d1ca5dd73d65760bfe720c95c332"
    },
    {
      "line": 44,
      "relation": "directlyIncreases",
      "evidence": "Combined blockade of Alk1 and Notch signaling further exacerbates hypervascularization, whereas activation of Alk1 by its high-affinity ligand BMP9 rescues hypersprouting induced by Notch inhibition",
      "citation": {
        "db": "PubMed",
        "db_id": "22421041"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 104,
      "target": 61,
      "key": "a7382c4fac36bafb6825243f1a8427f6"
    },
    {
      "line": 187,
      "relation": "directlyIncreases",
      "evidence": "In search of the cause, the authors found that the resistant cells had amplified the MET oncogene, which encodes a transmembrane tyrosine kinase receptor that is activated by hepatocyte growth factor (also called scatter factor). MET gene amplification or activating mutations are found across a spectrum of primary human cancers10.",
      "citation": {
        "db": "PubMed",
        "db_id": "17554333"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 109,
      "target": 136,
      "key": "f60dc1abfcf7807432c63e3649e20edc"
    },
    {
      "line": 187,
      "relation": "directlyIncreases",
      "evidence": "Hepatocyte growth factor (HGF), a cytokine involved in tumorigenesis and most metastases, initiates cell migration by binding to the protooncogene c-Met receptor. In epithelial carcinoma cells, c-Met activation causes the breakdown of E-cadherin cell-cell contacts leading to cell spreading.",
      "citation": {
        "db": "PubMed",
        "db_id": "14697335"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 109,
      "target": 136,
      "key": "76a9316a4f1424132c3b03f6ed222a1a"
    },
    {
      "line": 187,
      "relation": "directlyIncreases",
      "evidence": "A CD44 isoform containing variant exon v6 sequences is strictly required for c-Met activation by HGF/SF in rat and human carcinoma cells, in established cell lines as well as in primary keratinocytes.",
      "citation": {
        "db": "PubMed",
        "db_id": "12464636"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 109,
      "target": 136,
      "key": "f85dcea7e4c497dbb5bbf97faf206b89"
    },
    {
      "line": 187,
      "relation": "directlyIncreases",
      "evidence": "The c-met protooncogene product (Met), which is a high-affinity receptor for hepatocyte growth factor, plays an important role in controlling the invasion of many types of cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "16099863"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 109,
      "target": 136,
      "key": "dd2e1887b3a9cb7b764cdab0d26bc7d5"
    },
    {
      "line": 187,
      "relation": "directlyIncreases",
      "evidence": "The results presented here delineate a novel signaling pathway from HGF to the GTPase Rap1 which depends on the interaction of the adapter protein CRKL with the exchange factor C3G and could be linked to cell migration.",
      "citation": {
        "db": "PubMed",
        "db_id": "10753869"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 109,
      "target": 136,
      "key": "e926fbf2866826f34a20e1b61a6bde64"
    },
    {
      "line": 187,
      "relation": "directlyIncreases",
      "evidence": "In the HGF-producing myeloma cell line ANBL-6, PHA-665752 revealed an autocrine HGF-c-Met-mediated growth loop. The inhibitor also blocked proliferation of purified primary myeloma cells, suggesting that autocrine HGF-c-Met-driven growth loops are important for progression of multiple myeloma.",
      "citation": {
        "db": "PubMed",
        "db_id": "15475459"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 109,
      "target": 136,
      "key": "debeea3ee9d6b39b5084d19d13778d91"
    },
    {
      "line": 187,
      "relation": "directlyIncreases",
      "evidence": "P311 mRNA expression was decreased sharply in both neural and smooth muscle cells when the cells were transformed by coexpression of the oncogenic tyrosine kinase receptor Met and its ligand hepatocyte growth factor/scatter factor.",
      "citation": {
        "db": "PubMed",
        "db_id": "10660586"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 109,
      "target": 136,
      "key": "703619404fa9c4effffbcc89477d5455"
    },
    {
      "line": 37,
      "relation": "increases",
      "evidence": "In primary human endothelial cells, hypoxia, desferrioxamine, or infection with Ad2/HIF-1alpha/VP16, an adenoviral vector encoding a constitutively stable hybrid form of HIF-1alpha, increased the mRNA and protein levels of VEGF, angiopoietin-2 (Ang-2), and angiopoietin-4 (Ang-4)",
      "citation": {
        "db": "PubMed",
        "db_id": "12958144"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 110,
      "target": 106,
      "key": "4a8523e7d8fa24ffd9c6a2c6cf044b50"
    },
    {
      "line": 93,
      "relation": "increases",
      "evidence": "Notably, naturally occurring mutations cluster in hotspots and predominantly affect the elongin C and HIF-a interface regions of pVHL (Table 3 and Figure 2) [6]. The VHL-mediated proteolytic degradation of HIF suppresses a transcription programme that is normally engaged by HIF as part of the adaptive response of the cell to hypoxia, such as the activation of vascular endothelial growth factor (VEGF), which is a potent angiogenic factor that is involved in the formation and differentiation of blood vessels. Aberrant HIF control, therefore, partially helps to explain the highly vascular phenotype of VHL-null tumours. Additionally, HIF regulates genes that are involved in glucose transport and glycolysis, such as glucose transporter 1 (GLUT1) and hexokinase 1, which facilitate glycolytic changes that are capable of metabolically adjusting to fluctuations in normal oxygen tension.",
      "citation": {
        "db": "PubMed",
        "db_id": "15350900"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 110,
      "target": 2,
      "key": "46848a8a207fed0463eb7eb96d445151"
    },
    {
      "line": 93,
      "relation": "increases",
      "evidence": "in the absence of VHL function, continuous activation of HIF1alpha promotes angiogenesis",
      "citation": {
        "db": "PubMed",
        "db_id": "15286739"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 110,
      "target": 2,
      "key": "3bc538126eeae11aa504a709da703762"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "Tumor suppressor mutations, including PTEN, p53, p14ARF, and most strikingly pVHL, also activate the HIF system (reviewed in refs. 24,99,100). As outlined above, pVHL is a key component of the oxygen-sensitive pathway, and inactivation results in constitutive stabilization of HIF-alpha subunits and upregulation of the transcriptional response. Other mechanisms of oncogenic and growth factor stimulation of the HIF pathway are less clearly defined, although induction of HIF1alpha mRNA levels and enhanced translation, stability and activity of HIF-alpha protein have all been described. In keeping with the known transduction pathways mediating responses to these stimuli, both the MEK?MAP kinase101 and the phosphatidylinositol-3 kinase?Akt102 systems have been implicated in these processes. Microenvironmental activation of HIF in cancer occurs at the simplest level by physiological activation of the oxygen-sensitive pathways by hypoxia within the growing mass of cells. Surprisingly, however, studies using hydroxylation-specific antibodies have indicated that prolyl hydroxylation of HIF is often incomplete in tumor cells, even in fully oxygenated tissue culture103. Under these conditions, HIF-alpha degradation can be enhanced by supplementation with iron or ascorbate, most probably by promotion of HIF hydroxylase activity104. Precarious iron balance is a well-recognized characteristic of rapidly growing tumor cells105. Taken together, these findings suggest that reduction of cellular iron availability, as well as hypoxia, may limit HIF hydroxylase activity in cancer cells and contribute to the general activation of HIF in tumors (Fig. 4).",
      "citation": {
        "db": "PubMed",
        "db_id": "12778166"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "ee9b3cdb9225384bbc33c0c0c3cbd5a9"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "Hypoxia-inducible factor (HIF) is a master transcriptional regulator of hypoxia-inducible genes and consists of a labile alpha subunit (such as HIF1alpha) and a stable beta subunit (such as HIF1beta or ARNT). In the presence of oxygen, HIFalpha family members are hydroxylated on one of two conserved prolyl residues by members of the egg-laying-defective nine (EGLN) family. Prolyl hydroxylation generates a binding site for a ubiquitin ligase complex containing the von Hippel-Lindau (VHL) tumor suppressor protein, which results in HIFalpha destruction. In addition, the HIFalpha transcriptional activation function is modulated further by asparagine hydroxylation by FIH (factor-inhibiting HIF), which affects recruitment of the coactivators p300 and CBP. These findings provide new mechanistic insights into oxygen sensing by metazoans and are the first examples of protein hydroxylation being used in intracellular signaling. The existence of three human EGLN family members, as well as other putative hydroxylases, raises the possibility that this signal is used in other contexts by other proteins. In the presence of oxygen, HIFalpha family members are hydroxylated on one of two conserved prolyl residues by members of the egg-laying-defective nine (EGLN) family. Prolyl hydroxylation generates a binding site for a ubiquitin ligase complex containing the von Hippel-Lindau (VHL) tumor suppressor protein, which results in HIFalpha destruction.",
      "citation": {
        "db": "PubMed",
        "db_id": "15952883"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "a8b4f01b44ebbcd878f0c1fc1a5bf184"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "Tumors of patients with the same disease stage but with high CTGF protein expression had reduced microvessel density compared with tumors with low expression. Transfection with antisense-ARD1 decreased the level of acetylated HIF-1alpha and restored HIF-1alpha and VEGF-A expression in CTGF-overexpressing cells. CONCLUSION: CTGF inhibition of metastasis involves the inhibition of VEGF-A-dependent angiogenesis, possibly by promoting HIF-1alpha protein degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "16849681"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "67173d029ccff9d6ce2d3b4859fa80ec"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "Here we show using suppression by small interference RNA that each of the three PHD isoforms contributes in a non-redundant manner to the regulation of both HIF-1alpha and HIF-2alpha subunits and that the contribution of each PHD under particular culture conditions is strongly dependent on the abundance of the enzyme. From Gene summary: At normal oxygen levels, the alpha subunit of HIF is targeted for degration by prolyl hydroxylation.",
      "citation": {
        "db": "PubMed",
        "db_id": "15247232"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "04e130a904273d9a377b25576c251651"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "Here we provide evidence that lactate and pyruvate regulate hypoxia-inducible gene expression independently of hypoxia by stimulating the accumulation of hypoxia-inducible Factor 1alpha (HIF-1alpha). In human gliomas and other cancer cell lines, the accumulation of HIF-1alpha protein under aerobic conditions requires the metabolism of glucose to pyruvate that prevents the aerobic degradation of HIF-1alpha protein, activates HIF-1 DNA binding activity,",
      "citation": {
        "db": "PubMed",
        "db_id": "11943784"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "5d951d60e47ac105885fa930d5285173"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "Hypoxia and induction of hypoxia-inducible factors (HIF-1alpha and HIF-2alpha) is a hallmark of many tumors. Under normal oxygen tension HIF-alpha subunits are rapidly degraded through prolyl hydroxylase dependent interaction with the von Hippel-Lindau (VHL) tumor suppressor protein, a component of E3 ubuiquitin ligase complex.",
      "citation": {
        "db": "PubMed",
        "db_id": "15156561"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "1b5df8681178737175f055f51b026fad"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "Hypoxia-inducible factor-1 (HIF-1) has a key role in cellular responses to hypoxia, including the regulation of genes involved in energy metabolism, angiogenesis and apoptosis. The alpha subunits of HIF are rapidly degraded by the proteasome under normal conditions, but are stabilized by hypoxia. Cobaltous ions or iron chelators mimic hypoxia, indicating that the stimuli may interact through effects on a ferroprotein oxygen sensor. Here we demonstrate a critical role for the von Hippel-Lindau (VHL) tumour suppressor gene product pVHL in HIF-1 regulation. In VHL-defective cells, HIF alpha-subunits are constitutively stabilized and HIF-1 is activated. Re-expression of pVHL restored oxygen-dependent instability. pVHL and HIF alpha-subunits co-immunoprecipitate, and pVHL is present in the hypoxic HIF-1 DNA-binding complex. In cells exposed to iron chelation or cobaltous ions, HIF-1 is dissociated from pVHL. These findings indicate that the interaction between HIF-1 and pVHL is iron dependent, and that it is necessary for the oxygen-dependent degradation of HIF alpha-subunits. Thus, constitutive HIF-1 activation may underlie the angiogenic phenotype of VHL-associated tumours. The pVHL/HIF-1 interaction provides a new focus for understanding cellular oxygen sensing.",
      "citation": {
        "db": "PubMed",
        "db_id": "10353251"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "afae3daf41444f1919ba53104bd99516"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "In addition, it became apparent that Hsp90 protects HIF-1alpha from oxygen-independent degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "14726529"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "b9cb5837d3f8d7383d447bc09d0644ae"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "Under normoxia, HIFs are targeted for proteasomal degradation by the von Hippelâ€“Lindau (VHL) tumor suppressor, pVHL. It has been shown that pVHL is the substrate recognition component of an E3 ubiquitin ligase complex that interacts with HIF-a in an oxygen-dependent manner.",
      "citation": {
        "db": "PubMed",
        "db_id": "18259193"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "2231a0075c192535a02193dea19a42bd"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "The protein pVHL functions in a multi-subunit E3 ubiquitin ligase that targets the hypoxia-inducible transcription factor Hif1 alpha for proteasomal degradation during normoxia.",
      "citation": {
        "db": "PubMed",
        "db_id": "14556007"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "7a0170d339d225762d4981a89ad01a27"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "Furthermore, siRNA silencing of PHD-2, which stabilizes HIF-1a protein under normoxic conditions, increased MIP-1b mRNA expression by ?14-fold in the absence of ET-1 (Fig. 3B, lane 4) compared with that of nontransfected THP-1 cells (Fig. 3B, lane 1).",
      "citation": {
        "db": "PubMed",
        "db_id": "20952681"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "bbcfc2a211d644c9b4c9ced07ddfff05"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "These results indicate that ligand-dependent degradation and lower HIF-1alpha levels may be potential causes of lowered levels of CXCR4 in the lymph nodes compared to the primary tumors.",
      "citation": {
        "db": "PubMed",
        "db_id": "16756955"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "751ec4a91076b6038ed50bc36c27419c"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "Since PHD activity is dependent on oxygen and ferrous iron, HIF-1 mediates not only oxygen- but also iron-regulated transcriptional gene expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "15741220"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "8e9960bee977a3f764c551d7b876b732"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "this interaction causes HIF1A to become ubiquitylated and targeted to the proteasome, where it is degraded",
      "citation": {
        "db": "PubMed",
        "db_id": "11902584"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "50d9c4f2afe096b165943fb6168eac21"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor",
      "citation": {
        "db": "PubMed",
        "db_id": "11559532"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "6940822a90e05f6c1dcae9961510d182"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "in hypoxic conditions, this factor is stabilized, it cannot interact with VHL protein, because prolyl hyroxylase (EGLN2), an enzyme that normally modifies HIF1alpha to promote its interactions with VHL protein, is not active in hypoxic conditions",
      "citation": {
        "db": "PubMed",
        "db_id": "12793895"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "a151cd1e9985487efa31d4eafa2d9da4"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "# Ariadne: Hypoxia and iron chelation dramatically  increase the half-life of HIF-1alpha, permitting the formation of functionally  active HIF-1alpha/ARNT heterodimers. [Binding]",
      "citation": {
        "db": "PubMed",
        "db_id": "10477715"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "77d52f379a5b78eb17442f6b76167b35"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "Both NO and CO inhibited HIF-1 DNA binding by abrogating hypoxia-induced accumulation of HIF-1alpha protein.",
      "citation": {
        "db": "PubMed",
        "db_id": "10085152"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "7ce95ff5d90357a412c6c7f5e4074e58"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "# Ariadne: Chelating agents such as desferrioxamine (DFO) have been demonstrated  previously to stabilize HIF-1alpha in vivo . [Regulation]",
      "citation": {
        "db": "PubMed",
        "db_id": "11504942"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "23c86d0b6e38369f3abb2dccd86006bf"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "Jab1 also interacts with hypoxia-inducible factor 1a (HIF1a) and enhances its stability, leading to increased expression of vascular endothelial growth factor, a major HIF-1a target, under hypoxic conditions (Bae et al., 2002).",
      "citation": {
        "db": "PubMed",
        "db_id": "15480426"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "79cf5f6517607159382c7ae39c3482be"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "Cellular iron is needed for cell survival and hydroxylation of hypoxia-inducible factor-1alpha (HIF-alpha) by prolyl hydroxylases (PHD). One mechanism of iron uptake is mediated by the cell surface transferrin receptor (TfR). Because iron is required for cell growth and suppression of HIF-alpha levels",
      "citation": {
        "db": "PubMed",
        "db_id": "16510596"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "8ff9c101f82f53f4e1b2fd5d2cf491b7"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "Accordingly, our observations suggested that CIM has an ability to regulate HIF-1a through sequestration of OS-9 from a complex with HIF-1a and PHD2, leading to inhibition of HIF-1a degradation and its consequential upregulation",
      "citation": {
        "db": "PubMed",
        "db_id": "21118962"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "43b5583cebba8ef77241b176235dc1af"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "In this setting, pVHL targets the a-subunits of hypoxiainducible factor (HIF) for ubiquitin-mediated proteolysis under normal oxygen conditions [18].",
      "citation": {
        "db": "PubMed",
        "db_id": "15350900"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "80bf7d2581972c58b944ded3e3753f9a"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "Moreover, Jab1-enhanced transcriptional activity of HIF-1 under hypoxia led to increase the expression of VEGF, a major HIF-1 target gene. Furthermore, Jab1 increased HIF-1alpha protein levels, which was due to the enhanced HIF-1alpha stability",
      "citation": {
        "db": "PubMed",
        "db_id": "11707426"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "97d478466feb944a29cae8312cbbdeb3"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "Ectopic expression of constitutively active Erk5 blocks endothelial cell morphogenesis and causes HIF1-alpha destabilization/degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "20185831"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "aaff400ab364e6a34682834c17404fa2"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "Under hypoxic conditions, the rate of asparagine and proline hydroxylation decreases. VHL cannot bind to HIF-1a that is not prolyl-hydroxylated, resulting in a decreased rate of HIF-1a degradation. By contrast, p300 and CBP can bind to HIF-1a that is not asparaginyl-hydroxylated, allowing transcriptional activation of HIF-1 target genes.",
      "citation": {
        "db": "PubMed",
        "db_id": "13130303"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "2f2763087671e02f4c571fc802c7ed4e"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "The ROS oxidize and inactivate the ferrous ion within the active sites of the PHDs. This renders the PHDs incapable of modifying the HIF? subunit, resulting in the stabilization of the HIFs30",
      "citation": {
        "db": "PubMed",
        "db_id": "18046334"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "796c7a45a35dc49061c66941184509ac"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "activated STAT3 increased HIF-1alpha protein levels due to the HIF-1alpha stability by blocking HIF-1alpha degradation and accelerated its de novo synthesis.",
      "citation": {
        "db": "PubMed",
        "db_id": "15919761"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "f4fcbdc55beace9959082ba3444b4332"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "p53 promotes MDM2-mediated ubiquitulation and proteasomal degradation of HIF1A",
      "citation": {
        "db": "PubMed",
        "db_id": "12778130"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "a802ce9e5c38fcc1475c635719e0d1dc"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "In cells with stable gain and loss of MUC1 function, we have shown that MUC1 up-regulates prolyl hydroxylase 3 (PHD3) expression and promotes HIF-1alpha degradation.  PHD3 = EGLN3",
      "citation": {
        "db": "PubMed",
        "db_id": "17102128"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "d550ab56302bcc14c9cde0ef61472343"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "Mechanistically, KLF2 promoted HIF-1alpha degradation in a von Hippel-Lindau protein-independent but proteasome-dependent manner. Finally, KLF2 disrupted the interaction between HIF-1alpha and its chaperone Hsp90, suggesting that KLF2 promotes degradation of HIF-1alpha by affecting its folding and maturation",
      "citation": {
        "db": "PubMed",
        "db_id": "19491109"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "170d7938d7f29009f9ce2a41cbbae962"
    },
    {
      "line": 272,
      "relation": "directlyDecreases",
      "evidence": "A mechanistic explanation for these effects is provided by our finding a reduced half-life and reduced accumulation of HIF-1alpha in hypoxic cells transfected with BRCA1-siRNAs and that proteasome inhibitors blocked these effects of BRCA1-siRNAs.",
      "citation": {
        "db": "PubMed",
        "db_id": "16543242"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 110,
      "target": 110,
      "key": "9e9beffa8f443203cbb370ce2ebc9741"
    },
    {
      "line": 303,
      "relation": "directlyIncreases",
      "evidence": "These findings implicate HIF-1 in the activation of VEGF transcription in hypoxic cells.",
      "citation": {
        "db": "Other",
        "db_id": "8756616"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 110,
      "target": 50,
      "key": "d59f5fe72fa17461efd6c76cebbce3c9"
    },
    {
      "line": 309,
      "relation": "increases",
      "evidence": "The results reveal that FGF2 is induced at the protein level during ischemia, concomitant with HIF-1alpha induction",
      "citation": {
        "db": "Other",
        "db_id": "18728783"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 110,
      "target": 90,
      "key": "7522410ac61c024b60548cf8924a69fc"
    },
    {
      "line": 316,
      "relation": "directlyIncreases",
      "evidence": "While hypoxia induced the transcription factor hypoxia-inducible factor-1alpha (HIF-1alpha) in all endothelial cells tested.\nplatelet-derived growth factor-B (PDGF-B)",
      "citation": {
        "db": "Other",
        "db_id": "15350545"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 110,
      "target": 148,
      "key": "5812bca17514e253fcb440e83f0e9452"
    },
    {
      "line": 321,
      "relation": "increases",
      "evidence": "The latter is a bona fide renal-cell mitogen that activates the Ras Raf MAP kinase signalling cascade through its cognate epidermal growth factor (EGF) cell surface receptor [26]. The overproduction of TGFa in RCC cells is, at least in part, HIF-dependent and a major contributory event that confers a growth advantage to these cells [25,27].",
      "citation": {
        "db": "PubMed",
        "db_id": "15350900"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 110,
      "target": 40,
      "key": "3ee36779c5bc0ea3d31d42c70bd25339"
    },
    {
      "line": 165,
      "relation": "directlyDecreases",
      "evidence": "O2-dependent hydroxylation of asparagine (N) residue 803 in HIF-1a by the enzyme FIH-1 (factor inhibiting HIF-1) blocks the binding of p300 and CBP to HIF-1a and therefore inhibits HIF-1-mediated gene transcription.",
      "citation": {
        "db": "PubMed",
        "db_id": "13130303"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 60,
      "target": 110,
      "key": "bf2a6ed3c93cf6bc7217f0715415b04a"
    },
    {
      "line": 130,
      "relation": "directlyIncreases",
      "evidence": "We examined the effect of blockade of type 1 IGF tyrosine kinase receptor (IGF-IR) in a murine model of bleomycin-induced lung injury and fibrosis. Mice were treated with a monoclonal antibody against the IGF-I receptor (A12) or vehicle after intratracheal bleomycin instillation. MEASUREMENTS AND MAIN RESULTS: Mice treated with A12 antibody had significantly improved survival after bleomycin injury compared with control mice. Both groups of mice had a similar degree of fibrosis on days 7 and 14, but by Day 28 the A12-treated group had significantly less fibrosis. Delayed treatment with A12 also resulted in decreased fibrosis. A12-treated mice had significantly decreased apoptotic cells on Day 28 compared with control mice. We confirmed that A12 treatment induced mouse lung fibroblast apoptosis in vitro. In addition, IGF-I increased lung fibroblast migration. The primary pathway activated by IGF-I in lung fibroblasts was the insulin receptor substrate-2/phosphatidylinositol 3-kinase/Akt axis.",
      "citation": {
        "db": "PubMed",
        "db_id": "19011156"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 113,
      "target": 114,
      "key": "014d604a428305084cffe678e71a85b4"
    },
    {
      "line": 130,
      "relation": "directlyIncreases",
      "evidence": "Recent studies have shown that the expression of two musclespecific ubiquitin ligases,MuRF1 [11] and Atrogin-1/MAFbx [11,12], is upregulated in multiple settings of atrophy. Mice in which either the MuRF1 or the Atrogin-1/MAFbx genes were deleted demonstrated sparing of skeletal muscle during atrophy conditions, as assessed by maintenance of skeletal muscle mass [11]. Stimulation of muscle cells with IGF-1 is sufficient to induce hypertrophy [3]. Transgenic mice in which IGF-1 expression is increased using a muscle-specific promoter have muscles that are at least twofold greater in mass when compared with wild-type mice [4,5]. IGF-1 binding activates the IGF-1 receptor (IGFR), a receptor tyrosine kinase.",
      "citation": {
        "db": "PubMed",
        "db_id": "12928036"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 113,
      "target": 114,
      "key": "cb2eb066f34f1916e54deff9ae8985eb"
    },
    {
      "line": 130,
      "relation": "directlyIncreases",
      "evidence": "p85 is a direct in vitro substrate of the IGF-I receptor kinase a tight association occurs between phosphorylated IGF-I receptor and phosphatidylinositol 3-kinase, that the region of phosphatidylinositol 3-kinase that contains its SH2 domains is directly involved in this association, and that this region is a direct substrate for IGF-I receptor tyrosine kinase",
      "citation": {
        "db": "PubMed",
        "db_id": "1317864"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 113,
      "target": 114,
      "key": "3afde49370ad87154c4e16b289ea6a8d"
    },
    {
      "line": 130,
      "relation": "directlyIncreases",
      "evidence": "LDL, in pathophysiological concentrations, affect the IGF-I signaling pathway at multiple levels: 1) they induce phosphorylation of IGF-I receptor beta and IRS-1 in a time- and dose-dependent manner; 2) they up-regulate IRS-1-associated PI3 kinase/Akt activation in response to IGF-I at early times; and 3) they show additive effects with IGF-I on extracellular signal-regulated MAPK 1/2 phosphorylation.",
      "citation": {
        "db": "PubMed",
        "db_id": "11606453"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 113,
      "target": 114,
      "key": "1f0781ff9a009bb00fef94f4ab14bc9b"
    },
    {
      "line": 130,
      "relation": "directlyIncreases",
      "evidence": "IGF-I-stimulated activation of IGF-IR and downstream signaling intermediates were enhanced in the intestine of SOCS2 null mice and were decreased by SOCS2 overexpression in Caco-2 cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "16574995"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 113,
      "target": 114,
      "key": "a7dddbdea2e76c86766c3408ff885672"
    },
    {
      "line": 130,
      "relation": "directlyIncreases",
      "evidence": "from full text - Figure 2",
      "citation": {
        "db": "PubMed",
        "db_id": "11739335"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 113,
      "target": 114,
      "key": "bde543d1b0c0fa5fab68a16b9dc4b6a6"
    },
    {
      "line": 130,
      "relation": "directlyIncreases",
      "evidence": "The IGF-I-promoted macrophage differentiation was blocked specifically by preincubation of HL-60 cells with a mAb (alphaIR3) directed against the IGF type I receptor.",
      "citation": {
        "db": "PubMed",
        "db_id": "9570559"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 113,
      "target": 114,
      "key": "7d3df1a39ff7733086a59b2c3e8b9dea"
    },
    {
      "line": 247,
      "relation": "increases",
      "evidence": "In addition to activation by hypoxia, the HIF system is also induced or amplified by a wide range of growth-promoting stimuli and oncogenic pathways such as the insulin, insulin-like growth factor-1, epidermal growth factor and mutant Ras and Src kinase pathways.",
      "citation": {
        "db": "PubMed",
        "db_id": "12778166"
      },
      "annotations": {},
      "source": 113,
      "target": 110,
      "key": "75a21e9f994602c51abc7756e83f2c06"
    },
    {
      "line": 247,
      "relation": "increases",
      "evidence": "In this report, we studied the action of IGF-I on the regulation of HIF-1 in human retinal epithelial cells. We show that IGF-I stimulates HIF-1alpha accumulation, HIF-1alpha nuclear translocation, and HIF-1 activity",
      "citation": {
        "db": "PubMed",
        "db_id": "15695372"
      },
      "annotations": {},
      "source": 113,
      "target": 110,
      "key": "022129cc89cb1ad4048abb2eb45f584b"
    },
    {
      "line": 18,
      "relation": "increases",
      "evidence": "Several growth factors, most notably insulin-like growth factor-2 (IGF2) and transforming growth factor-a (TGF-a), are also HIF-1 target genes. Binding of these factors to their cognate receptors the insulin-like growth factor 1 receptor (IGF1R) and epidermal growth-factor receptor (EGFR), respectively activates signal-transduction pathways that lead both to HIF-1a expression (as described above) and to cell proliferation survival. HIF-1 therefore contributes to autocrine-signalling pathways that are crucial for cancer progression (FIG. 6).",
      "citation": {
        "db": "PubMed",
        "db_id": "13130303"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 114,
      "target": 110,
      "key": "1ea9829b34af2ad1e2a385f3b561b02a"
    },
    {
      "line": 135,
      "relation": "increases",
      "evidence": "Given that the three ubiquitously expressed SFK members c-Src, Fyn, and Yes have been previously identified in 3T3-L1 cells (34) , we immunoprecipitated Src, Fyn, and Yes from IGF-I-stimulated proliferating cells and measured kinase activity with an in vitro assay using enolase as a substrate (35) . IGF-I stimulated c-Src kinase activity in proliferating cells at a peak stimulation time of 1 min (Fig. 5A)Citation . The kinetics of IGF-I-stimulated c-Src and MAPK are consistent with SFK activation occurring upstream of MAPK: both activities are back to baseline by 10 min, and our previous studies demonstrated peak MAPK activation was at 5 min (15) . IGF-I stimulation of c-Src and Fyn activity was comparable, ~3-fold more than baseline, and dependent on immunoprecipitation with specific antibodies (Fig. 5B)Citation . IGF-I activation of both c-Src and Fyn is not surprising,",
      "citation": {
        "db": "PubMed",
        "db_id": "11457735"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 114,
      "target": 38,
      "key": "2b585a0de6f9b8ebe8a06f2251f39823"
    },
    {
      "line": 256,
      "relation": "directlyIncreases",
      "evidence": "we show that activation of the Notch pathway by the ligand Jagged1 reduces the proliferation of endothelial cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "15456857"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 121,
      "target": 21,
      "key": "034a137d9bf8221076ddc78c64758837"
    },
    {
      "line": 256,
      "relation": "directlyIncreases",
      "evidence": "Notch signaling is important for Th2 differentiation.44, 45  It has been shown that Jag1/Notch interaction induces Th2 differentiation.whereas Dll1/Notch interaction results in Th1 polarization.44",
      "citation": {
        "db": "PubMed",
        "db_id": "20065998"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 121,
      "target": 21,
      "key": "da16f27cb900efc69abae933df4b3cf0"
    },
    {
      "line": 256,
      "relation": "directlyIncreases",
      "evidence": "mTOR positively regulates the mRNA expression of Notch ligand Jagged1.",
      "citation": {
        "db": "PubMed",
        "db_id": "20038814"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 121,
      "target": 21,
      "key": "54b321156e61cb3ec2c59018bc12cedf"
    },
    {
      "line": 256,
      "relation": "directlyIncreases",
      "evidence": "To generate tools for pursuing the role of the Notch pathway in human disease and development, we have cloned and analyzed the expression of three human homologues of the Notch ligands Delta and Serrate, human Jagged1 (HJ1), human Jagged2 (HJ2), and human Delta1 (H-Delta-1), and determined their chromosomal localizations.",
      "citation": {
        "db": "PubMed",
        "db_id": "10079256"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 121,
      "target": 21,
      "key": "c30537331b02086237933408b0e03db8"
    },
    {
      "line": 17,
      "relation": "decreases",
      "evidence": "Blockade of VEGF receptors (VEGFR2- official Gene symbol KDR) in rats induces apoptosis of alveolar cells",
      "citation": {
        "db": "PubMed",
        "db_id": "15602009"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 122,
      "target": 6,
      "key": "300a061ca247ecb9fb4558a67bc7e4fa"
    },
    {
      "line": 124,
      "relation": "increases",
      "evidence": "We show here that VEGF-A controls angiogenic sprouting in the early postnatal retina by guiding filopodial extension from specialized endothelial cells situated at the tips of the vascular sprouts. The tip cells respond to VEGF-A only by guided migration; the proliferative response to VEGF-A occurs in the sprout stalks. These two cellular responses are both mediated by agonistic activity of VEGF-A on VEGF receptor 2.",
      "citation": {
        "db": "PubMed",
        "db_id": "12810700"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 122,
      "target": 4,
      "key": "2674426701b4519321999756d729c009"
    },
    {
      "line": 124,
      "relation": "increases",
      "evidence": "Interestingly, the RhoA activation can be partially inhibited by overexpression of Rac1-17N, but overexpression of RhoA-19N has no effect on Rac1 activation. Finally, Gq/11 and Gbetagamma subunits are also required for VPF/VEGF-stimulated HUVEC migration.",
      "citation": {
        "db": "PubMed",
        "db_id": "12244099"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 122,
      "target": 4,
      "key": "9d4bf3d0b9f9a88e2a0736570bbcb1d2"
    },
    {
      "line": 171,
      "relation": "increases",
      "evidence": "Effects of hypoxia on molecular determinants of angiogenesis Angiogenesis is a complex process, involving multiple gene products expressed by different cell types, all contributing to an integrated sequence of events44. Consistent with a major role for hypoxia in the overall process, a large number of genes involved in different steps of angiogenesis are independently responsive to hypoxia in tissue culture. Examples include nitric oxide synthases involved in governing vascular tone, growth factors such as VEGF, angiopoietins, fibroblast growth factors and their various receptors, and genes involved in matrix metabolism, including matrix metalloproteinases, plasminogen activator receptors and inhibitors, and collagen prolyl hydroxylase16, 17, 18, 19, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61 (Table 1). Similarly, many of the individual phenotypic processes in angiogenesis such as cell migration or endothelial tube formation can be induced by hypoxic tissue culture62, 63, 64. These analyses in isolated systems have sometimes apparently shown both positive and negative effects of hypoxia, for instance on endothelial proliferation65, 66, 67. It is not yet clear whether such phenomena reflect fundamentally different responses based on severity of hypoxia, or counter-regulatory controls that are normally integrated in a productive way.",
      "citation": {
        "db": "PubMed",
        "db_id": "12778166"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 122,
      "target": 5,
      "key": "d50e19bedcad64d178103507dc066330"
    },
    {
      "line": 171,
      "relation": "increases",
      "evidence": "VEGFR2 transactivation mediates IL-8/CXCL8-induced permeability.",
      "citation": {
        "db": "PubMed",
        "db_id": "17928406"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 122,
      "target": 5,
      "key": "46f4823d1e1a8d9682457f9720426445"
    },
    {
      "line": 27,
      "relation": "decreases",
      "evidence": "Mechanistically, KLF2 promoted HIF-1alpha degradation in a von Hippel-Lindau protein-independent but proteasome-dependent manner. Finally, KLF2 disrupted the interaction between HIF-1alpha and its chaperone Hsp90, suggesting that KLF2 promotes degradation of HIF-1alpha by affecting its folding and maturation",
      "citation": {
        "db": "PubMed",
        "db_id": "19491109"
      },
      "annotations": {},
      "source": 123,
      "target": 110,
      "key": "70acb5197b0282a73307b6e13181b8cb"
    },
    {
      "line": 52,
      "relation": "directlyIncreases",
      "evidence": "(Jubilant) Pretreatment with C3 transferase exoenzyme, an inhibitor of Rho small GTP binding proteins (Rho A, B and C) inhibited the bradykinin induced NFkB activity. Treatment with calpain I or PDTC completely inhibited the DNA binding activity of NFkB. Transfection of cell with dominant negative RhoA-T19N inhibited the bradykinin induced NFkB activity. A dominant-negative form of RhoA (T19N) inhibited BK-stimulated reporter gene expression in a dose-dependent and kappaB-dependent manner.",
      "citation": {
        "db": "PubMed",
        "db_id": "9510209"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 124,
      "target": 30,
      "key": "0fdceeddb56a4ecc97d6f5f9ba9d25da"
    },
    {
      "line": 52,
      "relation": "directlyIncreases",
      "evidence": "Bradykinin (BK) is a potent inflammatory mediator, which can release other inflammatory mediators by interacting with bradykinin B1 and B2 receptors ... It is concluded that BK causes increased leak by inducing PMN elastase release via activation of both B1 and B2 receptors",
      "citation": {
        "db": "PubMed",
        "db_id": "8856176"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 124,
      "target": 30,
      "key": "616bd2ecb516fa7fba19d619bcd72440"
    },
    {
      "line": 162,
      "relation": "directlyIncreases",
      "evidence": "(Jubilant) Pretreatment with C3 transferase exoenzyme, an inhibitor of Rho small GTP binding proteins (Rho A, B and C) inhibited the bradykinin induced NFkB activity. Treatment with calpain I or PDTC completely inhibited the DNA binding activity of NFkB. Transfection of cell with dominant negative RhoA-T19N inhibited the bradykinin induced NFkB activity. A dominant-negative form of RhoA (T19N) inhibited BK-stimulated reporter gene expression in a dose-dependent and kappaB-dependent manner.",
      "citation": {
        "db": "PubMed",
        "db_id": "9510209"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 124,
      "target": 31,
      "key": "8cae4b9121c928c97539b34e77dbf184"
    },
    {
      "line": 162,
      "relation": "directlyIncreases",
      "evidence": "Bradykinin (BK) is a potent inflammatory mediator, which can release other inflammatory mediators by interacting with bradykinin B1 and B2 receptors ... It is concluded that BK causes increased leak by inducing PMN elastase release via activation of both B1 and B2 receptors",
      "citation": {
        "db": "PubMed",
        "db_id": "8856176"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 124,
      "target": 31,
      "key": "ab8d340a5d7fa0f77c5d376add73f41a"
    },
    {
      "line": 178,
      "relation": "increases",
      "evidence": "CCM1 strongly induces DLL4-NOTCH signaling, which promotes AKT phosphorylation but reduces phosphorylation of the mitogen-activated protein kinase ERK",
      "citation": {
        "db": "PubMed",
        "db_id": "20616044"
      },
      "annotations": {},
      "source": 59,
      "target": 73,
      "key": "afd5c5a4626178bd9677751a34fcb57b"
    },
    {
      "line": 64,
      "relation": "increases",
      "evidence": "Employing a Western blot analysis approach, we found that galectin-3 induces phosphorylation of VEGF-R2 in endothelial cells",
      "citation": {
        "db": "PubMed",
        "db_id": "21715322"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 125,
      "target": 122,
      "key": "76d5ed628e2bd35fd41ea15aa4e222ec"
    },
    {
      "line": 107,
      "relation": "increases",
      "evidence": "To study the effect of galectin-3 on endothelial cell tube formation, we have analyzed the dose response of HUV-EC-C to soluble human galectin-3. Cells (5 Ã— 104) were plated on a gel formed by diluted Matrigel, in the presence of varying concentrations of galectin-3. Figure 1, Aâ€“D  , show a concentration-dependent anastomosing network of endothelial cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "10702407"
      },
      "annotations": {},
      "source": 125,
      "target": 3,
      "key": "d0bd8f782a425aa180488a975c350e0f"
    },
    {
      "line": 107,
      "relation": "increases",
      "evidence": "galectin-3 exerts its effect on MDCK cells in a three-dimensional environment through modulation of both cell-cell and cell-substratum adhesions, and the interplay between these adhesions is important in the growth of multicellular aggregates and extensions occurring during normal kidney tubulogenesis.",
      "citation": {
        "db": "PubMed",
        "db_id": "7593320"
      },
      "annotations": {},
      "source": 125,
      "target": 3,
      "key": "916832e1115f033058af5c3f94e6e0a7"
    },
    {
      "line": 183,
      "relation": "increases",
      "evidence": ". Furthermore, galectin-3 promoted the clustering of integrin alphavbeta3 and activated focal adhesion kinase",
      "citation": {
        "db": "PubMed",
        "db_id": "20713592"
      },
      "annotations": {},
      "source": 125,
      "target": 12,
      "key": "50b0d0c50d24feb67517b4a117602551"
    },
    {
      "line": 160,
      "relation": "directlyIncreases",
      "evidence": "To elucidate the role of MAPKs in keratinocyte differentiation, activation of ERK, JNK, and p38 in response to stimulation with extracellular calcium was analyzed. We provide evidence that calcium-induced differentiation of keratinocytes is associated with rapid and transient activation of the Raf/MEK/ERK pathway. Stimulation of keratinocytes with extracellular calcium resulted in activation of Raf isozymes and their downstream effector ERK within 10-15 min, but did not increase JNK or p38 activity",
      "citation": {
        "db": "PubMed",
        "db_id": "11018025"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 133,
      "key": "67d0ba0ed5c1c4b162025f0d8fe721f5"
    },
    {
      "line": 160,
      "relation": "directlyIncreases",
      "evidence": "Finally, Ark-mediated repression was significantly attenuated by a dominant negative MEF2C, whereas repression induced by constitutively active Rac was unaffected, indicating that MEF2 proteins are not targets of the Ark -- Rac -- MEK -- ERK cascade.",
      "citation": {
        "db": "PubMed",
        "db_id": "12138087"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 133,
      "key": "507dcb848745de08413f66adcfae421d"
    },
    {
      "line": 160,
      "relation": "directlyIncreases",
      "evidence": "The dual phosphorylation of Thr-183 and Tyr-185 in ERK2 is catalyzed by MAPK/ERK kinase 1 (MEK1).",
      "citation": {
        "db": "PubMed",
        "db_id": "12082107"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 133,
      "key": "36d314eeb38b6de6b9f9a00062e231e1"
    },
    {
      "line": 160,
      "relation": "directlyIncreases",
      "evidence": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
      "citation": {
        "db": "PubMed",
        "db_id": "16729045"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 133,
      "key": "31619e08d3bc3593268f44fbaf5de8ab"
    },
    {
      "line": 160,
      "relation": "directlyIncreases",
      "evidence": "Once activated, Raf-1 phosphorylates serines in the catalytic sites of MKK/MEK [345,367]. MKK1/MEK1 and MKK2/MEK2 activate members of the MAP kinase family (ERK-1/ERK-2),",
      "citation": {
        "db": "PubMed",
        "db_id": "10699758"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 133,
      "key": "5acdd938e7a99c5b7647226c68463d68"
    },
    {
      "line": 160,
      "relation": "directlyIncreases",
      "evidence": "in embryonic kidney cells expressing full-length DCC, NTN1 causes increased transient phosphorylation and activity of ERK1 and ERK2 but not of JNK1, JNK2 or MAPK14 this phosphorylation was mediated by MAP2K1 (aka MEK1) and/or MAP2K2 (aka MEK2)",
      "citation": {
        "db": "PubMed",
        "db_id": "11986622"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 133,
      "key": "f5c4da05144139c4ae0f136b989021f3"
    },
    {
      "line": 160,
      "relation": "directlyIncreases",
      "evidence": "Fig.1",
      "citation": {
        "db": "PubMed",
        "db_id": "15567848"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 133,
      "key": "f8d807e605c608c48f7c33dc2404795c"
    },
    {
      "line": 160,
      "relation": "directlyIncreases",
      "evidence": "Raf-1 phosphorylates and activates MEK-1, a kinase that activates the extracellular signal regulated kinases (ERK)",
      "citation": {
        "db": "PubMed",
        "db_id": "10490027"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 133,
      "key": "acfdd9c03e1b93e4fee887dca0a00c31"
    },
    {
      "line": 224,
      "relation": "directlyIncreases",
      "evidence": "To elucidate the role of MAPKs in keratinocyte differentiation, activation of ERK, JNK, and p38 in response to stimulation with extracellular calcium was analyzed. We provide evidence that calcium-induced differentiation of keratinocytes is associated with rapid and transient activation of the Raf/MEK/ERK pathway. Stimulation of keratinocytes with extracellular calcium resulted in activation of Raf isozymes and their downstream effector ERK within 10-15 min, but did not increase JNK or p38 activity",
      "citation": {
        "db": "PubMed",
        "db_id": "11018025"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 134,
      "key": "d922b96f447e1809aa472d84f0318239"
    },
    {
      "line": 224,
      "relation": "directlyIncreases",
      "evidence": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
      "citation": {
        "db": "PubMed",
        "db_id": "16729045"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 134,
      "key": "8126b20243f4ebc248af2663e6425fbe"
    },
    {
      "line": 224,
      "relation": "directlyIncreases",
      "evidence": "Finally, Ark-mediated repression was significantly attenuated by a dominant negative MEF2C, whereas repression induced by constitutively active Rac was unaffected, indicating that MEF2 proteins are not targets of the Ark -- Rac -- MEK -- ERK cascade.",
      "citation": {
        "db": "PubMed",
        "db_id": "12138087"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 134,
      "key": "447574e52270ed37895e0846cfb4b3db"
    },
    {
      "line": 224,
      "relation": "directlyIncreases",
      "evidence": "The activated GST-MEK1 was then used to activate the purified recombinant extracellular signal-regulated kinase 1, whose activity was measured by the [32P-g]ATP incorporation into MBP, an extracellular signal-regulated kinase 1 substrate.",
      "citation": {
        "db": "PubMed",
        "db_id": "8621729"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 134,
      "key": "62e072f6811dcd2ff3fc964f25ab31c9"
    },
    {
      "line": 224,
      "relation": "directlyIncreases",
      "evidence": "Raf-1 phosphorylates and activates MEK-1, a kinase that activates the extracellular signal regulated kinases (ERK)",
      "citation": {
        "db": "PubMed",
        "db_id": "10490027"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 134,
      "key": "df62c8239cd57483f3271b4b05b3a004"
    },
    {
      "line": 224,
      "relation": "directlyIncreases",
      "evidence": "Once activated, Raf-1 phosphorylates serines in the catalytic sites of MKK/MEK [345,367]. MKK1/MEK1 and MKK2/MEK2 activate members of the MAP kinase family (ERK-1/ERK-2),",
      "citation": {
        "db": "PubMed",
        "db_id": "10699758"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 134,
      "key": "a58d1bc65c758138ffae93936c891e12"
    },
    {
      "line": 224,
      "relation": "directlyIncreases",
      "evidence": "Fig.1",
      "citation": {
        "db": "PubMed",
        "db_id": "15567848"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 134,
      "key": "b9ee8bc01fc262afd45adeb8d18a4ef1"
    },
    {
      "line": 224,
      "relation": "directlyIncreases",
      "evidence": "For comparison, ElkC was also phosphorylated using recombinant ERK1 that had been activated by phosphorylation with a constitutively active mutant of the MAPK/ERK kinase MKK1 [23].",
      "citation": {
        "db": "PubMed",
        "db_id": "8548291"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 134,
      "key": "a8921a642fd5f9603ceb3d96314400db"
    },
    {
      "line": 224,
      "relation": "directlyIncreases",
      "evidence": "in embryonic kidney cells expressing full-length DCC, NTN1 causes increased transient phosphorylation and activity of ERK1 and ERK2 but not of JNK1, JNK2 or MAPK14 this phosphorylation was mediated by MAP2K1 (aka MEK1) and/or MAP2K2 (aka MEK2)",
      "citation": {
        "db": "PubMed",
        "db_id": "11986622"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 134,
      "key": "f3af6108914b20d7593f4b14760a24e6"
    },
    {
      "line": 9,
      "relation": "increases",
      "evidence": "Rapid ERK1/2 activation that preceded FAK and paxillin activation was detected",
      "citation": {
        "db": "PubMed",
        "db_id": "15944210"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 133,
      "target": 159,
      "key": "74646a951730a410110a05a520ceea6b"
    },
    {
      "line": 72,
      "relation": "increases",
      "evidence": "Rapid ERK1/2 activation that preceded FAK and paxillin activation was detected",
      "citation": {
        "db": "PubMed",
        "db_id": "15944210"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 134,
      "target": 159,
      "key": "b3ace347454c5f28ff560e99142424bd"
    },
    {
      "line": 123,
      "relation": "increases",
      "evidence": "In HepG2 cells, ectopic expression of miR-34a potently inhibited tumor cell migration and invasion in a c-Met-dependent manner. miR-34a directly targeted c-Met and reduced both mRNA and protein levels of c-Met; thus, decreased c-Met-induced phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK1/2).",
      "citation": {
        "db": "PubMed",
        "db_id": "19006648"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 136,
      "target": 134,
      "key": "c1f457032d9fb909c41ea883ffae876a"
    },
    {
      "line": 123,
      "relation": "increases",
      "evidence": "HGF activates P42/P44MAPK (extracellular signal regulated kinase 2/1) and P38 MAPK two and three-fold respectively compared to basal level in a PKC independent manner. The phosphorylation level peaked within 5-10 minutes of HGF treatment.",
      "citation": {
        "db": "PubMed",
        "db_id": "11781826"
      },
      "annotations": {
        "cl": {
          "0000148": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 136,
      "target": 134,
      "key": "438f75b392f35439dcc1dbfa474076ff"
    },
    {
      "line": 123,
      "relation": "increases",
      "evidence": "In parental Fr3T3 cells only the phosphorylated inactive forms of ERK1 and ERK2 were detected as determined by shift in EMSA. In contrast, Met-transformed cells (Met activated) a significant portion of ERK1 and ERK2 was seen to have a retarded mobility in SDS-PAGE indicative of phosphorylation. There was increase in the MAP kinase activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "9184210"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 136,
      "target": 134,
      "key": "142f57c4b75b2fd753dbab4ae19545f1"
    },
    {
      "line": 179,
      "relation": "increases",
      "evidence": "In HepG2 cells, ectopic expression of miR-34a potently inhibited tumor cell migration and invasion in a c-Met-dependent manner. miR-34a directly targeted c-Met and reduced both mRNA and protein levels of c-Met; thus, decreased c-Met-induced phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK1/2).",
      "citation": {
        "db": "PubMed",
        "db_id": "19006648"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 136,
      "target": 133,
      "key": "ff7df73ef69d6e68435e786ad9d7ab6a"
    },
    {
      "line": 179,
      "relation": "increases",
      "evidence": "We also show that both Cbl and Gab1 enhance Met-induced activation of another MAP kinase cascade, the ERK pathway, in a Crk-independent manner. Taken together, our studies demonstrate a previously unidentified functional role for Cbl in Met signaling and suggest that Met utilizes at least two docking proteins, Gab1 and Cbl, to activate downstream signaling pathways.",
      "citation": {
        "db": "PubMed",
        "db_id": "10962563"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 136,
      "target": 133,
      "key": "26707dc2f15b48aa732159cecd150bdf"
    },
    {
      "line": 179,
      "relation": "increases",
      "evidence": "In parental Fr3T3 cells only the phosphorylated inactive forms of ERK1 and ERK2 were detected as determined by shift in EMSA. In contrast, Met-transformed cells (Met activated) a significant portion of ERK1 and ERK2 was seen to have a retarded mobility in SDS-PAGE indicative of phosphorylation. There was increase in the MAP kinase activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "9184210"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 136,
      "target": 133,
      "key": "cbfe23f93967adf109fefd2ec15d8310"
    },
    {
      "line": 179,
      "relation": "increases",
      "evidence": "HGF activates P42/P44MAPK (extracellular signal regulated kinase 2/1) and P38 MAPK two and three-fold respectively compared to basal level in a PKC independent manner. The phosphorylation level peaked within 5-10 minutes of HGF treatment.",
      "citation": {
        "db": "PubMed",
        "db_id": "11781826"
      },
      "annotations": {
        "cl": {
          "0000148": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 136,
      "target": 133,
      "key": "92423e1578acfae3aa51a4ef78007d9f"
    },
    {
      "line": 69,
      "relation": "increases",
      "evidence": "we show that EC tube morphogenesis (lumen formation and invasion) is primarily controlled by the TIMP-2 and -3 target membrane type (MT) 1 MMP",
      "citation": {
        "db": "PubMed",
        "db_id": "17030988"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 137,
      "target": 3,
      "key": "0d3c7ce8499f3435be8eddf36bd1871b"
    },
    {
      "line": 311,
      "relation": "increases",
      "evidence": "MMP-2 processing of HARP and CTGF released vascular endothelial growth factor (VEGF) from angiogenic inhibitory complexes",
      "citation": {
        "db": "PubMed",
        "db_id": "17908800"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 138,
      "target": 50,
      "key": "56c460a1562e9185d6f3f3cfdbb028a0"
    },
    {
      "line": 48,
      "relation": "increases",
      "evidence": "siRNA-dependent silencing of ninein in endothelial cells inhibited tubular morphogenesis",
      "citation": {
        "db": "PubMed",
        "db_id": "18772498"
      },
      "annotations": {},
      "source": 57,
      "target": 3,
      "key": "5b6328c7f7d4b6376afc6c0177b45ec0"
    },
    {
      "line": 26,
      "relation": "increases",
      "evidence": "angiogenesis, vessel diameter, blood flow rate, and vascular permeability were proportional to NO levels and were most impaired in eNOS-/- mice VEGF significantly increased permeability in both wild-type and inducible NOS-/- mice, but not in eNOS-/- mice",
      "citation": {
        "db": "PubMed",
        "db_id": "15294883"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 141,
      "target": 5,
      "key": "33bd39cda98651d6a954576c2fc15f73"
    },
    {
      "line": 99,
      "relation": "increases",
      "evidence": "Functional analysis showed that SDF-1alpha induced a concentration-dependent migration of endothelial progenitor cells and the migration was CXCR4 dependent as confirmed by the total inhibition by AMD3100, a CXCR4-specific peptide antagonist. The migration can also be nearly completely blocked by phosphoinositide 3-kinase inhibitors (LY294002 and wortmannin) and eNOS inhibitor (N-nitro-arginine methyl ester),",
      "citation": {
        "db": "PubMed",
        "db_id": "17878755"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 141,
      "target": 4,
      "key": "e1f271ee1e81325f900997ed61c0a859"
    },
    {
      "line": 146,
      "relation": "increases",
      "evidence": "Whereas angiopoietin 2 (Ang2) was exclusively regulated by Foxo1, eNOS, which is essential for postnatal neovascularization, was regulated by Foxo1 and Foxo3a. Consistent with these findings, constitutively active Foxo1 and Foxo3a repressed eNOS protein expression and bound to the eNOS promoter.",
      "citation": {
        "db": "PubMed",
        "db_id": "16100571"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 141,
      "target": 2,
      "key": "c7b60402873d45f228e8ff8afeb7d6de"
    },
    {
      "line": 146,
      "relation": "increases",
      "evidence": "angiogenesis, vessel diameter, blood flow rate, and vascular permeability were proportional to NO levels and were most impaired in eNOS-/- mice VEGF significantly increased permeability in both wild-type and inducible NOS-/- mice, but not in eNOS-/- mice",
      "citation": {
        "db": "PubMed",
        "db_id": "15294883"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 141,
      "target": 2,
      "key": "3645841de0a23ff7c9edfdea018d517f"
    },
    {
      "line": 6,
      "relation": "increases",
      "evidence": "N4IC activation of the RBP-J?-dependent promoter-reporter (5.1-fold up-regulation) was abolished by deletion of the ankyrin domain, whereas mutants lacking the RAM (5.9-fold up-regulation) or CT (5.5-fold up-regulation) domains were fully able to activate the RBP-J?-dependent promoter (Figure 3A).",
      "citation": {
        "db": "PubMed",
        "db_id": "15187023"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 142,
      "target": 115,
      "key": "02d093c58ec2754a5837158373115915"
    },
    {
      "line": 120,
      "relation": "decreases",
      "evidence": "Thus, COUP-TFII has a critical role in repressing Notch signalling",
      "citation": {
        "db": "PubMed",
        "db_id": "15875024"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 143,
      "target": 21,
      "key": "03820af2543d3d3849a3f4e2ee6b33e7"
    },
    {
      "line": 4,
      "relation": "increases",
      "evidence": "Recently, neuropilin-1 (NP-1), a cell surface glycoprotein that binds semaphorin/collapsins, mediators of neuronal guidance, has been identified as VEGF165 receptor. NP-1 is expressed in endothelial cells and enhances the mitogenic effects of Flk-1 upon VEGF165stimulation (222)",
      "citation": {
        "db": "PubMed",
        "db_id": "11172729"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 144,
      "target": 99,
      "key": "ee052c0f23eb8d6e51869d8577e90686"
    },
    {
      "line": 166,
      "relation": "directlyIncreases",
      "evidence": "The neuropilin-1 (np1) receptor binds the 165 amino-acid form of vascular endothelial growth factor165 (VEGF165) and functions as an enhancer that potentiates VEGF165 signaling via the VEGFR-2 tyrosine-kinase receptor.",
      "citation": {
        "db": "PubMed",
        "db_id": "17185751"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 144,
      "target": 122,
      "key": "180ffa59cbe7382cf0c4187f249ae15f"
    },
    {
      "line": 166,
      "relation": "directlyIncreases",
      "evidence": "In endothelial cells, NRP1 enhances the biological signals of VEGF-A mediated by binding to its receptor vascular endothelial growth factor 2 (VEGFR2).",
      "citation": {
        "db": "PubMed",
        "db_id": "20151671"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 144,
      "target": 122,
      "key": "92a73a8648f4fa02d6c296621694898b"
    },
    {
      "line": 77,
      "relation": "increases",
      "evidence": "Platelet-derived growth factor (PDGF) has multiple functions including inhibition of apoptosis and promotion of cell proliferation. In this study, we show that Na(+)/H(+) exchanger regulatory factor 2 (NHERF2) binds to the carboxyl-terminal PDZ domain-binding motif of the PDGF receptor through a PDZ domain-mediated interaction, and evaluate the consequence on PDGF-induced proliferation. Stable transfection with NHERF2 increased the PDGF-induced phosphorylation of ERK and Akt in Rat1 embryonic fibroblasts.",
      "citation": {
        "db": "PubMed",
        "db_id": "15115658"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 150,
      "target": 134,
      "key": "0e9b034b1cc906853e61214856a3b483"
    },
    {
      "line": 335,
      "relation": "increases",
      "evidence": "Platelet-derived growth factor (PDGF) has multiple functions including inhibition of apoptosis and promotion of cell proliferation. In this study, we show that Na(+)/H(+) exchanger regulatory factor 2 (NHERF2) binds to the carboxyl-terminal PDZ domain-binding motif of the PDGF receptor through a PDZ domain-mediated interaction, and evaluate the consequence on PDGF-induced proliferation. Stable transfection with NHERF2 increased the PDGF-induced phosphorylation of ERK and Akt in Rat1 embryonic fibroblasts.",
      "citation": {
        "db": "PubMed",
        "db_id": "15115658"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 150,
      "target": 133,
      "key": "a42825266aae3be5f3b7c4e7f2bce095"
    },
    {
      "line": 172,
      "relation": "increases",
      "evidence": "Our cellular and molecular dissection showed that the PDGF-BB/PDGFRbeta kinase axis promoted MM tumor growth and vessel sprouting by activating ERK1/2, AKT, and the transcription of MMEC-released proangiogenic factors, such as vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8)",
      "citation": {
        "db": "PubMed",
        "db_id": "18524994"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 151,
      "target": 134,
      "key": "44c7c4bd4a0553e6cfb00dc2e7aa8141"
    },
    {
      "line": 172,
      "relation": "increases",
      "evidence": "Because PDGFRb activation, through transphosphorylation of tyrosine residues in its cytoplasmic domain, triggers a cascade of phosphorylation events which eventually lead to the activation of extracellular regulated-protein kinases (Erks), phosphorylated- Erk1/2 was used as an indicator of PDGFRb activation [7].",
      "citation": {
        "db": "PubMed",
        "db_id": "19742316"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 151,
      "target": 134,
      "key": "742f34c5f5b299c2e9c2064737cd2802"
    },
    {
      "line": 172,
      "relation": "increases",
      "evidence": "Therefore, PDGF beta receptor, ERK1/2, PLC and PKC are involved in the signal transduction of PDGF-induced growth response of rat cardiac myocytes.",
      "citation": {
        "db": "PubMed",
        "db_id": "15680465"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 151,
      "target": 134,
      "key": "c6645bb1a77a7ce2469ea253ef3319b3"
    },
    {
      "line": 220,
      "relation": "increases",
      "evidence": "Because PDGFRb activation, through transphosphorylation of tyrosine residues in its cytoplasmic domain, triggers a cascade of phosphorylation events which eventually lead to the activation of extracellular regulated-protein kinases (Erks), phosphorylated- Erk1/2 was used as an indicator of PDGFRb activation [7].",
      "citation": {
        "db": "PubMed",
        "db_id": "19742316"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 151,
      "target": 133,
      "key": "aeecdd0a2314b77a39a6d6066778ccb7"
    },
    {
      "line": 220,
      "relation": "increases",
      "evidence": "Ectopic expression of the wild type APS, but not C-terminal truncated APS, in NIH3T3 fibroblasts suppressed PDGF-induced MAP kinase (Erk2) activation, c-fos and c-myc induction as well as cell proliferation.",
      "citation": {
        "db": "PubMed",
        "db_id": "9989826"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 151,
      "target": 133,
      "key": "7cffbbc8fd79fd07d50a8ee808e325b3"
    },
    {
      "line": 220,
      "relation": "increases",
      "evidence": "Our cellular and molecular dissection showed that the PDGF-BB/PDGFRbeta kinase axis promoted MM tumor growth and vessel sprouting by activating ERK1/2, AKT, and the transcription of MMEC-released proangiogenic factors, such as vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8)",
      "citation": {
        "db": "PubMed",
        "db_id": "18524994"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 151,
      "target": 133,
      "key": "90deccdb4fc1c26e95065477d7295ae3"
    },
    {
      "line": 220,
      "relation": "increases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "12097282"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 151,
      "target": 133,
      "key": "a8e47585586770cd4bb6b59dc92cf245"
    },
    {
      "line": 220,
      "relation": "increases",
      "evidence": "Therefore, PDGF beta receptor, ERK1/2, PLC and PKC are involved in the signal transduction of PDGF-induced growth response of rat cardiac myocytes.",
      "citation": {
        "db": "PubMed",
        "db_id": "15680465"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 151,
      "target": 133,
      "key": "0be4ac2670562d35a6f8c23aebeb4bda"
    },
    {
      "line": 323,
      "relation": "increases",
      "evidence": "The APP-Gal4 processing induced by PDGF is dependent on the gamma-secretase activity, being abolished by an inhibitor of this enzyme, and is the consequence of the activation of a pathway downstream of the PDGF-receptor, which includes the non-receptor tyrosine kinase Src and the small G-protein Rac1",
      "citation": {
        "db": "PubMed",
        "db_id": "12645527"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 151,
      "target": 38,
      "key": "8a16299343712bf1ce5d2e2450fb9eb9"
    },
    {
      "line": 182,
      "relation": "increases",
      "evidence": "E2-stimulated ERK required ER in breast cancer and endothelial cells and was substantially prevented by expression of a dominant negative EGFR or by tyrphostin AG1478, a specific inhibitor for EGFR tyrosine kinase activity. Transactivation/phosphorylation of EGFR by E2 was dependent on the rapid liberation of heparin-binding EGF (HB-EGF) from cultured MCF-7 cells and was blocked by antibodies to this ligand for EGFR. Expression of dominant negative mini-genes for Galpha(q) and Galpha(i) blocked E2-induced, EGFR-dependent ERK activation, and Gbetagamma also contributed. G protein activation led to activation of matrix metalloproteinases (MMP)-2 and -9. This resulted from Src-induced MMP activation, implicated using PP2 (Src family kinase inhibitor) or the expression of a dominant negative Src protein.",
      "citation": {
        "db": "PubMed",
        "db_id": "12421825"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 152,
      "target": 24,
      "key": "b46f5022f4ac806f271ea16f4d4e9516"
    },
    {
      "line": 182,
      "relation": "increases",
      "evidence": "These results indicate that continuous stretch-induced IL-6 secretion in HUVECs depends on outside-in signaling via integrins followed by a PI3-K-PLC-gamma-PKC-IKK-NF-kappaB signaling cascade.",
      "citation": {
        "db": "PubMed",
        "db_id": "15613495"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 152,
      "target": 24,
      "key": "c8a85105a1d100d0c604ad93bfa3ea2b"
    },
    {
      "line": 182,
      "relation": "increases",
      "evidence": "Figure 1 | The ErbB signalling network.",
      "citation": {
        "db": "PubMed",
        "db_id": "11252954"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 152,
      "target": 24,
      "key": "62e6568abf91a34735a17c75606fd777"
    },
    {
      "line": 182,
      "relation": "increases",
      "evidence": "The FGFR-1 mediates activation of protein kinase C (PKC) through direct binding and activation of phospholipase C-gamma (PLC-gamma)",
      "citation": {
        "db": "PubMed",
        "db_id": "10362356"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 152,
      "target": 24,
      "key": "0e1381bbdf3c5fb6c6b324d4234e3d00"
    },
    {
      "line": 158,
      "relation": "decreases",
      "evidence": "At the molecular level, fenofibrate markedly decreased basic fibroblast growth factor-induced Akt activation and cyclooxygenase 2 gene expression",
      "citation": {
        "db": "PubMed",
        "db_id": "12785728"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 154,
      "target": 18,
      "key": "3e1135a514912507a7d4232e92513fdc"
    },
    {
      "line": 138,
      "relation": "increases",
      "evidence": "AMPKalpha1 plays an essential role in VEGF-induced angiogenesis in vitro (tube formation and sprouting from spheroids) and in vivo (Matrigel plug assay)",
      "citation": {
        "db": "PubMed",
        "db_id": "20129920"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 155,
      "target": 3,
      "key": "aa06c37558585940deaac325ef11e97f"
    },
    {
      "line": 209,
      "relation": "increases",
      "evidence": "In turn, phosphorylation of Ser732 would change the conformation of FAK, making it accessible to Pyk2 activated in response to its association with integrin beta3. Then, activated Pyk2 triggers the phosphorylation of FAK on Tyr407, promoting cell migration.",
      "citation": {
        "db": "PubMed",
        "db_id": "16760434"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 157,
      "target": 4,
      "key": "0d862ec45aff3655fe520a6f7311877c"
    },
    {
      "line": 209,
      "relation": "increases",
      "evidence": "Reconstitution of FAK-null cells, FAK overexpression studies, and the inhibition of FAK activity have all supported a role for FAK-Src signaling in promoting cell migration [2].",
      "citation": {
        "db": "PubMed",
        "db_id": "15108811"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 157,
      "target": 4,
      "key": "e7b777bb33bd328001d8a007d6538aeb"
    },
    {
      "line": 209,
      "relation": "increases",
      "evidence": "In conclusion, these results suggest that Ang II mediates an increase in FAK and paxillin phosphorylation and induces HUVEC migration",
      "citation": {
        "db": "PubMed",
        "db_id": "15652490"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 157,
      "target": 4,
      "key": "c79d2f9c6f1bac77470a37183e3d02f3"
    },
    {
      "line": 209,
      "relation": "increases",
      "evidence": "Focal adhesion kinase (FAK) is a cytoplasmic protein-tyrosine kinase that promotes cell migration, survival, and gene expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "17438336"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 157,
      "target": 4,
      "key": "cb8ce91f03a6db59ddf2d3cf591ee434"
    },
    {
      "line": 301,
      "relation": "increases",
      "evidence": "PTN increased proliferation in EPCs and HUVECs to a similar extent as VEGF",
      "citation": {
        "db": "Other",
        "db_id": "17960557"
      },
      "annotations": {},
      "source": 158,
      "target": 2,
      "key": "7ae88abd44db33895a080809873ce88f"
    },
    {
      "line": 301,
      "relation": "increases",
      "evidence": "our results indicate that PTN induces angiogenesis and utilizes PI3K- but not eNOS-dependent pathways for its angiogenic activity",
      "citation": {
        "db": "Other",
        "db_id": "11241349"
      },
      "annotations": {},
      "source": 158,
      "target": 2,
      "key": "36f8208cd41a8ae1c24d5ef7d9da255b"
    },
    {
      "line": 302,
      "relation": "increases",
      "evidence": "PTN at 10-500 ng/ml elicited dose-dependent chemotaxis of both EPCs and human umbilical vein endothelial cells (HUVECs)",
      "citation": {
        "db": "Other",
        "db_id": "17960557"
      },
      "annotations": {},
      "source": 158,
      "target": 4,
      "key": "d093ddc14ee2d6c0e10211df2ef27c1e"
    },
    {
      "line": 90,
      "relation": "increases",
      "evidence": "In conclusion, these results suggest that Ang II mediates an increase in FAK and paxillin phosphorylation and induces HUVEC migration",
      "citation": {
        "db": "PubMed",
        "db_id": "15652490"
      },
      "annotations": {},
      "source": 159,
      "target": 4,
      "key": "010243b1c29887b8455718d0675bb4c4"
    },
    {
      "line": 49,
      "relation": "increases",
      "evidence": "This Raf-1-mediated fine tuning of Rok-a signaling allows the activation of junctional myosin and the timely maturation of AJ essential for maintaining cell cohesion during sprouting angiogenesis",
      "citation": {
        "db": "PubMed",
        "db_id": "22209329"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 160,
      "target": 29,
      "key": "2c55378be35ebaf979f98c4e72041b90"
    },
    {
      "line": 33,
      "relation": "directlyIncreases",
      "evidence": "Notch proteins are the receptors for an evolutionarily highly conserved signalling pathway that regulates numerous cell fate decisions during development. Signal transduction involves the presenilin-dependent intracellular processing of Notch and nuclear translocation of the intracellular domain of Notch, Notch-IC. Notch-IC associates with the DNA-binding protein RBP-Jkappa/CBF-1 to activate transcription of Notch target genes. In the absence of Notch signalling, RBP-Jkappa/CBF-1 acts as a transcriptional repressor through the recruitment of histone deacetylase (HDAC) corepressor complexes. We identified SHARP as an RBP-Jkappa/CBF-1-interacting corepressor in a yeast two-hybrid screen. In cotransfection experiments, SHARP-mediated repression was sensitive to the HDAC inhibitor TSA and facilitated by SKIP, a highly conserved SMRT and RBP-Jkappa-interacting protein. SHARP repressed Hairy/Enhancer of split (HES)-1 promoter activity, inhibited Notch-1-mediated transactivation and rescued Notch-1-induced inhibition of primary neurogenesis in Xenopus laevis embryos. Based on our data, we propose a model in which SHARP is a novel component of the HDAC corepressor complex, recruited by RBP-Jkappa to repress transcription of target genes in the absence of activated Notch. Notch-IC associates with the DNA-binding protein RBP-Jkappa/CBF-1 to activate transcription of Notch target genes.",
      "citation": {
        "db": "PubMed",
        "db_id": "12374742"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 115,
      "target": 21,
      "key": "27bebf50741d67b149e417a5f25eaf3b"
    },
    {
      "line": 251,
      "relation": "directlyIncreases",
      "evidence": "NICD activates the HERP1 promoter in an RBP-J kappa-dependent manner, and induces expression of endogenous HERP1 mRNA as well as HERP1 protein in A10 cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "11741889"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 115,
      "target": 108,
      "key": "4c4c61c2f162e44a789d7f7f52701c91"
    },
    {
      "line": 118,
      "relation": "directlyIncreases",
      "evidence": "When expressed in cells, XPLN activates RhoA and RhoB, but not RhoC, and stimulates the assembly of stress fibers and focal adhesions in a Rho kinase-dependent manner.",
      "citation": {
        "db": "PubMed",
        "db_id": "12221096"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 126,
      "target": 28,
      "key": "bc338f6ca1417406828986ba83018efd"
    },
    {
      "line": 118,
      "relation": "directlyIncreases",
      "evidence": "p160ROCK, a serine/threonine protein kinase, is a direct RhoA target mediating RhoA-induced assembly of focal adhesions and stress fibers.",
      "citation": {
        "db": "PubMed",
        "db_id": "10845663"
      },
      "annotations": {
        "cl": {
          "0000632": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 126,
      "target": 28,
      "key": "3c7963817b6d3fd78e2440a0a54c6686"
    },
    {
      "line": 118,
      "relation": "directlyIncreases",
      "evidence": "Figure 2. Signaling from Rho to the CytoskeletonThe pathways from Rho to the formation of stress fibers are described in the text. Direct activating signals are presented by solid arrows. Inhibitory signals are depicted as red bars. Double-lined arrows and bars represent the net result of a signaling pathway. Abbreviations used: LIMK, LIM kinase; MLC-P, phosphorylated myosin II regulatory light chain; MLC phosphatase, myosin light chain phosphatase.",
      "citation": {
        "db": "PubMed",
        "db_id": "14744429"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 126,
      "target": 28,
      "key": "f39b7a3affdd30bb0829742ee800ac08"
    },
    {
      "line": 10,
      "relation": "increases",
      "evidence": "Shh activity in ECs is mediated by Rho, rather than through the \\\"classic\\\" Shh signaling pathway, which involves the Gli transcription factors. The Rho dependence of Shh-induced EC angiogenic activity was documented both in vitro, with dominant-negative RhoA and Rho kinase (ROCK) constructs, and in vivo, with the ROCK inhibitor Y27632 in the mouse corneal angiogenesis model. Finally, experiments performed in MMP-9- and OPN-knockout mice confirmed the roles of the ROCK downstream targets MMP-9 and OPN in Shh-induced angiogenesis.",
      "citation": {
        "db": "PubMed",
        "db_id": "20478312"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 28,
      "target": 2,
      "key": "c5008c4f098b2fb5c68cc88bebd3b84d"
    },
    {
      "line": 8,
      "relation": "increases",
      "evidence": "Surprisingly, we found that VEGF directly controls the expression of Plexin-D1, the receptor for the traditional repulsive axon guidance cue, semaphorin 3E (Sema3E). Sema3E-Plexin-D1 signaling then negatively regulates the activity of the VEGF-induced Delta-like 4 (Dll4)-Notch signaling pathway, which controls the cell fate decision between tip and stalk cells. Using the mouse retina as a model system, we show that Plexin-D1 is selectively expressed in endothelial cells at the front of actively sprouting blood vessels and its expression is tightly controlled by VEGF secreted by surrounding tissues.",
      "citation": {
        "db": "PubMed",
        "db_id": "21724832"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 34,
      "target": 165,
      "key": "c2c133aaf9e642562421892a0351fad6"
    },
    {
      "line": 304,
      "relation": "decreases",
      "evidence": "Fig. S2A shows increased PdgfrÎ² mRNA and protein levels in total lung tissue homogenates of Sesn2 KO mice when compared with the corresponding control tissue",
      "citation": {
        "db": "Other",
        "db_id": "24046361"
      },
      "annotations": {},
      "source": 65,
      "target": 151,
      "key": "aeee0d7210f9e892d9ce16a450e60191"
    },
    {
      "line": 305,
      "relation": "decreases",
      "evidence": "Fig. S2A shows increased PdgfrÎ² mRNA and protein levels in total lung tissue homogenates of Sesn2 KO mice when compared with the corresponding control tissue",
      "citation": {
        "db": "Other",
        "db_id": "24046361"
      },
      "annotations": {},
      "source": 65,
      "target": 169,
      "key": "fc734b4d722bf16ace22135c06dbb328"
    },
    {
      "line": 185,
      "relation": "increases",
      "evidence": "A mutant ErbB3 protein was generated in which Tyr-1325 in a consensus Shc phosphotyrosine-binding domain recognition site was mutated to Phe (ErbB3-Y/F). This mutation abolished the association of Shc with ErbB3 and blocked the activation of mitogen-activated protein kinase by heregulin.",
      "citation": {
        "db": "PubMed",
        "db_id": "9694850"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 35,
      "target": 133,
      "key": "95e69ab7b452ffaf7d802dbdeda2fbed"
    },
    {
      "line": 185,
      "relation": "increases",
      "evidence": "stimulation of Erk by alpha6beta4 was suppressed by dominant-negative Shc, Ras and RhoA",
      "citation": {
        "db": "PubMed",
        "db_id": "9171350"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 35,
      "target": 133,
      "key": "c001c7c69de8d2df4a1536577a86d67f"
    },
    {
      "line": 211,
      "relation": "increases",
      "evidence": "A mutant ErbB3 protein was generated in which Tyr-1325 in a consensus Shc phosphotyrosine-binding domain recognition site was mutated to Phe (ErbB3-Y/F). This mutation abolished the association of Shc with ErbB3 and blocked the activation of mitogen-activated protein kinase by heregulin.",
      "citation": {
        "db": "PubMed",
        "db_id": "9694850"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 35,
      "target": 134,
      "key": "25bc8aff49f969ca130f11dc585c19d0"
    },
    {
      "line": 211,
      "relation": "increases",
      "evidence": "stimulation of Erk by alpha6beta4 was suppressed by dominant-negative Shc, Ras and RhoA",
      "citation": {
        "db": "PubMed",
        "db_id": "9171350"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 35,
      "target": 134,
      "key": "d142e3bd45c965792b00f00f4a0c2c73"
    },
    {
      "line": 112,
      "relation": "increases",
      "evidence": "Shh activity in ECs is mediated by Rho, rather than through the \\\"classic\\\" Shh signaling pathway, which involves the Gli transcription factors. The Rho dependence of Shh-induced EC angiogenic activity was documented both in vitro, with dominant-negative RhoA and Rho kinase (ROCK) constructs, and in vivo, with the ROCK inhibitor Y27632 in the mouse corneal angiogenesis model. Finally, experiments performed in MMP-9- and OPN-knockout mice confirmed the roles of the ROCK downstream targets MMP-9 and OPN in Shh-induced angiogenesis.",
      "citation": {
        "db": "PubMed",
        "db_id": "20478312"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 36,
      "target": 126,
      "key": "e36f88097c73ab958b0966b9ce506152"
    },
    {
      "line": 112,
      "relation": "increases",
      "evidence": "Consistent with the required cytoskeletal re-arrangement for tubulogenesis, Shh, Ihh and Dhh all stimulated the small GTPase RhoA and the formation of actin stress fibers.",
      "citation": {
        "db": "PubMed",
        "db_id": "20081366"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 36,
      "target": 126,
      "key": "044ab8b8ae881fbf0453f7bdcdb125a6"
    },
    {
      "line": 319,
      "relation": "increases",
      "evidence": "miR-34a impairs EPC-mediated angiogenesis by induction of senescence via inhibiting Sirt1",
      "citation": {
        "db": "PubMed",
        "db_id": "20424141"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 58,
      "target": 2,
      "key": "dcbbb0b75d4c7395cd9541ff0b4dba7d"
    },
    {
      "line": 319,
      "relation": "increases",
      "evidence": "We show that SIRT1 is highly expressed in the vasculature during blood vessel growth, where it controls the angiogenic activity of endothelial cells. Loss of SIRT1 function blocks sprouting angiogenesis and branching morphogenesis of endothelial cells with consequent down-regulation of genes involved in blood vessel development and vascular remodeling",
      "citation": {
        "db": "PubMed",
        "db_id": "17938244"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 58,
      "target": 2,
      "key": "5a4f2a74679ba95b82bdbb1d7c67e37b"
    },
    {
      "line": 175,
      "relation": "increases",
      "evidence": "Activation of Robo4 by Slit2 inhibits vascular endothelial growth factor (VEGF)-165-induced migration, tube formation and permeability in vitro and VEGF-165-stimulated vascular leak in vivo by blocking Src family kinase activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "18345009"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 37,
      "target": 164,
      "key": "86cadabad7e9b830afbae4b38c685158"
    },
    {
      "line": 43,
      "relation": "increases",
      "evidence": "ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration",
      "citation": {
        "db": "PubMed",
        "db_id": "15664386"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 127,
      "target": 4,
      "key": "0d30b5eaf0e6d981fd2d14290d6fec7c"
    },
    {
      "line": 116,
      "relation": "decreases",
      "evidence": "ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration",
      "citation": {
        "db": "PubMed",
        "db_id": "15664386"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 128,
      "target": 4,
      "key": "367a9bdb6c8f65a8a27022bc9e2a7be4"
    },
    {
      "line": 116,
      "relation": "decreases",
      "evidence": "endoglin interferes with ALK-5 signaling through Smad2/3 which normally inhibits endothelial cell proliferation and migration.",
      "citation": {
        "db": "PubMed",
        "db_id": "16462725"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 128,
      "target": 4,
      "key": "78cf447951a7f35dd96c156342433449"
    },
    {
      "line": 133,
      "relation": "decreases",
      "evidence": "endoglin interferes with ALK-5 signaling through Smad2/3 which normally inhibits endothelial cell proliferation and migration.",
      "citation": {
        "db": "PubMed",
        "db_id": "16462725"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 129,
      "target": 4,
      "key": "1ed17f1e265ed22f554d40239a8aeca3"
    },
    {
      "line": 133,
      "relation": "decreases",
      "evidence": "ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration",
      "citation": {
        "db": "PubMed",
        "db_id": "15664386"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 129,
      "target": 4,
      "key": "f3f025c7156da5a8d04f8da39e995b34"
    },
    {
      "line": 329,
      "relation": "increases",
      "evidence": "Silencing of Smad3 by siRNA not only eliminated the stimulatory effect of CSE on VEGF release but also inhibited baseline VEGF production.",
      "citation": {
        "db": "Other",
        "db_id": "23618901"
      },
      "annotations": {},
      "source": 129,
      "target": 50,
      "key": "f154d646cc358b01daf59c6ff5d997cb"
    },
    {
      "line": 103,
      "relation": "increases",
      "evidence": "TGF-beta-induced cell cycle arrest and migration, but not epithelial-mesenchymal transition, are abolished after silencing of Smad4. Altogether our results suggest that loss of Smad4 might promote TGF-beta-mediated tumorigenesis by abolishing tumor-suppressive functions of TGF-beta while maintaining some tumor-promoting TGF-beta responses.",
      "citation": {
        "db": "PubMed",
        "db_id": "16135802"
      },
      "annotations": {},
      "source": 130,
      "target": 4,
      "key": "e4a0dd87ef83cea1c4fdab89448e31d1"
    },
    {
      "line": 1,
      "relation": "increases",
      "evidence": "ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration",
      "citation": {
        "db": "PubMed",
        "db_id": "15664386"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 131,
      "target": 4,
      "key": "70c43164f3e506dcc6de08e49240cc06"
    },
    {
      "line": 76,
      "relation": "increases",
      "evidence": "Activation of Robo4 by Slit2 inhibits vascular endothelial growth factor (VEGF)-165-induced migration, tube formation and permeability in vitro and VEGF-165-stimulated vascular leak in vivo by blocking Src family kinase activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "18345009"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 38,
      "target": 5,
      "key": "b8a46d75293ca2a1eb57ce27bb6ea4c7"
    },
    {
      "line": 76,
      "relation": "increases",
      "evidence": "Also depicted are other representative regulatory proteins whose activity either increases (green background) or decreases (white background) EC tension.",
      "citation": {
        "db": "PubMed",
        "db_id": "11568129"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 38,
      "target": 5,
      "key": "77008458d83f1844ba5f58502dc21464"
    },
    {
      "line": 236,
      "relation": "increases",
      "evidence": "Monitoring of the intracellular levels of inositol phosphates in c-Src-as1 SNF cells revealed a moderate (~30%), but statistically significant, decrease in PLC{gamma} activity when c-Src was inhibited",
      "citation": {
        "db": "PubMed",
        "db_id": "16135530"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 38,
      "target": 152,
      "key": "cd0bd59d3cd19c40bc4f5b70cbdf0572"
    },
    {
      "line": 236,
      "relation": "increases",
      "evidence": "short-term NO production induced by VEGF is mediated via increased cytosolic Ca, resulting from activation of PLCG1 and subsequent generation of IP3 Src has been implicated in signaling upstream of PLCG1",
      "citation": {
        "db": "PubMed",
        "db_id": "11350732"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 38,
      "target": 152,
      "key": "8b2855d8d19ac06cfedd1e10983748ef"
    },
    {
      "line": 236,
      "relation": "increases",
      "evidence": "Phospholipase Cgamma1 is expressed ubiquitously, especially in the brain, thymus and lungs. PLCgamma1 can be activated by receptor tyrosine kinases (i.e.: PDGFR, EGFR, FGFR, Trk), as well as non-receptor protein kinases (Src, Syk, Tec)",
      "citation": {
        "db": "PubMed",
        "db_id": "21918248"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 38,
      "target": 152,
      "key": "90ea7dbaea49cb9a2e7e88df1fb4c917"
    },
    {
      "line": 236,
      "relation": "increases",
      "evidence": "Adhesion to fibronectin induced PLC-gamma1 tyrosine phosphorylation that was inhibited by a Src-kinase inhibitor",
      "citation": {
        "db": "PubMed",
        "db_id": "15657076"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 38,
      "target": 152,
      "key": "9beaaef4592dd7388352f0414c5f6dab"
    },
    {
      "line": 299,
      "relation": "directlyIncreases",
      "evidence": "In the first case, recruited FAK autophosphorylates at 397Y and associates with c-Src or Fyn, which further phosphorylates it at 925Y. Phosphorylated FAK binds to the Grb2-Sos complex and activates the Ras-ERK cascade [60,61].",
      "citation": {
        "db": "PubMed",
        "db_id": "14984767"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 38,
      "target": 157,
      "key": "f9b380b9b4508a8a6203bd08d6dc3474"
    },
    {
      "line": 299,
      "relation": "directlyIncreases",
      "evidence": "These data show that Src-mediated phosphorylation of FAKÂ ...",
      "citation": {
        "db": "Other",
        "db_id": "22766276"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 38,
      "target": 157,
      "key": "05b7ece7721a370501ef7aa9fe8954bf"
    },
    {
      "line": 74,
      "relation": "decreases",
      "evidence": "It has been reported that inhibition of FoxO activity is an important mechanism for Ang1-stimulated Tie2-mediated endothelial function. Consistent with this, we found that phosphorylation of FoxO mediated by Tie2 activation was attenuated by lipid raft disruption. Therefore, we propose that lipid rafts serve as signaling platforms for Tie2 receptor tyrosine kinase in vascular endothelial cells",
      "citation": {
        "db": "PubMed",
        "db_id": "19615361"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 39,
      "target": 102,
      "key": "bfcc8e0bc226ab5340cac355a45f7257"
    },
    {
      "line": 152,
      "relation": "decreases",
      "evidence": "It has been reported that inhibition of FoxO activity is an important mechanism for Ang1-stimulated Tie2-mediated endothelial function. Consistent with this, we found that phosphorylation of FoxO mediated by Tie2 activation was attenuated by lipid raft disruption. Therefore, we propose that lipid rafts serve as signaling platforms for Tie2 receptor tyrosine kinase in vascular endothelial cells",
      "citation": {
        "db": "PubMed",
        "db_id": "19615361"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 39,
      "target": 101,
      "key": "1f742013a712f7335eb14d33e6e4b5cd"
    },
    {
      "line": 219,
      "relation": "increases",
      "evidence": "Recently, however, it has been realized that the susceptibility of established tumor blood vessels to an interference with VEGF/VEGFR-2 signaling may be restricted to a fraction of immature vessels that lack colocalization with pericytes (8). This is supported by the observation that contact between endothelial cells and periendothelial support cells, such as pericytes or smooth muscle cells, stabilizes new blood vessels, promotes endothelial survival, and inhibits endothelial cell proliferation (9). The fact that only immature vessels may be forced into regression by interference with VEGF/VEGFR-2 signaling is of therapeutic relevance since the literature on the pericyte coverage on tumor vessels suggests that the pericyte-free fraction of tumor blood vessels may be little or none for a significant number of both experimental and human tumor types (10-14). As a consequence, additional targeting of pericyte recruitment and pericyte/ endothelial cell interaction may enhance tumor vessel destruction after interference with VEGF/VEGFR-2 signaling. Although the detailed molecular basis of how pericytes confer vessel stabilization remains unknown, studies of embryogenesis have highlighted the involvement of the angiopoetin (Ang)- 1/Tie2 system and the platelet-derived growth factor (PDGF)-B/PDGF receptor (PDGFR)-? system. Transgenic mice lacking adequate Ang-1/Tie2 or PDGF-B/PDGFR-B signaling failed to adequately recruit pericytes to newly formed blood vessels, which was associated with severe perturbation of blood vessel stabilization and maturation (15-18).",
      "citation": {
        "db": "PubMed",
        "db_id": "14657001"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 39,
      "target": 4,
      "key": "5f8d45e618890d59b61ac22f4e4cbaf4"
    },
    {
      "line": 219,
      "relation": "increases",
      "evidence": "Furthermore, exposure of aortic rings from p47(phox-/-) mice to Ang-1 demonstrated fewer vessel sprouts than WT mice. Inhibition of the Tie-2 receptor inhibited Ang-1-induced endothelial migration and vessel sprouting",
      "citation": {
        "db": "PubMed",
        "db_id": "16679392"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 39,
      "target": 4,
      "key": "d88e387c3aa118ee82dc8a59ab3e585f"
    },
    {
      "line": 219,
      "relation": "increases",
      "evidence": "This is accompanied by the loosening of PERICYTE covering,which is thought to be a function of ANG2 (REF. 23) - a ligand of TIE2. TIE2 is a tyrosine kinase receptor that is selectively expressed in endothelial cells24.",
      "citation": {
        "db": "PubMed",
        "db_id": "12778130"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 39,
      "target": 4,
      "key": "42b3a2cb7ecc96f3169b94cd28ab079f"
    },
    {
      "line": 260,
      "relation": "decreases",
      "evidence": "The ability of Ang1 to inhibit induction of apoptosis in response to serum deprivation was completely blocked by suppression of Tie2 expression, but not diminished by suppression of Tie1 expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "18848573"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 39,
      "target": 6,
      "key": "89ce6bb7cb1cea0099cbe05fc5de2686"
    },
    {
      "line": 223,
      "relation": "directlyIncreases",
      "evidence": "For these experiments, E19 type II epithelial cells were incubated with different recombinant EGFR ligands for 16 h. Samples were processed by Northern blot to analyse SP-B and SP-C mRNA expression. As shown in Fig. 1A, incubation with amphiregulin (AR), epiregulin (EPR) or betacellulin (BTC) did not change SP-B/SP-C gene expression when compared to vehicle samples. In contrast, the addition of HB-EGF or TGF-? clearly increased SP-B and SP-C mRNA expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "19237431"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 40,
      "target": 77,
      "key": "42f38dffeb36efaa5513924970b9beab"
    },
    {
      "line": 223,
      "relation": "directlyIncreases",
      "evidence": "In an airway epithelial cell line (NCI-H292), TNF-alpha-converting enzyme (TACE) small interfering RNA (siRNA) was used to confirm that TACE is the MP involved in TLR (2,3,5,6)-ligand-induced IL-8 and VEGF production. We show that transforming growth factor (TGF)-alpha is the EGFR ligand in this signaling cascade by using TGF-alpha neutralizing antibody and by showing that epithelial production of TGF-alpha occurs in response to TLR ligands.",
      "citation": {
        "db": "PubMed",
        "db_id": "18375743"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 40,
      "target": 77,
      "key": "d2890d30655ccdca9117f5b1110f0914"
    },
    {
      "line": 223,
      "relation": "directlyIncreases",
      "evidence": "The ErbB family of four receptor tyrosine kinases occupies a central role in a wide variety of biological processes from neuronal development to breast cancer. New information continues to expand their biologic significance and to unravel the molecular mechanisms that underlie the signaling capacity of these receptors. Here, we review several aspects of ErbB receptor physiology for which new and significant information is available.",
      "citation": {
        "db": "PubMed",
        "db_id": "17085050"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 40,
      "target": 77,
      "key": "68dd5b5d036ed1920eb4d588eae929ac"
    },
    {
      "line": 223,
      "relation": "directlyIncreases",
      "evidence": "EGFR and its ligands EREG, AREG, DTR (HB-EGF), and TGFA",
      "citation": {
        "db": "PubMed",
        "db_id": "19138943"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 40,
      "target": 77,
      "key": "b3c9d7813c6538e38535cb38ba802bde"
    },
    {
      "line": 223,
      "relation": "directlyIncreases",
      "evidence": "Both EGFR and GRPR are activated in NSCLC by their corresponding ligands, TGF-a and GRP, in an autocrine manner.",
      "citation": {
        "db": "PubMed",
        "db_id": "15967120"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 40,
      "target": 77,
      "key": "d3cadd36ffa59ca65b4c1d6f3ab6baf7"
    },
    {
      "line": 223,
      "relation": "directlyIncreases",
      "evidence": "Transforming growth factor (TGF)-alpha is a ligand for the epidermal growth factor receptor (EGFR).",
      "citation": {
        "db": "PubMed",
        "db_id": "19244201"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 40,
      "target": 77,
      "key": "9820be62150add1479770d82595d0328"
    },
    {
      "line": 223,
      "relation": "directlyIncreases",
      "evidence": "MMP-7 activates the epidermal growth factor (EGF) receptor by releasing an EGF ligand, tumor growth factor (TGF)-alpha.",
      "citation": {
        "db": "PubMed",
        "db_id": "15623600"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 40,
      "target": 77,
      "key": "aeb6f2c653a9de5f1beebd22814914a4"
    },
    {
      "line": 53,
      "relation": "directlyIncreases",
      "evidence": "P/CAF potentiated the transcriptional activity of heterologous Gal4-Smad2 and Gal4-Smad3 fusion proteins. In addition, P/CAF potentiated the TGF-beta/Smad3-induced transcriptional responses, which could be further enhanced by co-activators p300 and Smad4.",
      "citation": {
        "db": "PubMed",
        "db_id": "11058129"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 43,
      "target": 129,
      "key": "821b595f1764d6bb0b5d0624a52eeadf"
    },
    {
      "line": 127,
      "relation": "increases",
      "evidence": "TGF-beta led to activation of Smad2/3, p38, p42/44, and c-Jun NH2-terminal kinase (JNK) pathways, assessed by phosphorylation, immunofluorescence, and reporter gene analysis. TGF-beta-dependent growth inhibition was specifically attenuated by pharmacological blockade of the TGF-beta type I receptor (TbetaRI) kinase or p38 mitogen-activated protein kinase pathways, whereas blockade of p42/44 or JNK kinases did not influence the effect of TGF-beta. TbetaRI kinase inhibition blocked all downstream pathways including Smad and p38 phosphorylation",
      "citation": {
        "db": "PubMed",
        "db_id": "16120811"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 43,
      "target": 26,
      "key": "3d2c7cadb343e7f4878bb84b2554a502"
    },
    {
      "line": 184,
      "relation": "directlyIncreases",
      "evidence": "P/CAF potentiated the transcriptional activity of heterologous Gal4-Smad2 and Gal4-Smad3 fusion proteins. In addition, P/CAF potentiated the TGF-beta/Smad3-induced transcriptional responses, which could be further enhanced by co-activators p300 and Smad4.",
      "citation": {
        "db": "PubMed",
        "db_id": "11058129"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 43,
      "target": 128,
      "key": "0a614c0835dcc544225d2e9eb2d1358c"
    },
    {
      "line": 332,
      "relation": "increases",
      "evidence": "Suppression of TÎ²R1 by the pharmacological inhibitor (SB431542) markedly reduced VEGF release by HFL-1 in response to CSE and this effect was confirmed by TÎ²R1 siRNA.",
      "citation": {
        "db": "Other",
        "db_id": "23618901"
      },
      "annotations": {},
      "source": 43,
      "target": 50,
      "key": "6c723b92515018dd2d1b0dfaee5e99c0"
    },
    {
      "line": 21,
      "relation": "increases",
      "evidence": "Through binding to the TGF-beta type II receptor, TGF-beta can activate two distinct type I receptors (ALK1 and ALK5) in endothelial cells",
      "citation": {
        "db": "PubMed",
        "db_id": "16595794"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 44,
      "target": 61,
      "key": "04d2841a4cb8f6ed4f58a2d74b0c7958"
    },
    {
      "line": 61,
      "relation": "directlyIncreases",
      "evidence": "These proteins signal by stimulating formation of specific heteromeric complexes of type I and type II serine/threonine kinase receptors. The type II receptors are encoded by five known mammalian genes, bind to ligands, and phosphorylate and activate the type I receptors, of which there are seven mammalian members (Fig. 1).",
      "citation": {
        "db": "PubMed",
        "db_id": "11792802"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 44,
      "target": 43,
      "key": "d84bb462ef24d7f1c015a3413d4dfb9f"
    },
    {
      "line": 196,
      "relation": "decreases",
      "evidence": "Tyrosine kinase with immunoglobulin and epidermal growth factor homology domains (Tie-1) is a receptor tyrosine kinase that regulates angiogenesis and antiapoptotic survival signaling.",
      "citation": {
        "db": "PubMed",
        "db_id": "12853700"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 45,
      "target": 6,
      "key": "6c9da1c2f1abfa1ccc62863d4778e7ff"
    },
    {
      "line": 324,
      "relation": "decreases",
      "evidence": "TIMP-2 is a better inhibitor of MT1-MMP. MT3-MMP requires TIMP-2 to accomplish full pro-MMP-2 activation",
      "citation": {
        "db": "Other",
        "db_id": "14681236"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 46,
      "target": 137,
      "key": "56470b6fc13a8dae653a250f81259b3a"
    },
    {
      "line": 147,
      "relation": "increases",
      "evidence": "CONCLUSION: TNX interacts with VEGF-B and enhances the ability of VEGF-B to stimulate cell proliferation. This enhanced mitogenecity is caused by increased signals mediated by the VEGFR-1 receptor.",
      "citation": {
        "db": "PubMed",
        "db_id": "11122379"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 47,
      "target": 99,
      "key": "02c20acfb2d6a06cc54c1cb8aa469bb7"
    },
    {
      "line": 22,
      "relation": "increases",
      "evidence": "Further results showed that VEGFA induced the activation of JNK/SAPK, p38 kinase and extracellular signal-regulated kinases 1 and 2 (ERK1/2), while JNK/SAPK inhibitor SP600125 and specific siRNA both blocked all those angiogenic effects induced by VEGFA.",
      "citation": {
        "db": "PubMed",
        "db_id": "22592917"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 26,
      "key": "fd98c03df62d1153ef93e804f6200d0f"
    },
    {
      "line": 57,
      "relation": "increases",
      "evidence": "an important mechanism through which VEGF could induce prolonged NO production is increased expression of eNOS mRNA and protein the mechanism mediating VEGF-stimulated eNOS expression is unclear, but the effect appears to occur via activation of VEGFR2",
      "citation": {
        "db": "PubMed",
        "db_id": "11350732"
      },
      "annotations": {},
      "source": 50,
      "target": 141,
      "key": "9a2b1f05caa2c610dd20a3133bc43703"
    },
    {
      "line": 203,
      "relation": "directlyIncreases",
      "evidence": "The beta3 integrin is necessary for the activation of PI 3-kinase in endothelial cells stimulated by VEGF-A165  PI 3-kinase belongs to the intracellular signals triggered by VEGF-A in bovine endothelial cells, as demonstrated by the phosphorylation of its regulatory protein p85 (Guo et al., 1995). As shown in Figure 5, wortmannin used at nanomolar concentrations specific for PI 3-kinase inhibition (Arcaro and Wymann, 1993), reduced the human endothelial cells migration induced by VEGF-A165. To determine whether beta3 integrin interferes in PI 3-kinase activation occurring after VEGFR-2 stimulation, we evaluated the effect of BV4 (anti-beta3 subunit mAb) on the phosphorylation in tyrosine residues of the p85 subunit and on the catalytic activity of the enzyme. After pre-incubation with BV4 or with anti-VEGFR-2 Ab for 20 min at 4Â°C, cells were stimulated with VEGF-A165. Cell lysates were immunoprecipitated with anti-p85 mAb, and the separated proteins by SDSâ€“PAGE were probed with anti-phosphotyrosine mAb. VEGF-A165 increased the tyrosine phosphorylation of p85, but it failed to phosphorylate the PI 3-kinase subunit when endothelial cells were pre-incubated with anti-beta3 or anti-VEGFR-2 antibodies (Figure 6).",
      "citation": {
        "db": "PubMed",
        "db_id": "10022831"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 122,
      "key": "41ed6e167dc21a63389f78ddde7b9a3b"
    },
    {
      "line": 203,
      "relation": "directlyIncreases",
      "evidence": "VEGF levels are also regulated by tissue oxygen tension. Exposure to hypoxia induces VEGF expression rapidly and reversibly, through both increased transcription and stabilization of the mRNA (108, 162).",
      "citation": {
        "db": "PubMed",
        "db_id": "11172729"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 122,
      "key": "2e0d86fa879f8991bd72a094535d8f52"
    },
    {
      "line": 203,
      "relation": "directlyIncreases",
      "evidence": "Herein we demonstrate that activation of NFATc1 in human pulmonary valve endothelial cells is specific to vascular endothelial growth factor (VEGF) signaling through VEGF receptor 2. VEGF-induced (VEGF165) NFATc1 nuclear translocation was inhibited by either cyclosporin A or a calcineurin-specific peptide inhibitor;",
      "citation": {
        "db": "PubMed",
        "db_id": "12427739"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 122,
      "key": "bc8935cebeee01b8303611d918874f35"
    },
    {
      "line": 203,
      "relation": "directlyIncreases",
      "evidence": "from full text - All VEGF-A isoforms bind to both VEGFR-1 and VEGFR-2, whereas PlGF and VEGF-B are selective ligands for VEGR-1.  VEGF-C and VEGF-D interact with both VEGFR-3 and VEGFR-2, whereas VEGF-E is a selective ligand for VEGFR-2 (VEGFR1=FLT1, VEGFR2=KDR, VEGFR3=FLT4, VEGFD=FIGF, VEGFE is virus-dervied, so not scripted)",
      "citation": {
        "db": "PubMed",
        "db_id": "16835467"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 122,
      "key": "bda3e3c69346a596156afc045521fda2"
    },
    {
      "line": 203,
      "relation": "directlyIncreases",
      "evidence": "VEGF-A, the prototype VEGF ligand, binds and activates two tyrosine kinase receptors: VEGFR1 (Flt-1) and VEGFR2 (KDR/Flk-1).",
      "citation": {
        "db": "PubMed",
        "db_id": "16336962"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 122,
      "key": "2d9e98db00c866fa6f7441e9bdc0f635"
    },
    {
      "line": 203,
      "relation": "directlyIncreases",
      "evidence": "as well as VEGFA, other VEGF-family members are produced by human tumors, including VEGFC and VEGFD, which both bind to VEGFR2 and activate many of the same pathways as VEGFA",
      "citation": {
        "db": "PubMed",
        "db_id": "12778130"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 122,
      "key": "d5d9d3a114b91e4ac49f99d4cc58982d"
    },
    {
      "line": 203,
      "relation": "directlyIncreases",
      "evidence": "once bound to its receptor, VEGF initiates an intracellular signaling cascade that leads to changes in expression of the gene that promote endothelial cell migration and proliferation",
      "citation": {
        "db": "PubMed",
        "db_id": "12793895"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 122,
      "key": "c5638854d9de4a55b844452896f12607"
    },
    {
      "line": 203,
      "relation": "directlyIncreases",
      "evidence": "Pharmacological intervention with a VEGFR-2-neutralizing Ab (anti-Flk1 mAb) abolished the production of IL-6 (but not IL-12p70) and the subsequent development of allergen-specific Th17 cell response.",
      "citation": {
        "db": "PubMed",
        "db_id": "20921519"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 122,
      "key": "29b6c163718b8a4eb5346c5be23a59c1"
    },
    {
      "line": 203,
      "relation": "directlyIncreases",
      "evidence": "VEGF actions are mediated through binding to 2 receptor tyrosine kinases, VEGFR1 (FLT1) and VEGFR2 (KDR)",
      "citation": {
        "db": "PubMed",
        "db_id": "15178810"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 122,
      "key": "aebc58ee40760dc7a41d0177c0661d3e"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "In vitro, VEGF stimulates ECM degradation, proliferation, migration and tube formation of endothelial cells and induces in these cells the expression of uPA, PAI-1, uPAR and MMP-1 (148, 182, 183, 243). In vivo, VEGF has been shown to regulate vascular permeability, which is considered important for the initiation of angiogenesis (57).",
      "citation": {
        "db": "PubMed",
        "db_id": "11172729"
      },
      "annotations": {},
      "source": 50,
      "target": 5,
      "key": "95f1895ef8688edbf29796d588412668"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "In human endothelial tumors like angiosarcoma or in hemangiomas where the vascular structures are profoundly altered, VE-cadherin is poorly expressed or is frequently misplaced from cell-cell contacts (1).  In addition, endothelial cells differentiating in vitro from embryonic stem cells in which VE-cadherin gene has been inactivated form cell aggregates but are unable to organize vascular structures (D. Vittet, T. Bouchou, E. Dejana, and P. Huber manuscript in preparation). These observations indirectly suggest that VE-cadherin and adherens junctions in general contribute to a correct vascular morphogenesis, but the question of what mechanisms are responsible for the process remains unanswered.  To form new vessels endothelial cells need to detach from the vascular wall, invade the underlying tissues, and then form tubes which branch and organize into extensive anastomotic networks. This process is complex and involves not only endothelial cell proliferation and migration but also cell-cell and cell-matrix adhesion, proteolytic remodeling of the matrix and changes in integrin expression. These activities need to be strictly controlled for a normal development of the vascular network. For instance, if endothelial cell proliferation or matrix proteolysis is not balanced, the vasculature becomes abnormal with the formation of vascular malformations.  Our hypothesis is that VE-cadherin and adherens junctions in general, may play a role in vascular remodeling by controlling and limiting endothelial cell migration and growth and possibly other specific endothelial cell functions.  During the first steps of angiogenesis, junctions need to become looser to let cells migrate and invade the underlying tissues. Since VE-cadherin inhibits cell migration from a monolayer (13), endothelial cell detachment from neighboring cells should be preceded by inactivation of VE-cadherin and adherens junctions in general. Indeed, in other types of cells, growth factors such as epithelial growth factor (EGF) and hepatocyte growth factor (HGF) induce tyrosine phosphorylation of adherens junctions components(19) and this effect is related to their cell scattering activity. Angiogenic factors as vascular endothelial growth factor (VEGF) act in a similar way inducing tyrosine phosphorylation of adherens junctions to allow endothelial cell motility (S. Esser, E. Dejana and W. Risau, manuscript in preparation). Interestingly, VEGF is known to increase endothelial cell permeability, and this effect may reflect, at least in part, a weakening of intercellular junctions.",
      "citation": {
        "db": "PubMed",
        "db_id": "9413393"
      },
      "annotations": {},
      "source": 50,
      "target": 5,
      "key": "d4bd215e90ded98cd3e5109de411d067"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "Effects of hypoxia on molecular determinants of angiogenesis Angiogenesis is a complex process, involving multiple gene products expressed by different cell types, all contributing to an integrated sequence of events44. Consistent with a major role for hypoxia in the overall process, a large number of genes involved in different steps of angiogenesis are independently responsive to hypoxia in tissue culture. Examples include nitric oxide synthases involved in governing vascular tone, growth factors such as VEGF, angiopoietins, fibroblast growth factors and their various receptors, and genes involved in matrix metabolism, including matrix metalloproteinases, plasminogen activator receptors and inhibitors, and collagen prolyl hydroxylase16, 17, 18, 19, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61 (Table 1). Similarly, many of the individual phenotypic processes in angiogenesis such as cell migration or endothelial tube formation can be induced by hypoxic tissue culture62, 63, 64. These analyses in isolated systems have sometimes apparently shown both positive and negative effects of hypoxia, for instance on endothelial proliferation65, 66, 67. It is not yet clear whether such phenomena reflect fundamentally different responses based on severity of hypoxia, or counter-regulatory controls that are normally integrated in a productive way.",
      "citation": {
        "db": "PubMed",
        "db_id": "12778166"
      },
      "annotations": {},
      "source": 50,
      "target": 5,
      "key": "b2a65ef9c22dcc90a12a9f976a75decb"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "The effect of ESM on TNF-alpha induced endothelial permeability and redistribution of VE-cadherin is likely due to a reduction of VEGF protein expression as a result of modulation of the ERK signaling pathway.",
      "citation": {
        "db": "PubMed",
        "db_id": "16039554"
      },
      "annotations": {},
      "source": 50,
      "target": 5,
      "key": "041e212cae6600e212989f345fdf35f1"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "The percentage of endothelial-precursor-cell incorporation is generally low and depends on the nature of the tumour, supporting the concept that most tumour neovascularization seems to occur via angiogenesis.However, in some model systems, tumours are reliant on endothelial- precursor-cell mobilization18 (FIG. 2).High levels of VEGFA expression alone are capable of initiating angiogenesis in a quiescent vasculature, and the steps and morphological changes that follow from the early formation of 'mother vessels' through maturation have been characterized22. The earliest stages are defined by vasodilation and an increased vascular permeability of pre-existing capillaries, or post-capillary venules, in response to VEGF. This allows extravasation of plasma proteins, which lay down a provisional matrix on which activated endothelial cells migrate.",
      "citation": {
        "db": "PubMed",
        "db_id": "12778130"
      },
      "annotations": {},
      "source": 50,
      "target": 5,
      "key": "29d0bf84bf67cdc597bad8b3edc2b82b"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "Because thrombin cleavage of OPN results in substantial enhancement of OPN's adhesive properties, and because VPF/VEGF promotes increased microvascular permeability leading to activation of the extrinsic coagulation pathway, we also investigated whether VPF/VEGF facilitates thrombin cleavage of OPN in vivo.",
      "citation": {
        "db": "PubMed",
        "db_id": "8686754"
      },
      "annotations": {},
      "source": 50,
      "target": 5,
      "key": "528c3a691185e76dd6ab8eeaffbb9cb0"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "consistent with a role in the regulation of vascular permeability, VEGF induces endothelial fenestration in some vascular beds and in cultured adrenal endothelial cells",
      "citation": {
        "db": "PubMed",
        "db_id": "15294883"
      },
      "annotations": {},
      "source": 50,
      "target": 5,
      "key": "5178b7910922c3dc829ade93ee3d78dc"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "VEGF/VPF and positive controls (platelet-activating factor [PAF], histamine, and bradykinin) all increased vascular permeability.",
      "citation": {
        "db": "PubMed",
        "db_id": "9443437"
      },
      "annotations": {},
      "source": 50,
      "target": 5,
      "key": "b3b3082556ca9d7e25587aebe765ec21"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "Enhanced gene and protein expression of VEGF may contribute to increased permeability of blood vessels. AQ4, a water transporting protein, is upregulated in astrocytes in hypoxia suggesting the cells are involved in edema formation.",
      "citation": {
        "db": "PubMed",
        "db_id": "16977604"
      },
      "annotations": {},
      "source": 50,
      "target": 5,
      "key": "e5e73f2572f7d5a968d6403a4ef57e5b"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "Knocking down ESAM expression in endothelial cells resulted in reduced levels of activated Rho, a GTPase implicated in the destabilization of tight junctions. Indeed, vascular permeability stimulated by vascular endothelial growth factor was reduced in ESAM(-/-) mice.",
      "citation": {
        "db": "PubMed",
        "db_id": "16818677"
      },
      "annotations": {},
      "source": 50,
      "target": 5,
      "key": "01b25b04f805d20adf50fd1f085e3e42"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "other actions of VEGF include increasing vascular permeability, inhibition of dendritic cell differentiation, upregulation of hexose transport into endothelial cells, induction of tissue factor, and induction of monocyte migration",
      "citation": {
        "db": "PubMed",
        "db_id": "15178810"
      },
      "annotations": {},
      "source": 50,
      "target": 5,
      "key": "87eac20dc6f27bd295df95f85b9fc744"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "VEGF increased P(a) in both isolated coronary venules and CVEC monolayers.",
      "citation": {
        "db": "PubMed",
        "db_id": "16627366"
      },
      "annotations": {},
      "source": 50,
      "target": 5,
      "key": "c58df5024599398f119ba0caac702aa1"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "Stimuli like histamine, atrial natriuretic factor, or thrombin, induce a rapid and short-lived increase in vascular permeability while others like cytokines or VEGF induce a sustained response. Most of these agonists are produced in acute or chronic inflammatory situations.",
      "citation": {
        "db": "PubMed",
        "db_id": "12891700"
      },
      "annotations": {},
      "source": 50,
      "target": 5,
      "key": "20f32f2e40e47bc4328543c1379f5392"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "VPF could be a mediator of the high permeability of tumor blood vessels",
      "citation": {
        "db": "PubMed",
        "db_id": "15294883"
      },
      "annotations": {},
      "source": 50,
      "target": 5,
      "key": "faa8b682a927741ec482f3ef3d589cf2"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "Furthermore, studies have demonstrated that vascular permeability induced by VEGF was mediated by PAF synthesis (26) and that VEGF-A stimulates PAF synthesis in endothelial cells",
      "citation": {
        "db": "PubMed",
        "db_id": "14715700"
      },
      "annotations": {},
      "source": 50,
      "target": 5,
      "key": "655bb78d8d5a47703165e7e1eea5c7cf"
    },
    {
      "line": 237,
      "relation": "directlyIncreases",
      "evidence": "Both ERK activation and fibronectin secretion appear to be mediated through the VEGF receptor flt-1, as evidenced by the effects of the flt-1-specific ligand placenta growth factor.",
      "citation": {
        "db": "PubMed",
        "db_id": "14633511"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 99,
      "key": "27bcb6cda99acedfb674bf2e60cbc3c2"
    },
    {
      "line": 237,
      "relation": "directlyIncreases",
      "evidence": "once bound to its receptor, VEGF initiates an intracellular signaling cascade that leads to changes in expression of the gene that promote endothelial cell migration and proliferation",
      "citation": {
        "db": "PubMed",
        "db_id": "12793895"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 99,
      "key": "12437ec32f4f74a8ebe1e1995e85110e"
    },
    {
      "line": 237,
      "relation": "directlyIncreases",
      "evidence": "VEGF levels are also regulated by tissue oxygen tension. Exposure to hypoxia induces VEGF expression rapidly and reversibly, through both increased transcription and stabilization of the mRNA (108, 162).",
      "citation": {
        "db": "PubMed",
        "db_id": "11172729"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 99,
      "key": "414f72665b82c7243cf7ed9bbfa65f47"
    },
    {
      "line": 237,
      "relation": "directlyIncreases",
      "evidence": "We have shown recently that Flt-1 VEGFR is expressed in the human MM cell line and patient MM cells and is tyrosine-phosphorylated upon VEGF stimulation",
      "citation": {
        "db": "PubMed",
        "db_id": "11751905"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 99,
      "key": "cfaa79f544a66ae9da02f6d79f72e24e"
    },
    {
      "line": 237,
      "relation": "directlyIncreases",
      "evidence": "VEGF actions are mediated through binding to 2 receptor tyrosine kinases, VEGFR1 (FLT1) and VEGFR2 (KDR)",
      "citation": {
        "db": "PubMed",
        "db_id": "15178810"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 99,
      "key": "9418376a835514d1996649bead2d1aa0"
    },
    {
      "line": 237,
      "relation": "directlyIncreases",
      "evidence": "VEGF-A, the prototype VEGF ligand, binds and activates two tyrosine kinase receptors: VEGFR1 (Flt-1) and VEGFR2 (KDR/Flk-1).",
      "citation": {
        "db": "PubMed",
        "db_id": "16336962"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 99,
      "key": "001e8bf312cf7e8d6fea928ecd6c9aad"
    },
    {
      "line": 237,
      "relation": "directlyIncreases",
      "evidence": "from full text - All VEGF-A isoforms bind to both VEGFR-1 and VEGFR-2, whereas PlGF and VEGF-B are selective ligands for VEGR-1.  VEGF-C and VEGF-D interact with both VEGFR-3 and VEGFR-2, whereas VEGF-E is a selective ligand for VEGFR-2 (VEGFR1=FLT1, VEGFR2=KDR, VEGFR3=FLT4, VEGFD=FIGF, VEGFE is virus-dervied, so not scripted)",
      "citation": {
        "db": "PubMed",
        "db_id": "16835467"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 99,
      "key": "db32fdbe26d08f84034b5e627673ac86"
    },
    {
      "line": 331,
      "relation": "association",
      "evidence": "The ability of lung fibroblasts to produce VEGF may play a role in pathogenesis of cigarette smoke induced lung disease.",
      "citation": {
        "db": "Other",
        "db_id": "23618901"
      },
      "annotations": {},
      "source": 50,
      "target": 167,
      "key": "2cf03436c83745f7fa38123da31608d3"
    },
    {
      "line": 314,
      "relation": "directlyIncreases",
      "evidence": "PIGF and VEGFB bind with high affinity only to VEGFR1",
      "citation": {
        "db": "PubMed",
        "db_id": "11350732"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 51,
      "target": 99,
      "key": "a787bf9eae033d89fbb8c108050ea981"
    },
    {
      "line": 314,
      "relation": "directlyIncreases",
      "evidence": "VEGF-B and PIGF binding and activating only VEGFR1",
      "citation": {
        "db": "PubMed",
        "db_id": "15178810"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 51,
      "target": 99,
      "key": "139d8d613e39142ca55cbc2ddf6331b8"
    },
    {
      "line": 314,
      "relation": "directlyIncreases",
      "evidence": "VEGF levels are also regulated by tissue oxygen tension. Exposure to hypoxia induces VEGF expression rapidly and reversibly, through both increased transcription and stabilization of the mRNA (108, 162).",
      "citation": {
        "db": "PubMed",
        "db_id": "11172729"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 51,
      "target": 99,
      "key": "a92f02544b255d98e9674616518990e2"
    },
    {
      "line": 314,
      "relation": "directlyIncreases",
      "evidence": "Nevertheless, we confirmed that VEGFR-1 mediated signaling by utilizing the VEGFR-1-specific ligand VEGF-B. Activated Erk-1/2 signaling was again observed in both L3.6pl and Panc-1 cells, with maximal stimulation at 3 minutes that decreased to baseline levels by 30 minutes (Fig. 3). No activation of Akt or JNK/SAPK signaling was detected (data not shown).",
      "citation": {
        "db": "PubMed",
        "db_id": "15952180"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 51,
      "target": 99,
      "key": "99ef6bba7181f9189df1721e4c5f474f"
    },
    {
      "line": 314,
      "relation": "directlyIncreases",
      "evidence": "VEGFa binds both VEGFR1 and VEGFR2 receptors, PlGF and VEGFb bind VEGFR1 and VEGFe binds VEGFR2. VEGFR3 is a receptor for VEGFs c and d (Veikkola and Alitalo, 1999).",
      "citation": {
        "db": "PubMed",
        "db_id": "10728593"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 51,
      "target": 99,
      "key": "fd5febd0682fdd37ad9dcc72a300152d"
    },
    {
      "line": 314,
      "relation": "directlyIncreases",
      "evidence": "from full text - All VEGF-A isoforms bind to both VEGFR-1 and VEGFR-2, whereas PlGF and VEGF-B are selective ligands for VEGR-1.  VEGF-C and VEGF-D interact with both VEGFR-3 and VEGFR-2, whereas VEGF-E is a selective ligand for VEGFR-2 (VEGFR1=FLT1, VEGFR2=KDR, VEGFR3=FLT4, VEGFD=FIGF, VEGFE is virus-dervied, so not scripted)",
      "citation": {
        "db": "PubMed",
        "db_id": "16835467"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 51,
      "target": 99,
      "key": "a2ad30f695f79d8a5cabffa73f26cedf"
    },
    {
      "line": 232,
      "relation": "directlyIncreases",
      "evidence": "HKa can potentially disrupt the binding of vitronectin to integrins that utilize vitronectin as ligand, such as avb3. As a result of either of these mechanisms, cells will not be able to adhere to vitronectin properly and will eventually undergo apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "15733059"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 54,
      "target": 12,
      "key": "f4be952297bb91c82647b44c40a2f0c9"
    },
    {
      "line": 312,
      "relation": "increases",
      "evidence": "We therefore propose that BAZF supports angiogenic sprouting via BAZF-CUL3-based polyubiquitination-dependent degradation of CBF1 to down-regulate Notch signaling",
      "citation": {
        "db": "PubMed",
        "db_id": "22279058"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 163,
      "target": 166,
      "key": "8bba229f3102077292baf9814502d1a0"
    },
    {
      "line": 59,
      "relation": "decreases",
      "evidence": "Surprisingly, we found that VEGF directly controls the expression of Plexin-D1, the receptor for the traditional repulsive axon guidance cue, semaphorin 3E (Sema3E). Sema3E-Plexin-D1 signaling then negatively regulates the activity of the VEGF-induced Delta-like 4 (Dll4)-Notch signaling pathway, which controls the cell fate decision between tip and stalk cells. Using the mouse retina as a model system, we show that Plexin-D1 is selectively expressed in endothelial cells at the front of actively sprouting blood vessels and its expression is tightly controlled by VEGF secreted by surrounding tissues.",
      "citation": {
        "db": "PubMed",
        "db_id": "21724832"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 165,
      "target": 21,
      "key": "b225de0096fdc967c01a0acfe76054a8"
    },
    {
      "line": 313,
      "relation": "directlyDecreases",
      "evidence": "We therefore propose that BAZF supports angiogenic sprouting via BAZF-CUL3-based polyubiquitination-dependent degradation of CBF1 to down-regulate Notch signaling",
      "citation": {
        "db": "PubMed",
        "db_id": "22279058"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 166,
      "target": 115,
      "key": "0434699183795291fbdb7e424b55b47b"
    },
    {
      "line": 23,
      "relation": "decreases",
      "evidence": "Activation of Robo4 by Slit2 inhibits vascular endothelial growth factor (VEGF)-165-induced migration, tube formation and permeability in vitro and VEGF-165-stimulated vascular leak in vivo by blocking Src family kinase activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "18345009"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 164,
      "target": 3,
      "key": "9a71b445775ec6b7f43178ec05704e39"
    },
    {
      "line": 7,
      "relation": "increases",
      "evidence": "Akt/phosphoinositide 3-kinase (PI3-kinase) pathway with LY294002 and wortmannin prevents the ability of ET-1 to induce alpha-SMA, ezrin, paxillin, and moesin and to promote matrix contraction.",
      "citation": {
        "db": "PubMed",
        "db_id": "15047866"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 159,
      "key": "8994c51731ae7d1ab3761388d3aeae87"
    },
    {
      "line": 199,
      "relation": "increases",
      "evidence": "Akt activation by VEGF and shear stress mediates phosphorylation of eNOS at serine 1179 to cause calcium independent NO generation",
      "citation": {
        "db": "PubMed",
        "db_id": "11350732"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 18,
      "target": 141,
      "key": "b117329336d834e88b5d0ee33e1c04d8"
    },
    {
      "line": 199,
      "relation": "increases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "11904450"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 18,
      "target": 141,
      "key": "493f6ebe72d55727e500c1174206cc41"
    },
    {
      "line": 199,
      "relation": "increases",
      "evidence": "phosphorylation of eNOS by AKT leads to increase endothelial NO release in a ligand-dependent manner corticosteroids activate PI3K and AKT",
      "citation": {
        "db": "PubMed",
        "db_id": "12682725"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 18,
      "target": 141,
      "key": "6a9cddbba87865aa59c960ac392ff15f"
    },
    {
      "line": 199,
      "relation": "increases",
      "evidence": "Phosphorylation of the serine-threonine kinase Akt, which activates eNOS",
      "citation": {
        "db": "PubMed",
        "db_id": "16142243"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 18,
      "target": 141,
      "key": "394dbb51207c762e935f379a626897b3"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "PKB/ Akt-dependent signaling controls many essential cellular processes such as cellular metabolism, transcription, cell proliferation, migration and survival [37,73,74]. PKB/Akt is believed to promote endothelial cell survival and angiogenesis via the phosphorylation and inactivation of the pro-apoptotic molecules Bad, Bax, caspase 9, and the Forkhead (FRKH) transcription factor [75], the stimulation of nitric oxide (NO) production [76,77], and the inhibition of the stressactivated kinases p38 and JNK [78].",
      "citation": {
        "db": "PubMed",
        "db_id": "14984767"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 6,
      "key": "5ef600ec34e6562a0aa86eaed6e7c200"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Serine 167 in AF1 is also phosphorylated, this time by the 90-kDa ribosomal S6 kinase RSK 89, which is itself activated by ERK1 and ERK2. Another signalling pathway that might have an important role in ER activity is the phosphatidylinositol- 3-OH kinase (PI3K) signalling pathway. The serine/threonine protein kinase AKT (or PKB) is one of the downstream targets of PI3K97. Its activation promotes cellular proliferation and anti-apoptotic responses. ER phosphorylation by AKT occurs at serine 167 and results in ligand-independent activation of ER98,99.",
      "citation": {
        "db": "PubMed",
        "db_id": "12635173"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 6,
      "key": "5445ee2136da2e5acc3d5669f15ff87e"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Cancer arises from a stepwise accumulation of genetic changes that liberates neoplastic cells from the homeostatic mechanisms that govern normal cell proliferation. In humans, at least four to six mutations are required to reach this state, but fewer seem to be required in mice. By rationalizing the shared and unique elements of human and mouse models of cancer, we should be able to identify the molecular circuits that function differently in humans and mice, and use this knowledge to improve existing models of cancer.",
      "citation": {
        "db": "PubMed",
        "db_id": "12044009"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 6,
      "key": "3896efc793d1792d8d191e0eb14efccb"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Cells producing Y353F ezrin are defective in activation of the protein kinase Akt, a downstream target of PI 3-kinase that protects cells against apoptosis. Furthermore, the apoptotic phenotype of these cells is rescued by production of a constitutively activated form of PI 3-kinase. Taken together, these results establish a novel function for ezrin in determining survival of epithelial cells by activating the PI 3-kinase/Akt pathway.",
      "citation": {
        "db": "PubMed",
        "db_id": "10377409"
      },
      "annotations": {
        "cl": {
          "0002518": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 6,
      "key": "2c5aa06f19b55cda8853ef3a03bc7615"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Recent studies have identified a direct interaction of Akt with Smad3 that prevents Smad3 phosphorylation and Smad3 nuclear translocation, and inhibits both Smad3- mediated transcriptional events and apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "15774796"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 6,
      "key": "3b3ba7724e7fd9658bc65227440454a2"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "To confirm these results, we infected BEAS-2B and BEAS-2B/NNK cells with adenoviruses expressing dominant- negative Akt. At lower doses of adenoviral infectivity, immortalized BEAS-2B cells underwent greater apoptosis than did BEAS-2B/NNK cells, but at the higher doses each cell type underwent apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "15136436"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 6,
      "key": "683e9fdcc307fb6d441a91d6f094cef9"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Once activated, Akt1 phosphorylates an ever increasing set of substrates, including proteins that block apoptosis, induce protein synthesis, gene transcription and cell proliferation [20,21].",
      "citation": {
        "db": "PubMed",
        "db_id": "12928036"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 6,
      "key": "78450c3a34ac7dcc6dc5b15b2f1ce38e"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "In general, survival signals are mediated by the phosphatidylinositol- 3-kinase (PI3K)/Akt pathway [57, 58] and the activated Akt pathway leads to survival of cancer cells through inhibition of apoptosis [59] (Fig. 2).",
      "citation": {
        "db": "PubMed",
        "db_id": "19663788"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 6,
      "key": "2d9ece51114f84d73e1dc8db05a3a4a1"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Under normal growth conditions, blocking PI3K/Akt signals by LY294002 causes LNCaP cell arrest in G1 phase rather than apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "16061480"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 6,
      "key": "0c4e86d2b0724befdc35dccbc06f9a91"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Phosphorylation of glycogen synthase kinase-3 (GSK-3) by Akt has also been reported to contribute to cell survival (36),",
      "citation": {
        "db": "PubMed",
        "db_id": "10409722"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 6,
      "key": "7e0dc059777d4fc78e1625e414562c73"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Indeed, activation of PKB in the absence of cytokines was sufficient to rescue cytokine-starved myrPKB:ER* cells from apoptosis, as measured by annexin V-FITC staining.",
      "citation": {
        "db": "PubMed",
        "db_id": "11815629"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 6,
      "key": "4ed786409d293bd294adc98faa3cb2e5"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Shc and FRS2 mediates recruitment of Grb2-SOS complexes leading to Ras/ERK stimulation, and of Grb2-GAB1/2 complexes leading to stimulation of the phosphatidylinositol-3-kinase (PI3K)/AKT pathway. ShcC and IRS are required to trigger PI3K/AKT activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "15583857"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 6,
      "key": "788384399212954a5832f8e218d8fae1"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "AKT signaling exerts a strong antiapoptotic effect through the phosphorylation and inhibition of key pro-apoptotic proteins, such as BAD, MDM2 and members of the Forkhead family (del Peso et al., 1997; Biggs et al., 1999; Brunet et al., 1999; Guo et al., 1999; Kops et al., 1999; Nakae et al., 1999; Rena et al., 1999; Takaishi et al., 1999; Tang et al., 1999; Mayo and Donner, 2001; Ashcroft et al., 2002).",
      "citation": {
        "db": "PubMed",
        "db_id": "18794886"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 6,
      "key": "e9b20ab2a8ca2436321bde2c3f47355b"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Phosphatidylinositol 3,4,5-triphosphate is involved in the activation of the anti-apoptotic effector target, Akt.",
      "citation": {
        "db": "PubMed",
        "db_id": "11799112"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 6,
      "key": "730225aacc544c64fe9e4d4ac272c649"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Serum deprived peripheral blood monocytes rapidly undergo apoptosis, but when co-cultured with human SMCs, the monocytes survive 51. This effect was found to be mediated by an increase in Bcl-2 expression and increased activity of the Akt and MAPK pathways. Furthermore, the effect was blocked by a neutralizing antibody to VCAM-1, suggesting that the VCAM-1/VLA4 interaction may be essential 51.",
      "citation": {
        "db": "PubMed",
        "db_id": "18276911"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 6,
      "key": "86d98d898660d5f150a32ed153f3ff9c"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Enforced expression of constitutively active MKK1 or AKT vectors could restore Rad51 protein levels, which were inhibited by erlotinib, and decrease erlotinib-induced cytotoxicity",
      "citation": {
        "db": "PubMed",
        "db_id": "19671683"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 6,
      "key": "8a74e007b2494ee6480882f7c1157883"
    },
    {
      "line": 114,
      "relation": "increases",
      "evidence": "As stated above, FGFs exert their biological activities by binding to high affinity tyrosine kinase FGFRs on the surface of target cells. In vitro, endothelial cells of different origin express FGFR1 [9,10] and, under some circumstances, FGFR2 [11] whereas the expression of FGFR3 or FGFR4 has never been reported in endothelium.",
      "citation": {
        "db": "PubMed",
        "db_id": "15863032"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 19,
      "target": 20,
      "key": "49127694fe01b1f48f636d7382d0e826"
    },
    {
      "line": 114,
      "relation": "increases",
      "evidence": "FGFs bind and activate alternatively spliced forms of four tyrosine kinase FGF receptors (FGFRs 1-4).",
      "citation": {
        "db": "PubMed",
        "db_id": "16597617"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 19,
      "target": 20,
      "key": "380649b2d98f16e00bef543081a013ae"
    },
    {
      "line": 32,
      "relation": "increases",
      "evidence": "Mutation of Lys650-->Glu in the activation loop of the FGFR3 kinase domain causes the lethal human skeletal disorder thanatophoric dysplasia type II (TDII) and is also found in patients with multiple myeloma, bladder and cervical carcinomas. This mutation leads to constitutive activation of FGFR3.  We show that the kinase domains of FGFR1, FGFR3, and FGFR4 containing the activation loop mutation, when targeted to the plasma membrane by a myristylation signal, can transform NIH3T3 cells and induce neurite outgrowth in PC12 cells. Phosphorylation of Shp2, PLC-gamma, and MAPK was also stimulated by all three 'TDII-like' FGFR derivatives. Additionally, activation of Stat1 and Stat3 was observed in cells expressing the activated FGFR derivatives. Finally, we demonstrate that FGFR1, FGFR3, and FGFR4 derivatives can stimulate PI-3 kinase activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "10918587"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 20,
      "target": 152,
      "key": "5c366e9358729e864493f5bcb1a4fbd4"
    },
    {
      "line": 32,
      "relation": "increases",
      "evidence": "Phospholipase Cgamma1 is expressed ubiquitously, especially in the brain, thymus and lungs. PLCgamma1 can be activated by receptor tyrosine kinases (i.e.: PDGFR, EGFR, FGFR, Trk), as well as non-receptor protein kinases (Src, Syk, Tec)",
      "citation": {
        "db": "PubMed",
        "db_id": "21918248"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 20,
      "target": 152,
      "key": "23d069c2d08e60cc15013e39e837e55b"
    },
    {
      "line": 32,
      "relation": "increases",
      "evidence": "Activation of FGF receptors can activate multiple signal transduction pathways including the phospholipase Cgamma, phosphatidyl inositol 3-kinase, mitogen-activated protein kinase and signal transducers and activators of transcription (STAT) pathways",
      "citation": {
        "db": "PubMed",
        "db_id": "15613447"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 20,
      "target": 152,
      "key": "68e9762a047f3da4f8a5ab5b77c37dc1"
    },
    {
      "line": 88,
      "relation": "increases",
      "evidence": "Heparin-DOCA inhibited capillary-like tubular structures of endothelial cells and bFGF-induced neovascularizations in Matrigel plug assays. Signaling experiments showed that heparin-DOCA significantly inhibited angiogenesis by suppressing the phosphorylation of FGFR and its downstream signal pathways (ERK and p38 MAPK activities)",
      "citation": {
        "db": "PubMed",
        "db_id": "17109210"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 20,
      "target": 26,
      "key": "786aec0b3984a4e339100b08f4dc9b81"
    },
    {
      "line": 56,
      "relation": "increases",
      "evidence": "Activation of the tyrosine kinase receptor vascular endothelial growth factor receptor 2 (VEGFR2) by VEGF leads to the activation of stress-activated protein kinase (SAPK)2/p38 and then to actin polymerization and reorganization into stress fibers in endothelial cells. In turn, this triggers endothelial cell migration",
      "citation": {
        "db": "PubMed",
        "db_id": "14724572"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 26,
      "target": 4,
      "key": "c7aa08ff61fdade8def7283299aaf1b8"
    },
    {
      "line": 56,
      "relation": "increases",
      "evidence": "Using pharmacological inhibitors, we further show that p38 MAPK and Akt signaling pathways are crucial for the ErbB2-induced MMP-9 up-regulation, invasion and migration of MCF10A cells",
      "citation": {
        "db": "PubMed",
        "db_id": "19022565"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 26,
      "target": 4,
      "key": "26d29c480cbb4a516120cdf5c81c5fd5"
    },
    {
      "line": 24,
      "relation": "increases",
      "evidence": "Phospholipase Cgamma1 is expressed ubiquitously, especially in the brain, thymus and lungs. PLCgamma1 can be activated by receptor tyrosine kinases (i.e.: PDGFR, EGFR, FGFR, Trk), as well as non-receptor protein kinases (Src, Syk, Tec)",
      "citation": {
        "db": "PubMed",
        "db_id": "21918248"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 23,
      "target": 152,
      "key": "2fcccce6468bfef7c4c5dc8fc8d342ff"
    },
    {
      "line": 29,
      "relation": "increases",
      "evidence": "(Jubilant) Treatment of suspended G0-synchonized NIH 3T3 cells with PDGF resulted in the activation of ERK2 as determined by tyrosine phosphorylation and gel-shift. ERK2 activation was rapid and maximal at 10 min and transient",
      "citation": {
        "db": "PubMed",
        "db_id": "7612963"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 23,
      "target": 133,
      "key": "144b4ac6fd86fc9559034acc5c9a8176"
    },
    {
      "line": 157,
      "relation": "increases",
      "evidence": "Phorbol myristate acetate (PMA) induces a protein kinase C (PKC)-dependent increase in bovine pulmonary EC permeability without significantly increasing MLC phosphorylation,",
      "citation": {
        "db": "PubMed",
        "db_id": "11568129"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 24,
      "target": 5,
      "key": "73cbd73a05ad18921a3093d8463fc9d3"
    },
    {
      "line": 194,
      "relation": "increases",
      "evidence": "The MAP kinase phosphorylation and cell proliferation were suppressed by diphenylene iodonium chloride, an NADPH oxidase inhibitor, and by calphostin C, a protein kinase C (PKC)-specific inhibitor.",
      "citation": {
        "db": "PubMed",
        "db_id": "16162162"
      },
      "annotations": {
        "cl": {
          "0000632": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 24,
      "target": 133,
      "key": "abbd04b3ede734d3d1e5a225e38496f1"
    },
    {
      "line": 194,
      "relation": "increases",
      "evidence": "Enzastaurin specifically inhibits TPA-triggered phosphorylation of signaling molecules downstream of PKC...enzastaurin inhibited TPA-induced phosphorylation of downstream PKCu/ PKD, MARCKS, GSK3b, JNK1/2, ERK1/2, and c-Myc, but did not inhibit phosphorylation of PDK-1, a signaling molecule upstream of PKC, which triggers activation loop phosphorylation of cPKCs and nPKCs",
      "citation": {
        "db": "PubMed",
        "db_id": "17023575"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 24,
      "target": 133,
      "key": "f61a41e49a01f5175a48a88eaf5e2322"
    },
    {
      "line": 194,
      "relation": "increases",
      "evidence": "These effects were completely prevented by calphostin C, a protein kinase C inhibitor.",
      "citation": {
        "db": "PubMed",
        "db_id": "11343241"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 24,
      "target": 133,
      "key": "36e0a5c23c13ecb788bc6df4677138f4"
    },
    {
      "line": 194,
      "relation": "increases",
      "evidence": "PLCG1-mediated production of diacylglycerol leads to activation of PKC, and this pathway plays an important role in mediating VEGF-induced activation of ERKs ERK activation mediates cytosolic PLA2-mediated PGI2 synthesis",
      "citation": {
        "db": "PubMed",
        "db_id": "11350732"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 24,
      "target": 133,
      "key": "c5c1750e5018b3f2cfe716dd99ec35e3"
    },
    {
      "line": 194,
      "relation": "increases",
      "evidence": "Together, the results demonstrate that OxPAPC induces TF expression in HUVECs through activation of PKC/ERK/EGR-1 and Ca(++)/calcineurin/NFAT pathways rather than by NF-kappa B-mediated transcription",
      "citation": {
        "db": "PubMed",
        "db_id": "11756172"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 24,
      "target": 133,
      "key": "044b4b972dc73fb41c8c95af1675ebb7"
    },
    {
      "line": 257,
      "relation": "increases",
      "evidence": "PLCG1-mediated production of diacylglycerol leads to activation of PKC, and this pathway plays an important role in mediating VEGF-induced activation of ERKs ERK activation mediates cytosolic PLA2-mediated PGI2 synthesis",
      "citation": {
        "db": "PubMed",
        "db_id": "11350732"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 24,
      "target": 134,
      "key": "015e12e071c6fbf2f754c9840e9fbbf4"
    },
    {
      "line": 257,
      "relation": "increases",
      "evidence": "These effects were completely prevented by calphostin C, a protein kinase C inhibitor.",
      "citation": {
        "db": "PubMed",
        "db_id": "11343241"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 24,
      "target": 134,
      "key": "a441f6b7e0496da787d2318104e2701f"
    },
    {
      "line": 257,
      "relation": "increases",
      "evidence": "The MAP kinase phosphorylation and cell proliferation were suppressed by diphenylene iodonium chloride, an NADPH oxidase inhibitor, and by calphostin C, a protein kinase C (PKC)-specific inhibitor.",
      "citation": {
        "db": "PubMed",
        "db_id": "16162162"
      },
      "annotations": {
        "cl": {
          "0000632": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 24,
      "target": 134,
      "key": "dc98d22afd38973e84bda8b3025d531b"
    },
    {
      "line": 257,
      "relation": "increases",
      "evidence": "Enzastaurin specifically inhibits TPA-triggered phosphorylation of signaling molecules downstream of PKC...enzastaurin inhibited TPA-induced phosphorylation of downstream PKCu/ PKD, MARCKS, GSK3b, JNK1/2, ERK1/2, and c-Myc, but did not inhibit phosphorylation of PDK-1, a signaling molecule upstream of PKC, which triggers activation loop phosphorylation of cPKCs and nPKCs",
      "citation": {
        "db": "PubMed",
        "db_id": "17023575"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 24,
      "target": 134,
      "key": "ff627be1978bcb3f2438a99c786c2ad8"
    },
    {
      "line": 257,
      "relation": "increases",
      "evidence": "Together, the results demonstrate that OxPAPC induces TF expression in HUVECs through activation of PKC/ERK/EGR-1 and Ca(++)/calcineurin/NFAT pathways rather than by NF-kappa B-mediated transcription",
      "citation": {
        "db": "PubMed",
        "db_id": "11756172"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 24,
      "target": 134,
      "key": "4add78ddfcb6d12a2facc039da069cc0"
    },
    {
      "line": 336,
      "relation": "directlyIncreases",
      "evidence": "These proteins signal by stimulating formation of specific heteromeric complexes of type I and type II serine/threonine kinase receptors. The type II receptors are encoded by five known mammalian genes, bind to ligands, and phosphorylate and activate the type I receptors, of which there are seven mammalian members (Fig. 1).",
      "citation": {
        "db": "PubMed",
        "db_id": "11792802"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 25,
      "target": 44,
      "key": "8f3a5608830c60b303db722cdac8831b"
    },
    {
      "line": 322,
      "relation": "decreases",
      "evidence": "In results, read the section \"eNOS immunostaining and eNOS gene and protein expressions\" and see the figure 2.\nRemember that eNOS is a alias of NOS3 (http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:7876)",
      "citation": {
        "db": "Other",
        "db_id": "24303177"
      },
      "annotations": {},
      "source": 167,
      "target": 141,
      "key": "8d3034f74d0cd4afe1897c443d8af250"
    },
    {
      "line": 326,
      "relation": "decreases",
      "evidence": "In humans, bronchiolar VEGF was significantly decreased in smokers with COPD compared to lifelong nonsmokers, as well as to smokers without COPD; however, there was no difference in bronchiolar VEGF levels between lifelong nonsmokers and smokers without COPD.",
      "citation": {
        "db": "Other",
        "db_id": "18300052"
      },
      "annotations": {},
      "source": 167,
      "target": 50,
      "key": "d31270ff0a9cddb2be873b8f84ce32b5"
    },
    {
      "line": 331,
      "relation": "association",
      "evidence": "The ability of lung fibroblasts to produce VEGF may play a role in pathogenesis of cigarette smoke induced lung disease.",
      "citation": {
        "db": "Other",
        "db_id": "23618901"
      },
      "annotations": {},
      "source": 167,
      "target": 50,
      "key": "eb3b6b3ce0b81c04cab9713e3798db46"
    },
    {
      "line": 334,
      "relation": "increases",
      "evidence": "We found that concentration of VEGF in blood serum of patients with COPD (189.9Â±16pg/ml) was significantly higher than the control group (16.4Â±3.48pg/ml) (p<0.001). Our results suggest VEGF serum concentration as the sensitive index for severity and activity of COPD and its prognosis.",
      "citation": {
        "db": "Other",
        "db_id": "25664286"
      },
      "annotations": {},
      "source": 167,
      "target": 50,
      "key": "20392298b7c3f69b33060bba4fe04a17"
    },
    {
      "line": 330,
      "relation": "increases",
      "evidence": "Biopsies from COPD patients had more (P < 0.001) Tn-C expression than the two control groups.",
      "citation": {
        "db": "Other",
        "db_id": "21496259"
      },
      "annotations": {},
      "source": 167,
      "target": 111,
      "key": "f161c86f79557df72451d1835986add3"
    },
    {
      "line": 38,
      "relation": "decreases",
      "evidence": "miR-34a impairs EPC-mediated angiogenesis by induction of senescence via inhibiting Sirt1",
      "citation": {
        "db": "PubMed",
        "db_id": "20424141"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 168,
      "target": 58,
      "key": "2fd7c8ef21460d0c84675010e3044f26"
    }
  ]
}